InterventionType,InterventionName_lower,Freq
,,920
Drug,placebo,399
Other,placebo,169
Drug,hydroxychloroquine,110
Biological,placebo,70
Other,no intervention,61
Other,standard of care,54
Biological,convalescent plasma,53
Drug,remdesivir,49
Drug,tocilizumab,41
Drug,azithromycin,40
Other,questionnaire,40
Drug,ivermectin,35
Drug,placebo oral tablet,32
Other,survey,31
Drug,favipiravir,29
Drug,standard of care,28
Drug,dexamethasone,21
Drug,nitazoxanide,18
Drug,methylprednisolone,18
Biological,covid-19 vaccine,18
Drug,enoxaparin,18
Dietary Supplement,placebo,17
Other,standard care,17
Drug,placebos,16
Drug,colchicine,16
Biological,bnt162b2,15
Other,data collection,14
Other,questionnaire administration,13
Drug,hydroxychloroquine sulfate,13
Other,usual care,13
Dietary Supplement,vitamin d,12
Drug,lopinavir/ritonavir,12
Biological,covid-19 convalescent plasma,11
Other,blood sample,11
Biological,mrna-1273,11
Drug,baricitinib,11
Drug,anakinra,11
Biological,blood sample,10
Drug,normal saline,10
Drug,ruxolitinib,10
Other,online survey,10
Diagnostic Test,nasopharyngeal swab,10
Drug,camostat mesilate,10
Diagnostic Test,lung ultrasound,10
Drug,losartan,9
Biological,azd1222,9
Other,questionnaires,9
Other,quality-of-life assessment,8
Other,blood sampling,8
Other,observational,8
Dietary Supplement,vitamin d3,8
Drug,rivaroxaban,8
Biological,gam-covid-vac,8
Other,standard of care (soc),8
Dietary Supplement,vitamin c,8
Biological,ad26.cov2.s,7
Drug,chloroquine,7
Biological,recombinant novel coronavirus vaccine (adenovirus type 5 vector),7
Drug,interferon beta-1a,7
Other,prone position,7
Drug,vitamin c,7
Other,saline,7
Drug,convalescent plasma,7
Drug,camostat,7
Drug,cholecalciferol,7
Other,covid-19,6
Procedure,biospecimen collection,6
Behavioral,questionnaire,6
Other,observation,6
Drug,oseltamivir,6
Drug,sarilumab,6
Drug,standard treatment,6
Drug,interferon beta-1b,6
Other,best practice,6
Drug,aspirin,6
Biological,mesenchymal stromal cells,6
Other,telerehabilitation,6
Drug,heparin,6
Drug,nafamostat mesilate,6
Other,control group,6
Biological,uc-mscs,6
Drug,das181,6
Drug,placebo administration,6
Drug,hydroxychloroquine (hcq),6
Other,questionnaire assesment,5
Drug,melatonin,5
Biological,saline,5
Other,interview,5
Biological,vir-7831,5
Other,online questionnaire,5
Drug,standard medical treatment,5
Other,telemedicine,5
Drug,prednisone,5
Drug,mavrilimumab,5
Biological,bcg vaccine,5
Drug,povidone-iodine,5
Drug,infliximab,5
Drug,clazakizumab,5
Drug,zinc,5
Drug,niclosamide,5
Drug,sargramostim,5
Biological,coronavac,5
Other,survey administration,5
Biological,covid-19 vaccines,5
Biological,ampion,5
Other,covid-19 pandemic,5
Diagnostic Test,rt-pcr,5
Biological,anti-sars-cov-2 convalescent plasma,5
Drug,fluvoxamine,5
Other,standard treatment,4
Drug,chloroquine or hydroxychloroquine,4
Biological,had5-s-fusion+n-etsd vaccine,4
Other,control,4
Drug,ascorbic acid,4
Drug,naltrexone,4
Drug,famotidine,4
Other,normal saline (0.9% sodium chloride solution) - stage 1,4
Diagnostic Test,blood sample,4
Other,exercise,4
Other,prone positioning,4
Radiation,low dose radiotherapy,4
Drug,opaganib,4
Drug,unfractionated heparin,4
Drug,hcq,4
Drug,hydroxychloroquine + azithromycin,4
Drug,tofacitinib,4
Drug,bamlanivimab,4
Biological,adsorbed covid-19 (inactivated) vaccine,4
Drug,soc,4
Drug,apixaban,4
Biological,cvncov vaccine,4
Drug,nitric oxide,4
Biological,covi-amg,4
Drug,azd7442,4
Other,other,4
Diagnostic Test,blood tests,4
Drug,lopinavir / ritonavir,4
Drug,ly3819253,4
Drug,standard of care (soc),4
Diagnostic Test,anti-sars-cov2 serology,4
Other,electronic health record review,4
Other,observational study,4
Other,pulmonary rehabilitation,4
Drug,rls-0071,4
Other,standard of care treatment,4
Device,transcranial direct current stimulation,4
Device,cellectra® 2000,4
Drug,acalabrutinib,4
Drug,colchicine tablets,4
Diagnostic Test,covid-19 rt-pcr,4
Drug,doxycycline,4
Drug,ivermectin tablets,4
Drug,proxalutamide,4
Drug,pirfenidone,4
Dietary Supplement,zinc,4
Drug,regn10933+regn10987 combination therapy,4
Procedure,prone position,4
Biological,inactivated sars-cov-2 vaccine (vero cell),4
Biological,sars-cov-2 convalescent plasma,4
Other,normal saline,4
Behavioral,behavioral intervention,4
Drug,dwrx2003,4
Drug,control,4
Procedure,prone positioning,3
Diagnostic Test,pcr,3
Drug,avigan 200 mg film tablets,3
Behavioral,survey,3
Drug,placebo (normal saline solution),3
Biological,convalescent plasma (cp),3
Device,coviage,3
Drug,standard therapy,3
Diagnostic Test,saliva collection,3
Biological,bnt162b1,3
Drug,selinexor,3
Drug,aerosolized 13 cis retinoic acid,3
Behavioral,blood donation sms,3
Other,phone call,3
Drug,telmisartan,3
Behavioral,prospective study with two measurement points investigating the impact of viral mitigation protocols on mental health,3
Diagnostic Test,ecg,3
Biological,covi-msc,3
Diagnostic Test,saliva sample,3
Other,data record,3
Drug,hydroxychloroquine sulfate 200 mg,3
Other,3d telemedicine,3
Drug,ibrutinib,3
Drug,hzvsf-v13,3
Other,exhaled breath sampling,3
Radiation,low dose radiation therapy,3
Drug,quercetin,3
Diagnostic Test,echocardiography,3
Drug,n-acetylcysteine,3
Drug,low molecular weight heparin,3
Drug,distilled water,3
Other,clinical data,3
Other,clinical assessment,3
Other,exposure,3
Biological,av-covid-19,3
Drug,methylprednisolone sodium succinate,3
Biological,chadox1 ncov-19,3
Drug,sodium bicarbonate,3
Drug,methotrexate,3
Biological,vpm1002,3
Biological,moderna covid-19 vaccine,3
Drug,cyclosporine,3
Drug,snpp protoporphyrin plus sunlight exposure,3
Drug,acetylsalicylic acid,3
Other,self-administered questionnaire,3
Drug,apixaban 2.5 mg,3
Drug,pulmozyme,3
Biological,tocilizumab,3
Drug,sng001,3
Biological,mesenchymal stem cell,3
Biological,rad26-s,3
Drug,vitamin d,3
Drug,slv213,3
Other,self supportive care (ssc) alone,3
Drug,niclosamide oral tablet,3
Drug,bcg vaccine,3
Drug,n-acetyl cysteine,3
Biological,bamlanivimab,3
Biological,recombinant new coronavirus vaccine (cho cells) placebo group,3
Drug,ly3832479,3
Behavioral,control,3
Drug,canakinumab,3
Other,0.9% saline,3
Device,splenic ultrasound,3
Drug,cannabidiol,3
Drug,matching placebo,3
Drug,at-527,3
Drug,povidone-iodine nasal spray and gargle,3
Procedure,blood sample,3
Procedure,blood sampling,3
Drug,leronlimab (700mg),3
Drug,oxygen,3
Other,,3
Drug,suspension of heat killed (autoclaved) mycobacterium w,3
Drug,colchicine 0.5 mg,3
Diagnostic Test,serology,3
Drug,ensovibep,3
Drug,ribavirin,3
Other,acupressure,3
Other,non-interventional,3
Drug,clopidogrel,3
Biological,bcg-denmark,3
Drug,chloroquine phosphate,3
Drug,remdesivir placebo,3
Dietary Supplement,vitamin super b-complex,3
Other,best supportive care,3
Drug,standard care,3
Drug,therapeutic anticoagulation,3
Other,human biological samples,3
Drug,atorvastatin,3
Drug,placebo inhalation,3
Biological,ub-612,3
Drug,ace inhibitor,3
Drug,interleukin-7,3
Drug,placebo intravenous,3
Drug,fostamatinib,3
Drug,corticosteroid,3
Diagnostic Test,sars-cov-2,3
Drug,hydrocortisone,3
Procedure,therapeutic plasma exchange,3
Drug,peginterferon lambda-1a,3
Drug,brii-196 and brii-198,3
Dietary Supplement,probiotic,3
Diagnostic Test,sars-cov-2 serology,3
Drug,nitric oxide gas,3
Behavioral,usual care,3
Diagnostic Test,blood test,3
Drug,placebo oral capsule,3
Drug,eidd-2801,3
Biological,ag0302-covid19,3
Radiation,phase 2,3
Drug,fisetin,3
Biological,ty027,3
Biological,dzif-10c,3
Diagnostic Test,spirometry,3
Drug,abatacept,2
Drug,thalidomide,2
Diagnostic Test,elisa,2
Diagnostic Test,elispot,2
Drug,50 mg/ml virazole,2
Combination Product,standard of care (soc),2
Drug,m5049,2
Biological,bbv152,2
Dietary Supplement,maltodextrin,2
Device,aerosol box,2
Device,aeonose,2
Drug,100 mg/ml virazole,2
Drug,standard covid-19 care,2
Drug,isoquercetin,2
Diagnostic Test,ct scan,2
Drug,0.9%sodium chloride,2
Drug,ivermectin pill,2
Drug,ivig,2
Other,routine care for covid-19 patients,2
Other,recop unit patient,2
Other,rehabilitation,2
Other,risk factors,2
Dietary Supplement,zinc gluconate,2
Drug,levamisole and isoprinosine,2
Combination Product,mw33 injection placebo,2
Combination Product,mw33 injection,2
Dietary Supplement,sivomixx (200 billion),2
Other,retrospective data collection,2
Drug,l-ascorbic acid,2
Drug,leronlimab,2
Drug,leflunomide,2
Other,retrospective analysis,2
Other,resistance exercise,2
Drug,lanadelumab,2
Drug,tacrolimus,2
Diagnostic Test,ct-scan,2
Biological,ag0301-covid19,2
Other,saline solution,2
Other,data collection and clinical testing of subjects,2
Drug,stc3141,2
Other,pulmonary ultrasound,2
Other,quality of life,2
Biological,vla2001,2
Other,electronic questionnaire,2
Drug,0.9% saline,2
Diagnostic Test,covid-19 serology,2
Other,data extraction from medical files,2
Other,sars-cov2 infection,2
Other,diagnostic laboratory biomarker analysis,2
Biological,anti-sars-cov-2 human convalescent plasma,2
Drug,lopinavir/ ritonavir,2
Drug,lopinavir-ritonavir,2
Drug,ivermectin and doxycycline,2
Other,education,2
Other,sample collection,2
Diagnostic Test,covid-19 test,2
Other,saliva collection,2
Biological,allocetra-ots,2
Drug,td-0903,2
Biological,eculizumab,2
Drug,simvastatin,2
Diagnostic Test,exercise capacity,2
Other,icu treatment,2
Diagnostic Test,sars-cov2 testing,2
Other,non interventional study,2
Other,non,2
Drug,regn10933+regn10987,2
Biological,saliva sample collection,2
Biological,saliva collection,2
Diagnostic Test,nasal swab,2
Biological,hyperimmune immunoglobulin to sars-cov-2 (hivig),2
Drug,paracetamol,2
Other,no interventions,2
Drug,recommended treatment schedule,2
Biological,sab-185,2
Biological,ruti® vaccine,2
Other,immunological profiling,2
Diagnostic Test,muscle ultrasound,2
Other,hyperimmune plasma,2
Biological,intramuscular vaccine,2
Drug,"resp301, a nitric oxide generating solution",2
Drug,olokizumab 64 mg,2
Diagnostic Test,serology test for covid-19,2
Diagnostic Test,serological testing,2
Biological,grad-cov2,2
Drug,resveratrol,2
Diagnostic Test,serological test,2
Biological,high dosage inactivated sars-cov-2 vaccine,2
Biological,human amniotic fluid,2
Biological,high dosage inactivated sars-cov-2 vaccine on a 0- and 28-day schedule,2
Drug,reparixin,2
Biological,sars-cov-2 inactivated vaccine,2
Diagnostic Test,mri,2
Other,normal saline (0.9% sodium chloride solution)- stage 2,2
Radiation,phase 1,2
Diagnostic Test,sars-cov-2 pcr,2
Diagnostic Test,sars-cov-2 diagnostic rapid test,2
Biological,biological data,2
Other,kb109 + self supportive care (ssc),2
Diagnostic Test,rapid diagnostic test vs pcr,2
Biological,mrna-1273.351,2
Biological,msc,2
Biological,placebo on a 0- and 28-day schedule,2
Diagnostic Test,pcr test,2
Other,meditation (1 x 20-minute guided audio training),2
Biological,nanocovax,2
Drug,pul-042 inhalation solution,2
Biological,placebo (0.9% normal saline),2
Diagnostic Test,pulmonary function tests,2
Diagnostic Test,pulmonary function test,2
Biological,novaferon,2
Drug,poly-iclc (hiltonol®) or placebo,2
Drug,plasma,2
Biological,plx-pad,2
Drug,placebo comparator,2
Biological,remestemcel-l,2
Biological,recombinant new coronavirus vaccine (cho cell) low-dose group,2
Biological,remdesivir,2
Other,no intervention (retrospective cohort observational),2
Drug,pentoxifylline,2
Biological,lenzilumab,2
Other,indicators of central sensitisation,2
Biological,recombinant new coronavirus vaccine (cho cells) high-dose group,2
Biological,low dosage inactivated sars-cov-2 vaccine on a 0- and 28-day schedule,2
Drug,placebo capsules,2
Drug,ravulizumab,2
Biological,recombinant covid-19 vaccine (sf9 cells),2
Radiation,radiation therapy,2
Biological,medium dosage inactivated sars-cov-2 vaccine,2
Biological,medium dosage inactivated sars-cov-2 vaccine on a 0- and 28-day schedule,2
Drug,pyronaridine-artesunate,2
Drug,ofatumumab,2
Diagnostic Test,serum testing,2
Drug,rivaroxaban 10 mg,2
Drug,montelukast,2
Other,practice details,2
Biological,"two doses of low dosage inactivated sars-cov-2 vaccine at the schedule of day 0,28",2
Drug,sofosbuvir,2
Diagnostic Test,flow cytometric analysis,2
Drug,molnupiravir,2
Drug,soc + placebo,2
Dietary Supplement,300 mg of omega3-fa,2
Biological,brii-196/brii-198,2
Other,placebo control,2
Other,placebo comparator,2
Other,placebo capsules,2
Drug,sirolimus,2
Drug,single dose of hydroxychloroquine,2
Biological,convalescent anti-sars-cov-2 mbt plasma,2
Dietary Supplement,bovine lactoferrin,2
Biological,"two doses of medium dosage inactivated sars-cov-2 vaccine at the schedule of day 0,28",2
Drug,nors (nitric oxide releasing solution),2
Biological,blood samples,2
Other,exercise & nutrition,2
Drug,matched placebo,2
Dietary Supplement,glycine,2
Biological,blood collection on admission and longitudinally,2
Biological,blood collection on their first consultation and 10 to 14 days later,2
Other,exercise brochure,2
Biological,blood sampling,2
Drug,metformin glycinate,2
Biological,blood test,2
Drug,sofosbuvir/daclatasvir,2
Drug,meplazumab for injection,2
Other,exercise training,2
Other,pregnant women with laboratory-confirmed 2019-n-cov,2
Drug,metformin,2
Biological,convalescent covid 19 plasma,2
Other,file scanning,2
Biological,convalescent plasma (anti-sars-cov-2 plasma),2
Drug,ruconest,2
Biological,scta01,2
Biological,cvncov,2
Diagnostic Test,stress levels and mental well-being assessment,2
Other,oxygen therapy,2
Drug,ruxolitinib oral tablet,2
Drug,nitrogen gas,2
Drug,nivolumab,2
Other,physiotherapy,2
Drug,rtb101,2
Other,additional biological samples,2
Biological,sars-cov-2 virus,2
Biological,epivaccorona (epivaccorona vaccine based on peptide antigens for the prevention of covid-19),2
Other,health supplements,2
Other,online questionnaires,2
Drug,nintedanib,2
Other,patient-reported online questionnaire on olfactory & taste disturbances,2
Biological,serology,2
Biological,covid-19 therapeutic biologics - spike-gm-csf protein lactated ringer's injection,2
Drug,scta01,2
Other,phone call interview,2
Biological,sputnik light,2
Biological,covid convalescent plasma,2
Drug,sevoflurane,2
Biological,covi-drops,2
Biological,coronovac vaccine,2
Other,physical exercise,2
Drug,silmitasertib,2
Other,follow up,2
Drug,siltuximab,2
Drug,silymarin,2
Biological,convalescent plasma from covid-19 donors,2
Drug,iodine complex,2
Drug,ivermectin oral product,2
Drug,abidol hydrochloride,2
Diagnostic Test,biosensor,2
Drug,control treatment schedule,2
Device,"taking blood samples (capillary and venous), saliva sampling and nasopharyngeal sampling.",2
Other,tele-yoga therapy,2
Diagnostic Test,blood sampling,2
Drug,txa127,2
Drug,enoxaparin 40 mg/0.4 ml injectable solution,2
Other,ayurveda,2
Other,telerehabilitation-based,2
Drug,hydroxychloroquine and azithromycin,2
Drug,hydroxychloroquine 200 mg oral tablet,2
Drug,hydroxychloroquine - weekly dosing,2
Drug,hydroxychloroquine - daily dosing,2
Diagnostic Test,biological sample collection,2
Drug,hydroxychloroquine sulfate 200 mg [plaquenil],2
Other,cohort,2
Behavioral,neurocognitive assessment,2
Drug,clevudine,2
Other,this is an online survey with no intervention.,2
Drug,human immunoglobulin,2
Device,transcranial direct-current stimulation,2
Diagnostic Test,binaxnow rapid antigen system,2
Drug,avigan,2
Drug,hormones,2
Drug,honey,2
Drug,exo 1 inhalation,2
Drug,ciclesonide,2
Procedure,mout-to-mouth ventilation,2
Procedure,mout-to-mouth ventilation with quantitative analysis,2
Procedure,peripheral blood draw,2
Drug,ebselen,2
Drug,icosapent ethyl,2
Drug,tranexamic acid,2
Other,supportive care,2
Behavioral,prone position,2
Drug,dwj1248,2
Procedure,ophthalmologic exam,2
Other,surgery,2
Drug,hyperbaric oxygen,2
Other,surgical mask,2
Drug,antithrombin iii,2
Diagnostic Test,breath test,2
Drug,early-dexamethasone,2
Drug,ec-18,2
Other,concert,2
Drug,eculizumab,2
Other,2d telemedicine,2
Behavioral,covid-19 pandemic,2
Drug,edp1815,2
Drug,apremilast,2
Drug,hydroxychloroquine sulfate tablets,2
Drug,hydroxychloroquine sulfate regular dose,2
Drug,hydroxychloroquine sulfate loading dose,2
Behavioral,covid-19 self-test,2
Drug,arb,2
Drug,arbidol,2
Behavioral,covid-19 test referral,2
Drug,exo 2 inhalation,2
Drug,veru-111,2
Drug,vir-7831,2
Drug,fuzheng huayu tablet,2
Drug,carrimycin,2
Device,lucira covid-19 all-in-one test kit,2
Procedure,blood draw,2
Diagnostic Test,6-minute walk test,2
Drug,bi 767551 intravenous,2
Other,blood samples,2
Drug,bicalutamide 150 mg oral tablet,2
Drug,camostat mesylate,2
Procedure,awake prone positioning,2
Device,volatile organic compounds analysis,2
Drug,c21,2
Other,blood test,2
Drug,bucillamine,2
Other,clinical examination,2
Device,ion mobility spectrometry (ims),2
Other,web based survey,2
Device,hyperbaric oxygen therapy,2
Device,hyperbaric oxygen therapy (hbot),2
Drug,fluoxetine,2
Other,breathing exercise,2
Behavioral,information,2
Device,vv-ecmo + cytokine adsorption (cytosorb adsorber),2
Other,canine odor detection of volatile organic compounds,2
Other,yoga,2
Device,vv-ecmo only (no cytokine adsorption),2
Drug,brequinar,2
Drug,bevacizumab injection,2
Drug,xav-19,2
Behavioral,interview,2
Device,high flow nasal cannula (hfnc),2
Drug,heparin sodium,2
Other,"two doses of placebo at the schedule of day 0,28",2
Drug,chloroquine sulfate,2
Drug,chloroquine diphosphate,2
Drug,azithromycin tablets,2
Behavioral,exercise training,2
Behavioral,mindfulness based intervention,2
Behavioral,expressive writing,2
Device,fit test,2
Behavioral,mindfulness,2
Drug,hb-admscs,2
Drug,baricitinib oral tablet,2
Diagnostic Test,antibody test,2
Drug,gx-i7,2
Drug,cenicriviroc,2
Drug,gx-19n,2
Behavioral,fear of covid-19 scale,2
Drug,guduchi ghan vati,2
Device,"magpro x100 stimulator, b70 fluid-cooled coil",2
Drug,bemiparin,2
Other,vehicle control,2
Other,venous ultrasound,2
Other,blood draw,2
Drug,best available treatment,2
Device,hfnc,2
Drug,duvelisib,2
Drug,convalescent plasma transfusion,2
Other,standard therapy,2
Other,soc,2
Device,seraph 100,2
Behavioral,attention placebo,2
Drug,deferoxamine,2
Device,breath biopsy face masks with removable filters and fitted pva strip,2
Drug,ambrisentan,2
Drug,tocilizumab (tcz),2
Other,covid-19 patients,2
Drug,tofacitinib 10 mg,2
Other,aerobic exercise training,2
Drug,doxycycline tablets,2
Drug,daclatasvir,2
Drug,acebilustat,2
Drug,covid-19 vaccine,2
Device,oxygen therapy,2
Drug,thymalfasin,2
Drug,tocilizumab injection,2
Drug,crizanlizumab,2
Drug,dexamethasone injection,2
Drug,alteplase 50 mg [activase],2
Behavioral,standard care,2
Drug,dose of tinzaparin or dalteparin,2
Procedure,stellate ganglion block,2
Behavioral,simple cognitive task intervention,2
Drug,dornase alfa inhalation solution [pulmozyme],2
Diagnostic Test,conjunctival swab,2
Behavioral,questionnaires,2
Procedure,prone positioning (pp),2
Drug,adg20,2
Drug,allocetra-ots,2
Other,covid-19 infection,2
Behavioral,assessment of behavioral response to emotional stimulation,2
Behavioral,assessment of work-related stress,2
Other,acute kidney injury,2
Device,nowdx covid-19 test,2
Diagnostic Test,coronary angiography,2
Drug,tinzaparin,2
Drug,angiotensin converting enzyme inhibitor,2
Other,standard treatment for covid-19,2
Drug,imu-838,2
Other,standard care therapy,2
Drug,angiotensin 1-7,2
Drug,ino-4800,2
Drug,cyproheptadine hydrochloride 4 mg,2
Behavioral,services as usual,2
Other,covid-19+ observational,2
Drug,disulfiram,2
Drug,angiotensin-(1-7),2
Drug,defibrotide,2
Drug,cyt107,2
Drug,prednisolone 5 mg,1
Drug,prednisolone,1
Drug,zyesami™ (aviptadil acetate),1
Other,acp decisions video program,1
Drug,zyesami (aviptadil acetate),1
Drug,ritonavir+oseltamivir,1
Other,"35 ml blood, 5 tubes lithium heparinate at each time (hospitalized patients )",1
Drug,zyil1 capsule,1
Other,a short video intervention,1
Drug,preservative-free saline,1
Genetic,covid-19 androgen sensitivity test (covast),1
Drug,rhdnase i,1
Drug,rhtpo,1
Genetic,complete thrombophilic profile testing by multiplex pcr,1
Genetic,blood sample for whole genome sequencing,1
Other,a questionnaire and scales.,1
Drug,ribavirin capsules,1
Drug,γ-globulin,1
Drug,ringer solution,1
Genetic,1. characterize the immune response after infection with sars-cov-2,1
Drug,prednisone tablet,1
Other,active comparator: self-care group,1
Drug,rintatolimod,1
Drug,ritonavir,1
Other,a vignette intervention,1
Other,a survey of 60 questions was created through the internet-based 'google forms surveys' site.,1
Drug,rnapc2,1
Drug,ritonavir/lopinavir,1
Drug,povidone-iodine 0.6% ni,1
Drug,povidone-iodine 0.5% ni,1
Drug,povidone-iodine 0.5%,1
Drug,povidone-iodine 0.4% ni,1
Drug,zilucoplan®,1
Drug,povidine iodine nasal swabs,1
Drug,zilucoplan placebo,1
Drug,ruxolitinib 5 mg,1
Drug,poractant alfa,1
Drug,ruxolitinib administration,1
Drug,zilucoplan,1
Drug,polyoxidonium,1
Drug,ruxolitinib plus simvastatin,1
Other,activity list,1
Drug,zavegepant (bhv-3500),1
Drug,zanubrutinib,1
Drug,pln-74809,1
Drug,s-1226,1
Drug,povidone-iodine 0.5% ns,1
Drug,povidone-iodine 0.6% ns,1
Drug,prazosin,1
Drug,zinc (placebo),1
Drug,zotatifin,1
Other,active covid-19 disease,1
Drug,prasugrel hydrochloride 10 mg oral tablet,1
Other,activity,1
Drug,rivaroxaban 15mg tab,1
Drug,rivaroxaban 2.5 mg,1
Drug,prasugrel,1
Drug,povidone-iodine solution 1.25% w/w [0.125% available iodine] usp,1
Drug,retrospective case-control analysis,1
Drug,ro7496998,1
Drug,roactemra iv,1
Drug,zofintm,1
Drug,roactemra sc,1
Drug,zithromax oral product,1
Drug,rosuvastatin,1
Drug,zinc sulfate,1
Drug,povidone-iodine 2%,1
Drug,rhace2 apn01,1
Drug,progesterone 100 mg,1
Other,[timp-2]*[igfbp-7],1
Other,5 times sit to stand test,1
Other,25 post non-icu patients,1
Other,6 minute walk test,1
Drug,pyronaridine-artesunate (pa),1
Drug,recombinant human interferon α2b spray,1
Other,6 minutes walk test,1
Other,20% adoption rate,1
Drug,pyridostigmine bromide,1
Drug,recombinant human plasma gelsolin (rhu-pgsn),1
Drug,pulmozyme/ recombinant human deoxyribonuclease (rh-dnase),1
Other,2 post-mortem transcutaneous lung biopsies (1 anterior ; 1 posterior) using anatomical landmarks,1
Drug,saline,1
Drug,reference: favipiravir 200 mg (avigan),1
Other,6 point likert scale,1
Other,6-min-walk fpp2,1
Other,6-min-walk surgical mask,1
Other,1: usual practice,1
Other,1 minute sit to stand test,1
Drug,regadenoson,1
Other,0.07% cetylpyridinium chloride (cpc) in mouthwash,1
Drug,recombinant human interferon α1β,1
Drug,recombinant human interferon alpha-1b,1
Genetic,covid-19 diagnostic and assessment tests,1
Drug,recombinant human annexin a5,1
Other,"35 ml blood, 5 tubes lithium heparinate at each time (cured patients)",1
Other,38 questions questionnaire,1
Drug,razuprotafib subcutaneous solution,1
Drug,rayaldee 30mcg extended-release (er) capsule,1
Other,38-questions questionnaire,1
Drug,rbt-9 (90 mg),1
Drug,rapamycin,1
Drug,rdv,1
Other,40% adoption rate,1
Drug,random donor plasma,1
Drug,rdv placebo,1
Drug,recombinant bacterial ace2 receptors -like enzyme of b38-cap (rbace2),1
Other,40ml blood sample,1
Other,4c mortality score,1
Other,5 blood samples,1
Drug,ramipril 2.5 mg oral capsule,1
Drug,ramelteon 8mg,1
Drug,quetiapine,1
Drug,recombinant human angiotensin-converting enzyme 2 (rhace2),1
Other,"0, 28 day schedule",1
Other,"0, 112 day schedule",1
Drug,regn10933 + regn10987,1
Other,0% adoption rate,1
Genetic,multi-omics,1
Drug,prophylactic heparin,1
Other,60% adoption rate,1
Genetic,massive parallel sequencing of host genome,1
Genetic,genetic blood collection,1
Drug,progesterone 200 mg oral capsule,1
Drug,remdesivir-hu,1
Drug,remestemcel-l,1
Other,80% adoption rate,1
Drug,remimazolam,1
Drug,renin-angiotensin system inhibitors,1
Genetic,genetic,1
Drug,resp301,1
Other,[11c]sl25.1188 pet scan,1
Genetic,expression of receptors and activating proteases,1
Drug,previfenon®,1
Genetic,epigenetic analyses,1
Other,[18f]feppa pet scan,1
Genetic,determination of cyp2c19 genotype,1
Genetic,next generation sequencing (ngs) analysis,1
Genetic,polymorphism of the hsd3b1,1
Drug,prophylactic lactoferrin daily,1
Drug,propofol,1
Other,- synthetic anti-malarial drugs,1
Drug,ptc299,1
Other,(standard of care) soc,1
Drug,proxalutamide (gt0918),1
Other,"""calm"" is a mindfulness meditation mobile app",1
Genetic,whole genome analysis,1
Drug,prothione™ (6g),1
Drug,propranolol hydrochloride,1
Genetic,whole exome sequencing,1
Drug,remdesivir (rdv),1
Genetic,tdr,1
Genetic,t-cell receptor (tcr) repertoire,1
Drug,rejuveinix (rjx) active comparator,1
Genetic,single-nucleotide polymorphisms (snp) within the tcra/d region,1
Genetic,sequencing,1
Genetic,sars-cov-2 viral composition,1
Drug,prophylactic/intermediate dose enoxaparin,1
Other,6-min-walk without mask,1
Drug,sacubitril / valsartan oral tablet [entresto],1
Drug,wharton's jelly derived mesenchymal stem cells.,1
Drug,yu-ping-feng formula,1
Drug,statins (cardiovascular agents),1
Drug,tpa,1
Drug,toremifene,1
Drug,stem cell product,1
Drug,topical steroids and cyclosporin-a,1
Drug,sterile normal saline (0.9%),1
Drug,sterile normal saline for intravenous use,1
Drug,sterile water for injection,1
Drug,sti-5656,1
Drug,sublingual methylene blue,1
Drug,sublingual micro-dose ketamine,1
Drug,tom's botanically bright peppermint,1
Drug,sulfonatoporphyrin(tpps) plus sunlight exposure.,1
Drug,sulfur hexafluoride lipid-type a microspheres,1
Drug,sulodexide,1
Drug,support treatment,1
Drug,tocilizumab prefilled syringe,1
Drug,tocilizumab injection [actemra],1
Drug,supportive and symptomatic treatment,1
Drug,supportive care,1
Drug,tocilizumab and ruxolitinib (advanced stage 3),1
Drug,surfactant,1
Drug,tocilizumab 200 mg/10 ml (20 mg/ml) intraven vial (ml),1
Drug,tocilizumab 20 mg/ml intravenous solution [actemra]_#1 (2 doses),1
Drug,tocilizumab 20 mg/ml intravenous solution [actemra]_#1,1
Drug,symptomatic drugs,1
Drug,tradipitant,1
Drug,standards of care,1
Drug,synthetic neutralising antibodies,1
Drug,traditional antirheumatic drugs,1
Drug,standard of care therapy,1
Drug,standard of care thromboprophylaxis,1
Drug,standard of care treatment,1
Drug,"treatment group: will receive a combination of nitazoxanide, ribavirin and ivermectin for a duration of seven days :",1
Drug,treatment as usual vitamin d,1
Drug,treatment and prophylaxis,1
Drug,standard of care_1,1
Drug,treamid,1
Drug,standard of care_2,1
Drug,standard prophylactic dose enoxaparin/ unfractionated heparin,1
Drug,standard therapeutic protocol,1
Drug,transfusion of standard plasma.,1
Drug,transfusion of sars-cov-2 convalescent plasma.,1
Drug,transfusion of covid-19 convalescent plasma,1
Drug,standard therapy for covid-19 according to the stablished hospital protocols.,1
Drug,standard therapy protocol (stp),1
Drug,transdermal estradiol gel,1
Drug,trans sodium crocetinate,1
Drug,tranexamic acid tablets,1
Drug,tramadol,1
Drug,standard treatment of covid-19,1
Drug,standard-of-care sars-cov-2 treatment,1
Drug,traditional chinese medicine prescription,1
Drug,standard-of-care treatment,1
Drug,standardized brazilian green propolis extract,1
Drug,symptomatic treatment (paracetamol or best symptomatic treatment based on doctor recommendations),1
Drug,tocilizumab 20 mg/ml intravenous solution [actemra],1
Drug,saline oral/nasal rinse,1
Drug,tinzaparin or unfractionated heparin,1
Drug,tice® bcg (for intravesical use) bcg live strain of the bcg (merck) vaccine,1
Drug,ticagrelor,1
Drug,telmisartan 40mg oral tablet,1
Drug,thymosin+standard treatment,1
Drug,thymosin alpha 1,1
Drug,telmisartan arm will receive 80 mg telmisartan twice daily plus standard care.,1
Drug,telmisartan oral product,1
Drug,tempol,1
Drug,ten-days oseltamivir,1
Drug,thromboprophylaxis with low-molecular-weight heparin or fondaparinux,1
Drug,tenecteplase,1
Drug,tenofovir disoproxil and emtricitabine,1
Drug,tenofovir disoproxyl fumarate 300 mg oral tablet,1
Drug,tenofovir disoproxyl fumarate 300 mg plus emtricitabine 200 mg oral tablet,1
Drug,tenofovir/ emtricitabine ( 300 mg / 200 mg daily during 60 days) + personal protective equipment (ppe),1
Drug,test: favipiravir 200 mg (loqular),1
Drug,tetracycline hydrochloride 3%,1
Drug,tetrandrine,1
Drug,thromboprophylaxis,1
Drug,"the pop02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care:",1
Drug,the standard of care,1
Drug,thiazide or thiazide-like diuretics,1
Drug,theraputic heparin,1
Drug,the standard therapy,1
Drug,theophylline powder,1
Drug,telmisartan 40mg,1
Drug,telmisartan 20mg oral tablet,1
Drug,t3 solution for injection,1
Drug,"tinzaparin, high dose prophylactic anticoagulation",1
Drug,t89,1
Drug,t89 capsule,1
Drug,tocilizumab 180 mg/ml,1
Drug,tocilizumab +/- ruxolitinib (stages 2b/3),1
Radiation,lung low dose radiation,1
Drug,tociliuzumab,1
Drug,tnkase,1
Drug,tm5614,1
Drug,tlc19 vehicle,1
Drug,tlc19,1
Drug,tafenoquine oral tablet,1
Drug,tl-895,1
Drug,tj003234,1
Drug,tak-671,1
Drug,tak-671 placebo,1
Drug,tb006,1
Drug,tissue plasminogen activator,1
Drug,tcb008,1
Drug,tirofiban injection,1
Drug,tcm prescriptions,1
Drug,plitidepsin 2.0 mg/day,1
Drug,"tinzaparin,therapeutic anticoagulation",1
Drug,"tinzaparin, low dose prophylactic anticoagulation",1
Drug,td139,1
Drug,telacebec,1
Drug,standard of care for sars-cov-2 infection,1
Drug,treatment with dexmedetomidine,1
Drug,standard of care for covid-19 as per the hospital guidelines,1
Drug,shock-dependent hydrocortisone,1
Drug,sildenafil citrate tablets,1
Drug,xc7 200 mg multiple,1
Drug,xc7 100 mg single,1
Drug,xc221,1
Drug,the usual treatment,1
Drug,wfi water nebulization,1
Drug,weight-based dexamethasone dose,1
Drug,voclosporin,1
Drug,vitis xtra forte©,1
Drug,vitamin e,1
Drug,vitamin d3 or placebo,1
Drug,"vitamin d3 50,000 iu",1
Drug,single high dose vitamin d,1
Drug,sir1-365,1
Drug,sirolimus 1 mg/ml,1
Drug,sirukumab,1
Drug,sitagliptin,1
Drug,sndx-6352,1
Drug,vitamin c tablets,1
Drug,vitamin c 500 mg oral tablet,1
Drug,sno,1
Drug,vitamin a,1
Drug,soc + ifx-1,1
Drug,soc + intravenous famotidine,1
Drug,vit-d 0.2 mg/ml oral solution [calcidol],1
Drug,sildenafil,1
Drug,sevoflurane inhalant product,1
Drug,standard of care (soc) for covid-19,1
Drug,xc7 200 mg single,1
Drug,saline placebo,1
Drug,sar443122,1
Drug,yinhu qingwen granula,1
Drug,yinhu qingwen decoction(low dose),1
Drug,yinhu qingwen decoction,1
Drug,sarilumab 200 mg/1.14 ml subcutaneous solution [kevzara],1
Drug,sarilumab 400 mg/2.28 ml subcutaneous solution [kevzara],1
Drug,sarilumab prefilled syringe,1
Drug,sarilumab sar153191,1
Drug,sars-cov-2 convalescent plasma,1
Drug,yin hu qing wen granula(low does),1
Drug,sars-cov-2 mrna vaccine,1
Drug,xylocaine,1
Drug,sars-cov-2 plasma,1
Drug,sars-cov-2 vaccine,1
Drug,secukinumab 150 mg/ml subcutaneous solution [cosentyx],1
Drug,selenium (as selenious acid),1
Drug,xvr011,1
Drug,xuanfei baidu granules,1
Drug,xlear nasal spray,1
Drug,xiyanping injection,1
Drug,xiang-sha-liu-jun formula,1
Drug,semaglutide,1
Drug,senicapoc,1
Drug,xcel-umc-beta,1
Drug,soc therapy,1
Drug,vit d,1
Drug,virgin coconut oil (vco),1
Drug,sodium bicarbonate 150meq/l/d5w inj,1
Drug,usual care treatment,1
Drug,usual care,1
Drug,usb002,1
Drug,unikinon (chloroquine phosphate) 200mg tablets,1
Drug,stabilized hypochlorous acid,1
Drug,uni911 inhalation,1
Drug,standar medical treatmen,1
Drug,unfractionated heparin sc,1
Drug,standard (specific) therapy for covid-19,1
Drug,unfractionated heparin nebulized,1
Drug,unfractionated heparin iv,1
Drug,standard concomitant therapy,1
Drug,umifenovir,1
Drug,ulinastatin,1
Drug,type ii diabetes mellitus and covid-19 group (group ii),1
Drug,standard covid-19 therapies,1
Radiation,non-enhanced ct scan of the chest,1
Drug,trv027,1
Drug,trimodulin,1
Drug,trimetazidine,1
Drug,tricor® 145mg tablets,1
Drug,triazavirin (riamilovir),1
Drug,standard of care (soc) + ang-3777,1
Drug,standard of care (soc) + placebo,1
Drug,standard of care (soc) and colchicine+rosuvastatin,1
Drug,uttr1147a,1
Drug,uttr1147a-matched placebo,1
Drug,spironolactone 100mg,1
Drug,sofosbuvir 400 mg/ daclatasvir 60mg,1
Drug,sodium chloride,1
Drug,sodium chloride 9mg/ml,1
Drug,"sodium chloride, usp, for injection (0.9% nacl)",1
Drug,sodium nitrite,1
Drug,sodium pyruvate,1
Drug,sodium pyruvate nasal spray,1
Drug,virgin coconut oil,1
Drug,vir-7832,1
Drug,sofosbuvir 400 mg plus daclatasvir 200mg,1
Drug,vib7734,1
Drug,verapamil,1
Drug,ventaprost (inhaled epoprostenol delivered via a dedicated delivery system),1
Drug,spironolactone + dexamethasone,1
Drug,vc,1
Drug,vb-201 + standard of care,1
Drug,sofosbuvir and ledipasvir,1
Drug,valsartan (diovan),1
Drug,sofosbuvir ledipsavir,1
Drug,valproate,1
Drug,sofosbuvir plus ledipasvir,1
Drug,vadadustat,1
Drug,vaccination,1
Drug,uvc irradiation,1
Drug,sofusbuvir + daclastavir 60 mg,1
Drug,plitidepsin 2.5 mg/day,1
Radiation,chest radiography,1
Drug,plitidepsin 1.5 mg/day,1
Drug,hypertonic saturated saline mouth rinse active arm,1
Drug,hyperpolarized 129xenon gas,1
Drug,"hydroxychloroquine, lopinavir/ritonavir or azithromycin and placebo (standard therapy)",1
Drug,"hydroxychloroquine, doxycycline",1
Drug,"hydroxychloroquine, clindamycin, primaquine - low dose.",1
Drug,"hydroxychloroquine, clindamycin, primaquine - high dose.",1
Drug,"hydroxychloroquine, clindamycin",1
Drug,"hydroxychloroquine, azithromycin",1
Drug,hydroxychloroquine tablets,1
Drug,hydroxychloroquine sulfate tablets plus lopinavir/ ritonavir oral tablets,1
Drug,hydroxychloroquine sulfate 600 mg twice a day,1
Drug,hydroxychloroquine sulfate 600 mg once a day,1
Drug,hydroxychloroquine sulfate 400 mg twice a day,1
Drug,hydroxychloroquine sulfate 200 milligram (mg) tab,1
Drug,hydroxychloroquine sulfate + azythromycin,1
Drug,hydroxychloroquine sulfate (hcq),1
Drug,hyperpolarized xe129,1
Drug,ibudilast,1
Drug,hydroxychloroquine sar321068,1
Drug,ibuprofen,1
Drug,immunosuppressive,1
Drug,immunoglubulins,1
Drug,immunoglobulin of cured patients,1
Drug,imatinib tablets,1
Drug,imatinib mesylate intravenous solution,1
Drug,imatinib mesylate,1
Drug,imatinib,1
Drug,iloprost,1
Drug,il-12 plasmid,1
Drug,igiv,1
Drug,ifn beta-1a,1
Drug,idoine complex,1
Drug,icosapent ethyl (ipe),1
Drug,icatibant,1
Drug,ic14,1
Drug,hydroxychloroquine sulfate &azithromycin,1
Drug,hydroxychloroquine pre-exposure prophylaxis,1
Drug,"imp 1,000 plus soc",1
Drug,hydroxychloroquin with azithromycin,1
Drug,"human fecal microbiota, mbiotix hbi",1
Drug,human ezrin peptide 1 (hep1),1
Drug,huaier granule,1
Drug,hospital standard of care for covid-19,1
Drug,hmw-ha,1
Drug,hlx71,1
Drug,hlx70,1
Drug,history of exposure to anti-cd20 treatment since 01/01/2010,1
Drug,high-titer anti-sars-cov-2 (covid 19) convalescent plasma,1
Radiation,thoracic computed tomography scan,1
Drug,high-dose dexamethasone,1
Drug,high dose interferon-beta 1a,1
Drug,high dose corticosteroid,1
Drug,hidroxicloroquina,1
Drug,hfb30132a,1
Drug,hydrogen peroxide,1
Radiation,single fraction whole lung radiotherapy,1
Drug,hydroxychloroquine plus standard preventive measures,1
Drug,hydroxychloroquine (placebo),1
Drug,hydroxychloroquine placebo,1
Drug,hydroxychloroquine pill,1
Drug,hydroxychloroquine oral product,1
Drug,hydroxychloroquine only product in oral dose form,1
Drug,hydroxychloroquine in combination with camostat mesylate,1
Drug,hydroxychloroquine in combination of azithromycin,1
Drug,hydroxychloroquine combined with azithromycin,1
Drug,hydroxychloroquine as post exposure prophylaxis,1
Drug,hydroxychloroquine and azithromycin treatment arm.,1
Drug,hydroxychloroquine and azithromycin treatment,1
Drug,"hydroxychloroquine , sofosbuvir, daclatasvir",1
Drug,hydroxychloroquine + sorbitol,1
Drug,hydroxychloroquine + placebo,1
Drug,hydroxychloroquine + metabolic cofactor supplementation,1
Drug,hydroxychloroquine + lopinavir/ritonavir,1
Drug,immunosuppressive agents,1
Drug,"imp 5,000 plus soc",1
Drug,ivermectin oral tablets or sublingual waffles,1
Radiation,radiotherapy,1
Drug,iv dexamethasone,1
Drug,itolizumab iv infusion,1
Drug,isotretinoin(aerosolized 13 cis retinoic acid) +standard treatment,1
Drug,isotretinoin only product in oral dose form,1
Drug,isotretinoin (13 cis retinoic acid ) capsules,1
Drug,isotonic saline 0.9%,1
Drug,isotonic saline,1
Drug,isoquercetin (iqc-950an),1
Drug,isoprinosine,1
Drug,isoflurane inhalant product,1
Drug,isis 721744,1
Drug,isavuconazonium injection [cresemba],1
Drug,irl201104,1
Drug,iota-carrageenan,1
Drug,intravenous sedation,1
Drug,iv tocillizumab (tcz),1
Drug,ivermectin (iver p®) arm will receive ivm 600 µg / kg once daily plus standard care. control arm will receive standard care.,1
Drug,intravenous drug,1
Drug,ivermectin (ivm),1
Drug,ivermectin nasal,1
Drug,ivermectin injectable solution,1
Drug,ivermectin and doxycyline,1
Drug,ivermectin 6 mg oral tablet (2 tablets),1
Drug,ivermectin 6 mg oral tablet,1
Drug,"ivermectin 5 mg/ml oral solution, aspirin 250 mg tablets",1
Drug,ivermectin 3mg tab,1
Drug,ivermectin 3 mg,1
Drug,ivermectin 1.0mg/kg/day,1
Drug,ivermectin 0.6mg/kg/day,1
Drug,ivermectin 0.4mg/kg/day for 5 days,1
Drug,ivermectin / iota-carrageenan,1
Drug,ivermectin + placebo,1
Drug,ivermectin + doxycycline + placebo,1
Drug,ivermectin + doxycycline,1
Drug,intravenous immunoglobulin,1
Drug,intranasal ivermectin spray,1
Drug,imp rp2d plus soc,1
Drug,ino (inhaled nitric oxide) delivered via the inopulse delivery system,1
Drug,inhaled type i interferon,1
Drug,inhaled sedation,1
Drug,inhaled nitric oxide gas,1
Drug,inhaled nitric oxide (ino),1
Drug,inhaled iloprost,1
Drug,inhaled hypertonic ibuprofen,1
Drug,inhaled hydroxychloroquine,1
Drug,inhaled budesonide,1
Drug,inhaled aviptadil,1
Drug,inhalable hydroxychloroquine (hcq),1
Drug,indomethacin,1
Drug,inc424 / ruxolitinib,1
Drug,inb03,1
Drug,inactivated convalescent plasma,1
Drug,imunor,1
Drug,inm005,1
Drug,instilled t3,1
Drug,intranasal heparin sodium (porcine),1
Drug,insulin,1
Drug,intramuscular injection,1
Drug,intermediate dose thromboprophylaxis,1
Drug,intermediate dose enoxaparin/ unfractionated heparin,1
Drug,interleukin-1 receptor antagonist,1
Drug,interleukin 6 (il6) antagonist and corticosteroids,1
Drug,interleukin 6 (il6) antagonist,1
Drug,interferon-β1a,1
Drug,interferon-β 1a,1
Drug,interferon-ß-1a,1
Drug,interferon-beta,1
Drug,interferon-alpha2b,1
Drug,interferon β-1b,1
Drug,interferon or glatiramer acetate,1
Drug,interferon alfa,1
Drug,insulin regimen,1
Drug,hesperidin and diosmin mixture,1
Drug,hesperidin,1
Drug,heparin sc,1
Drug,enoxaparin sodium,1
Drug,enoxaparin prefilled syringe [lovenox],1
Drug,enoxaparin higher dose,1
Drug,enoxaparin 40mg/0.4ml inj syringe 0.4ml,1
Drug,enoxaparin 1 mg/kg,1
Drug,enisamium iodide,1
Drug,endothelial protocol,1
Drug,emtricitabine/tenofovir disoproxil fumarate 200 mg-245 mg oral tablet [truvada],1
Drug,emtricitabine/tenofovir disoproxil,1
Drug,emtricitabine/tenofovir alafenamide 200 mg-25 mg oral tablet,1
Drug,emtricitabine/tenofovir,1
Drug,emricasan,1
Drug,eltrombopag,1
Drug,eicosapentaenoic acid gastro-resistant capsules,1
Drug,eg-hpcp-03a placebo,1
Drug,eg-hpcp-03a,1
Drug,enoxaparin prophylactic dose,1
Drug,enoxaparin/lovenox intermediate dose,1
Drug,dwj1248 with remdesivir,1
Drug,ensifentrine dose 1,1
Drug,exogenous surfactant,1
Drug,exo-cd24,1
Drug,exebacase,1
Drug,etoposide,1
Drug,ethanol with asprin,1
Drug,estrogen therapy,1
Drug,estradiol patch,1
Drug,estradiol cypionate 5 mg/ml,1
Drug,estetrol monohydrate 15 mg,1
Drug,essential oils,1
Drug,essential amino acids,1
Drug,escin,1
Drug,eritoran,1
Drug,enzalutamide pill,1
Drug,enzalutamide,1
Drug,edoxaban tablets,1
Drug,dutasteride 0.5 mg,1
Drug,heparin infusion,1
Drug,dornase alfa,1
Drug,disease-modifying antirheumatic drugs (dmards),1
Drug,dipyridamole er 200mg/ aspirin 25mg orally/enterally and standard of care,1
Drug,dipyridamole 100 milligram(mg),1
Drug,dipyridamole,1
Drug,diphenhydramine,1
Drug,dimethyl fumarate,1
Drug,dietary supplement containing resistant starch,1
Drug,dialyzable leukocyte extract,1
Drug,dfv890,1
Drug,dexmedetomidine injectable product,1
Drug,dexamethasone oral,1
Drug,dexamethasone low dose,1
Drug,dexamethasone high dose,1
Drug,dexamethasone and hydroxychloroquine,1
Drug,dexamethasone 2 mg/ml,1
Drug,dociparstat sodium,1
Drug,dornase alfa inhalation solution,1
Drug,dur-928,1
Drug,double-blind nt-i7,1
Drug,duact,1
Drug,drug: standard treatment standard treatment,1
Drug,drug: na-831 - 0.20 mg/kg,1
Drug,drug: na-831 - 0.10 mg/kg,1
Drug,drug: na-831,1
Drug,drug: isotretinoin(aerosolized 13 cis retinoic acid) plus aerosolized itraconazole,1
Drug,drug: isotretinoin(aerosolized 13 cis retinoic acid),1
Drug,drug: isotretinoin plus tamoxifen,1
Drug,drug: gs-5734 - 2.00 mg/kg,1
Drug,drug: gs-5734 - 1.00 mg/kg,1
Drug,drug isotretinoin (13 cis retinoic acid ) capsules+standard treatment,1
Drug,drug covid19-0001-usr,1
Drug,doxycycline hcl,1
Drug,doxycyclin,1
Drug,double-blind placebo,1
Drug,experimental drug,1
Drug,experimental group,1
Drug,extract psidii guava,1
Drug,group apixaban,1
Drug,group 2: control group with enoxaparin 40mg/d,1
Drug,group 1: rivaroxaban 20mg/d followed by enoxaparin/unfractionated heparin when needed,1
Drug,gns561,1
Drug,gls-1200,1
Drug,gls-1027,1
Drug,glenzocimab,1
Drug,gimsilumab,1
Drug,giga-2050,1
Drug,gc4419,1
Drug,gargle/mouthwash,1
Drug,ganovo+ritonavir+/-interferon nebulization,1
Drug,galidesivir,1
Drug,fx06,1
Drug,fultium® -d3 800,1
Drug,ft516,1
Drug,group a hcq,1
Drug,group b control,1
Drug,famotidine 20 mg,1
Drug,group hydroxychloroquine,1
Drug,heparin - therapeutic dosage,1
Drug,heparin - prophylactic dosage,1
Drug,hcq01,1
Drug,hcq+azt,1
Drug,hcq & az vs hcq+sir,1
Drug,hcq & az,1
Drug,hb-admsc,1
Drug,had5-sfusion+ n-etsd (oral capsule),1
Drug,gx-i7 vehicle,1
Drug,gx-19,1
Drug,gt0918 tablets or placebo,1
Drug,gse and xylitol,1
Drug,gs-441524,1
Drug,growth hormone,1
Drug,group hydroxychloroquine and apixaban,1
Drug,fsd201,1
Drug,fp-025 300 mg,1
Drug,fp-025 100 mg,1
Drug,foy-305,1
Drug,favipiravir tablets+chloroquine phosphatetablets tablets,1
Drug,favipiravir tablets,1
Drug,favipiravir plus nitazoxanide,1
Drug,favipiravir placebo,1
Drug,favipiravir combined with tocilizumab,1
Drug,favipiravir + standard of care,1
Drug,favipiravir + currently used therapy,1
Drug,favipiravir (3600 mg + 1600 mg),1
Drug,favipiravir (3200 mg + 1200 mg) combined with hydroxychloroquine,1
Drug,favipiravir (3200 mg + 1200 mg) combined with azithromycin,1
Drug,favipiravir (3200 mg + 1200 mg),1
Radiation,thoracic ct-scan,1
Drug,favicovir 200 mg film tablet,1
Drug,favicovir (standard treatment),1
Drug,famotidine 20 milligram tablet,1
Drug,favir 200 mg ft,1
Drug,favira 200 mg film tablet,1
Drug,favorable outcome,1
Drug,fnc dummy tablet+standard of care,1
Drug,fotv,1
Drug,fosmanogepix,1
Drug,fondaparinux,1
Drug,fondapariniux,1
Drug,folic acid,1
Drug,fnc+standard of care,1
Drug,fluvoxamine maleate 100 mg [luvox],1
Drug,fb2001,1
Drug,fluoxetine tablets,1
Drug,fixed-duration hydrocortisone,1
Drug,fixed-duration higher dose hydrocortisone,1
Drug,five-days oseltamivir,1
Drug,fingolimod 0.5 mg,1
Drug,fb2001 placebo,1
Drug,ivermectin oral,1
Drug,ivermectin powder,1
Drug,plitidepsin,1
Drug,oseltamivir 75mg,1
Drug,ortd-1 low dose,1
Drug,ortd-1 high dose,1
Drug,orally suspension of cov2-ogen1,1
Drug,oral-b mouth sore mouthwash,1
Drug,oral ivermectin,1
Drug,oral co-trimoxazole,1
Drug,oral administration of colchicine plus herbal phenolic monoterpene fractions,1
Drug,oral 25-hydroxyvitamin d3,1
Drug,oral 13 cis retinoic acid,1
Drug,oral,1
Drug,ophtamesone,1
Drug,open label bss (pepto bismol),1
Drug,op-101,1
Drug,only standard treatment,1
Drug,omeprazole 20mg,1
Drug,ortd-1 mid dose,1
Drug,osoc,1
Drug,omega-3 fatty acid supplement,1
Drug,ot-101,1
Drug,patients with the treatment agains covid19,1
Drug,"patch, placebo",1
Drug,"patch, nicotine",1
Drug,part b: upamostat 200 or 400 mg,1
Drug,part a: upamostat 400 mg,1
Drug,part a: upamostat 200 mg,1
Drug,part a and b: placebo,1
Drug,pamrevlumab,1
Drug,pacritinib,1
Drug,p2y12,1
Drug,p2et (caesalpinia spinosa extract),1
Drug,ozanimod,1
Drug,oxytocin,1
Drug,oxygen gas,1
Drug,oximen® 3%,1
Drug,omegaven®,1
Drug,omega 3/nigella sativa oil/quinine pills,1
Drug,pdno,1
Drug,no-immunosuppressive,1
Drug,nivolumab injection,1
Drug,nitroglycerin,1
Drug,nitric oxide-sessions,1
Drug,nitric oxide-releasing drug,1
Drug,nitric oxide-continuous and sessions,1
Drug,"nitric oxide lozenges, 30 mg",1
Drug,nitric oxide 0.5 % / nitrogen 99.5 % gas for inhalation,1
Drug,nitazoxanide tablets,1
Drug,nitazoxanide and ciclésonide,1
Drug,nitazoxanide and atazanavir/ritonavir,1
Drug,nitazoxanide 500mg oral tablet,1
Drug,nitazoxanide 500 mg,1
Drug,nintedanib 150 mg [ofev],1
Drug,nintedanib 150 mg,1
Drug,nigella sativa seed,1
Drug,nk-1r antagonist,1
Drug,non-acei/arb,1
Drug,omega 3/nigella sativa oil/indian costus,1
Drug,non-ras blocking antihypertensives,1
Drug,omega 3/nigella sativa oil/deglycyrrhizinated licorice,1
Drug,omega 3/nigella sativa oil/anise seed capsule,1
Drug,omega 3/nigella sativa oil,1
Drug,omega 3 fatty acid,1
Drug,octaplas,1
Drug,octagam,1
Drug,observational,1
Drug,nuvastatic,1
Drug,nusepin® 0.2 mg,1
Drug,nusepin® 0.1 mg,1
Drug,nt-i7,1
Drug,np-120 (ifenprodil),1
Drug,nox66,1
Drug,normal saline intranasal,1
Drug,normal saline infusion + standard of care,1
Drug,pd-1 blocking antibody+standard treatment,1
Drug,peginterferon lambda alfa-1a subcutaneous injection,1
Drug,janus kinase inhibitor (ruxolitinib),1
Drug,placebo pmdi,1
Drug,placebo patch,1
Drug,placebo oral capsule; from august 2020 'no additional treatment',1
Drug,placebo oral,1
Drug,placebo of nicotine transdermal patch,1
Drug,placebo of lpv/r tablets,1
Drug,placebo of hydroxychloroquine,1
Drug,placebo of fx06,1
Drug,placebo of excipient(s) will be administered,1
Drug,placebo nitazoxanide,1
Drug,placebo multiple,1
Drug,placebo inhaled,1
Drug,placebo hydroxychloroquine,1
Drug,placebo group,1
Drug,placebo gel,1
Drug,placebo for hydroxychloroquine,1
Drug,placebo plus standard preventive measures,1
Drug,placebo ribavirin,1
Drug,placebo for azithromycin,1
Drug,placebo single,1
Drug,plasma from covid-19 convalescent patient,1
Drug,plaquenil 200mg tablet,1
Drug,placebo: hydroxychloroquine,1
Drug,placebo: emtricitabine/tenofovir disoproxil placebo,1
Drug,placebo/control,1
Drug,placebo-lde phase 2,1
Drug,placebo- 2.00 mg/kg,1
Drug,placebo- 1.00 mg/kg,1
Drug,placebo- 0.20 mg/kg,1
Drug,placebo- 0.10 mg/kg,1
Drug,placebo with remdesivir,1
Drug,placebo to match rdv,1
Drug,placebo subcutaneous solution,1
Drug,placebo solution,1
Drug,placebo sofusbuvir + daclatasvir 60 mg,1
Drug,placebo for camostat mesilate,1
Drug,placebo for abbv-47d11,1
Drug,pegylated interferon lambda,1
Drug,piperacillin-tazobactam,1
Drug,pioglitazone 30 mg,1
Drug,pioglitazone,1
Drug,piclidenoson,1
Drug,physiological saline solution,1
Drug,physiological irrigating solution,1
Drug,phr160 spray,1
Drug,pf-07321332/ritonavir,1
Drug,pf-07304814,1
Drug,pf-06650833,1
Drug,pertuzumab and trastuzumab fixed-dose combination for subcutaneous administration (ph fdc sc),1
Drug,periogard,1
Drug,pentarlandir™ uppta,1
Drug,pentaglobin,1
Drug,pemziviptadil (pb1046),1
Drug,pegylated interferon-α2b,1
Drug,pioglitazone 45 mg,1
Drug,piperacillin/tazobactam,1
Drug,placebo for abbv-2b04,1
Drug,pitavastatin,1
Drug,"placebo for ""deficiency of qi and yin""",1
Drug,"placebo for ""deficiency of qi and yang""",1
Drug,placebo empty capsule,1
Drug,placebo ec-18,1
Drug,placebo daclatasvir 60 mg,1
Drug,placebo atazanavir,1
Drug,placebo 250 cc 24 hours continuous infusion for 15 days,1
Drug,placebo 0.9% nacl solution,1
Drug,placebo + soc,1
Drug,placebo (sc injections),1
Drug,placebo (pbo),1
Drug,placebo (oral tablet),1
Drug,placebo (iv),1
Drug,placebo (inhaled solution),1
Drug,placebo (im),1
Drug,nigella sativa / black cumin,1
Drug,nigella,1
Drug,nicotine patch,1
Drug,low dose interferon-beta 1a,1
Drug,lovenox 40 mg in 0.4 ml prefilled syringe,1
Drug,losmapimod oral tablet,1
Drug,losartan 50 mg and spironolactone 25 mg pillules oral use,1
Drug,lopinavir/ritonavir treatment,1
Drug,lopinavir/ritonavir tablets or arbidol or chloroquine phosphate,1
Drug,lopinavir/ritonavir group,1
Drug,lopinavir/ritonavir 400 mg/100 mg,1
Drug,lopinavir/ritonavir 200 mg/50 mg film tablet,1
Drug,lopinavir/ritonavir 200 mg/50 mg film coated tablet,1
Drug,lopinavir/ritonavir 200 mg-50 mg oral tablet,1
Drug,lopinavir/ritonavir + hydoxychloroquine,1
Drug,lopinavir/ ritonavir oral tablet,1
Drug,lopinavir/ ritonavir and remdesivir combination,1
Drug,lopinavir-ritonavir drug combination,1
Drug,lopinavir and ritonavir tablets,1
Drug,low dose (10 mg) control,1
Drug,low dose low molecular weight heparin or placebo,1
Drug,lopinavir 200mg/ritonavir 50mg tab,1
Drug,low dose prednisolone,1
Drug,maraviroc + currently used therapy,1
Drug,maraviroc,1
Drug,mannitol,1
Drug,management of covid-19,1
Drug,macrolide administered for up to 14 days,1
Drug,macrolide administered for 3-5 days,1
Drug,lyt-100,1
Drug,ly3853113,1
Drug,ly3127804,1
Drug,lucinactant,1
Drug,"ltx-109 gel, 3%",1
Drug,lsalt peptide,1
Drug,lower-dose prophylactic anticoagulation,1
Drug,low-molecular-weight heparin,1
Drug,low molecular weight heparin as standard of care treatment,1
Drug,lopinavir and ritonavir,1
Drug,lopinavir 200 mg / ritonavir 50 mg [kaletra],1
Drug,nicotine 7 mg/ 24h transdermal patch - 24 hour,1
Drug,lenzilumab,1
Drug,leaf-4l6715,1
Drug,lb1148,1
Drug,lau-7b,1
Drug,late-dexamethasone,1
Drug,late dexamethazone,1
Drug,lanadelumab placebo,1
Drug,lambda 180 mcg s.c,1
Drug,lactose monohydrate,1
Drug,lactoferrin,1
Drug,l-citrulline,1
Drug,kevzara sc,1
Drug,ketotifen 1 mg,1
Drug,ketamine,1
Drug,kan jang capsules,1
Drug,kaletra and beta interferon,1
Drug,"lenalidomide as a 5 mg capsule po daily, days 1, 3, and 5.",1
Drug,leukotriene receptor antagonist,1
Drug,"lopinavir / ritonavir, alpha-interferon nebulization,abidor hydrochloride",1
Drug,levamisole,1
Drug,lopinavir / ritonavir tablets combined with xiyanping injection,1
Drug,lopinavir,1
Drug,lmwh,1
Drug,liu-wei-di-huang formula,1
Drug,listerine zero mouthwash product,1
Drug,liposomal lactoferrin,1
Drug,linagliptin tablet,1
Drug,linagliptin 5 mg,1
Drug,linagliptin,1
Drug,lidocaine 2%,1
Drug,lidocaine,1
Drug,liberase enzyme (roche),1
Drug,lianhua qingwen,1
Drug,levilimab,1
Drug,levamisole pill + budesonide+formoterol inhaler,1
Drug,maraviroc 300 mg,1
Drug,maraviroc experimental group,1
Drug,maraviroc+favipiravir+ct,1
Drug,nangibotide,1
Drug,nafamostat mesylate,1
Drug,nacl,1
Drug,nac + bromhexine (bmx),1
Drug,na-831,1
Drug,n-acetylcysteine (nac),1
Drug,muscle relaxation,1
Drug,mucodentol,1
Drug,mstt1041a-matched placebo,1
Drug,mstt1041a,1
Drug,msc-exosomes delivered intravenously every other day on an escalating dose: (2:4:8),1
Drug,msc-exosomes delivered intravenously every other day on an escalating dose (8:4:8),1
Drug,msc-exosomes delivered intravenously every other day (8:8:8),1
Drug,mrx-4dp0004,1
Drug,mrg-001,1
Drug,mr or m-m-r ii ® vaccine,1
Drug,naltrexone hydrochloride,1
Drug,narsoplimab,1
Drug,mas825,1
Drug,nasafytol®,1
Drug,nicotinamide riboside,1
Drug,nicotinamide,1
Drug,niclosamide suspension,1
Drug,niclosamide + camostat,1
Drug,neuromuscular blocking agents,1
Drug,nebulized saline,1
Drug,nebulized furosemide,1
Drug,nebulised unfractionated heparin (ufh),1
Drug,nebulised recombinant tissue-plasminogen activator (rt-pa) - cohort 2 niv,1
Drug,nebulised recombinant tissue-plasminogen activator (rt-pa) - cohort 2 imv,1
Drug,nebulised recombinant tissue-plasminogen activator (rt-pa) - cohort 1,1
Drug,nebulised heparin,1
Drug,nbt-nm108,1
Drug,nasal spray,1
Drug,nasal dexamethasone,1
Drug,mpt0b640,1
Drug,moxifloxacin or levofloxacin,1
Drug,montmorrillonite,1
Drug,montelukast plus favicovir (favipiravir),1
Drug,methotrexate-lde phase 1,1
Drug,metformin extended release oral tablet,1
Drug,metenkefalin + tridecactide,1
Drug,mesenchymal stromal stem cells - ki-msc-pl-205,1
Drug,mesenchymal stem cells,1
Drug,merimepodib,1
Drug,melphalan,1
Drug,melatonin intravenous,1
Drug,melatonin 2mg,1
Drug,mefloquine as a prophylaxis against sars-cov-2 infection in household contacts of covid 19 confirmed cases,1
Drug,mefloquine,1
Drug,medium dose prednisolone,1
Drug,measles-mumps-rubella vaccine,1
Drug,"mcn (methylene blue, vitamin c, n-acetyl cysteine)",1
Drug,masitinib,1
Drug,methotrexate-lde phase 2,1
Drug,methylene blue,1
Drug,methylene blue 5 mg/ml,1
Drug,modafinil,1
Drug,montelukast oral tablet,1
Drug,montelukast 10mg,1
Drug,monalizumab,1
Drug,mometasone furoate nasal spray,1
Drug,molixan,1
Drug,molgramostim nebuliser solution,1
Drug,mk-5475,1
Drug,methylprednisolone 80 mg/ml injectable suspension,1
Drug,"mixture 3,6% h2 in n2 (96.4%)",1
Drug,"microcrystalline cellulose, nf",1
Drug,"methylprednisolone, placebo",1
Drug,methylprednisolone therapy,1
Drug,methylprednisolone injection,1
Drug,methylprednisolone injectable product,1
Other,additional and minimal collection of products of the human body carried out during a sample for standard of care,1
Other,chelsea critical care physical assessment tool,1
Other,additional blood tubes,1
Other,review of medical patient file,1
Other,saline placebo (single),1
Other,saline placebo (double),1
Other,saline nasal irrigation,1
Other,routine standard of care,1
Other,routine dental restorative procedures,1
Other,routine care (no sars-covsts),1
Other,rna vaccine,1
Other,revised home-cov score,1
Other,review of medical file,1
Other,semi-directive interview,1
Other,retrospective metagenomics on clinical samples collected during hospitalization,1
Other,retrospective data and biological samples,1
Other,respiratory training,1
Other,respiratory tele-rehabilitation program (trr).,1
Other,respiratory supports,1
Other,respiratory rehabilitation program (rr).,1
Other,respiratory physiotherapy,1
Other,respiratory mechanics,1
Other,saline with baby shampoo nasal irrigation,1
Other,saline-sodium citrate (ssc) buffer,1
Other,saliva based assay: crude rna extraction,1
Other,saliva samples,1
Other,self-prone position recommendation,1
Other,self-interest message,1
Other,self-help mindfulness/compassion exercises,1
Other,self-breathe,1
Other,self-assesment questionnaire,1
Other,self-administered questionnaires,1
Other,self measurement with pulse oximeter,1
Other,screening testing strategy,1
Other,sch intervention,1
Other,satisfaction evaluation,1
Other,sars-cov-2 questionnaire survey,1
Other,sars-cov-2 infection,1
Other,sars-cov-2 and/or mis-c exposure,1
Other,sarcopenia diagnosis,1
Other,sampling of tissue,1
Other,sampling by venipuncture (and eventually by nasopharyngeal swab),1
Other,samling of oropharynx and nasopharynx,1
Other,respiratory functions,1
Other,respiratory function rehabilitation training,1
Other,respiratory exercise training,1
Other,rapid-3,1
Other,rapid molecular test,1
Other,rapid antibody test,1
Other,"raman analysis of saliva, characterization of the raman database and building of the classification model",1
Other,radx chcs testing intervention strategy,1
Other,raas inhibitor [continued standard of care],1
Other,quetionnary,1
Other,questionnary,1
Other,"questionnaires, spirometry",1
Other,questionnaires on psychological quality of life,1
Other,questionnaires for specific phobia,1
Other,questionnaires covid-,1
Other,questionnaires covid+,1
Other,questionnaire-based observational study,1
Other,"questionnaire, same tools as before, with inclusion of pcl5 questionnaire too.",1
Other,"questionnaire, phone call",1
Other,questionnaire with precaution information,1
Other,questionnaire survey,1
Other,rapid serological test,1
Other,recording of hemodynamic monitoring,1
Other,respiratory and psychological rehabilitation,1
Other,recording of respiratory monitoring,1
Other,research specific blood sample,1
Other,removal of dead space filter,1
Other,"remote sms (short message service, also known as ""text message"") delivery",1
Other,remote monitoring of covid-19,1
Other,remote controlled exercise,1
Other,remote consultation,1
Other,remote automated monitoring system,1
Other,relationship scales questionnaire (rsq),1
Other,relation between frailty and clinical outcomes in elderly patients with covid-19.,1
Other,rehabilitation-focused program,1
Other,rehabilitation protocol through a digital platform,1
Other,rehabilitation programme,1
Other,rehabilitation exercise protocol,1
Other,rehabilitation by eccentric exercises,1
Other,rehabilitation by concentric exercises,1
Other,regular inpatient medical care,1
Other,regular care,1
Other,semi-directed entretien,1
Other,semi-structured interviews-health system,1
Other,storage of operating waste,1
Other,stakeholder of tip-oa program,1
Other,standard medical treatment,1
Other,standard medical care,1
Other,standard interface,1
Other,standard guidelines,1
Other,standard care plus monitoring,1
Other,standard care delivered in the isolation hospitals.,1
Other,standard administration of oxygen flow,1
Other,standar of care,1
Other,staff will wear and evaluate bubble-papr (non-ce marked papr),1
Other,semi-structured interviews-patients,1
Other,staff wellbeing centres,1
Other,st. george's respiratory questionnaire (sgrq),1
Other,spirometry,1
Other,spin-chat program,1
Other,sperm collection,1
Other,speq (specific psychotic experiences questionnaire) - paranoia and grandiosity subscales,1
Other,specimens specific for the study,1
Other,specific exercise rehabilitation treatment,1
Radiation,low dose radiation 35 cgy,1
Other,standard of care (paracetamol),1
Other,standard of care management,1
Other,standard of care therapies,1
Other,steroid taper (prednisone),1
Other,stepped-care model,1
Other,state-trait anxiety inventory scale,1
Other,standardized crisis management and coping protocol plan toward coronavirus disease 2019 (covid-19),1
Other,standardised questionnaires,1
Other,standard-of-care,1
Other,standard western medicine treatment,1
Other,standard ventilation strategy,1
Other,standard treatment according to the clinical protocols,1
Other,standard supportive care,1
Other,standard public health measures,1
Other,standard pt,1
Other,standard protocol,1
Other,standard physiotherapy program,1
Other,standard oxygen delivery system,1
Other,standard operating procedures,1
Other,standard of health care,1
Other,solution-focused support program,1
Other,"sodium chloride, 0.9%",1
Other,sodium chloride 0.9%,1
Other,sfrms/splf cpap-telemonitoring diagnosis/therapeutic algorithm.,1
Other,sf-12,1
Other,severity of lung involvement with covid-19.,1
Other,severe covid-19 pneumonia with et,1
Other,severe acute respiratory syndrome coronavirus 2 detection,1
Other,service of questionnaire,1
Other,"serum zinc, vitamin d vitamin b12 levels .",1
Other,serum protein level analysis,1
Other,serum chemistry analysis,1
Other,seroprevalence of sars-cov-2 infection in patients with hiv infection,1
Other,serology test follow-up,1
Other,serological test,1
Other,serological analyses to be lead on a pre-existing biobank,1
Other,serologic testing,1
Other,serial seroconversion measurements in hospital employees during the covid-19 pandemic,1
Other,separic-covid19 cohort,1
Other,sending thorax ct video images via smartphone applications,1
Other,semi-structured telephone questionnaire,1
Other,"sf12, eq-5d-5l and work status standardized quantitative assessments",1
Other,sham acupressure group,1
Other,social network strategy + covid-19 messaging,1
Other,sham inflation,1
Other,social and public health measures against covid-19,1
Other,soc plus placebo iv,1
Other,smell household items,1
Other,smartphone-based voice and self-reported symptom collection,1
Other,slef questionnaires fulfilment,1
Other,skin biopsy,1
Other,six-month arv dispensing,1
Other,six-minute walk test (6mwt),1
Other,six minutes walk test,1
Other,sit-to-stand test,1
Other,sirtuin1,1
Other,singstrong: strong lungs through song,1
Other,simulation of repurposed drugs for covid-19,1
Other,shorter duration higher frequency pt,1
Other,shanshamani vati plus,1
Other,sham irradiation,1
Other,sham intervention,1
Other,"questionnaire including validated tools such as patient health questionnaire (phq-9), the 7-item generalised anxiety disorder (gad- 7), the 7-item insomnia severity index",1
Other,questionnaire filling,1
Other,questionnaire collection,1
Other,physical exercise and computerized cognitive training,1
Other,placebo (1 tablet daily during 60 days) + personal protective equipment (ppe),1
Radiation,low dose radiation therapy (ld-rt),1
Other,pilates exercises,1
Other,physiology,1
Other,physiological serum,1
Other,physiological effects of awake prone position in covid 19 patients,1
Other,physical therapy exercise,1
Other,physical exercises,1
Other,physical activity program,1
Other,questionnaire by phone call,1
Other,physical activity level,1
Other,phsyiotherapy,1
Other,phq-9 depression scale,1
Other,phq-9 (patient health questionnaire) depression scale,1
Other,phq-9 (9-item patient health questionnaire),1
Other,phone-based monitoring,1
Other,phone interviews,1
Other,phone interview,1
Other,placebo (carrier control),1
Other,placebo (crossover vaccination period),1
Other,placebo (hartmann plus albumine),1
Other,placebo (human albumin 1%),1
Other,placebo rinse,1
Other,placebo plain water mouth rinse arm,1
Other,placebo oral tablet,1
Other,placebo oral solution,1
Other,placebo nebuliser solution,1
Other,placebo injection and placebo pill,1
Other,placebo group,1
Other,placebo granules,1
Other,placebo control + best supportive care,1
Other,placebo comparator: dw-ns,1
Other,placebo comparator: dw-ni,1
Other,placebo - starch powder soft gels,1
Other,"placebo (sodium chloride, a 0.9% solution for the preparation of dosage forms for injections)",1
Other,"placebo (sodium chloride bufus, solvent for the preparation of dosage forms for injection 0.9%)",1
Other,placebo (saline),1
Other,placebo (methylcellulose) capsule,1
Other,placebo (initial vaccination period),1
Other,phage therapy,1
Other,personal protective testing booth,1
Other,personal protective equipment from biological hazard,1
Other,pandemic control measures,1
Other,"oxygen-ozone therapy, probiotic supplementation and standard of care",1
Other,oxygen treatment,1
Other,oxygen saturation monitoring,1
Other,oxygen mask,1
Other,overnight intensive recovery / extended post anaesthetic care in pacu,1
Other,others(no intervention),1
Other,osteopathic manipulative treatment (omt),1
Other,oropharyngeal and intestinal microbiota,1
Other,oral-b® gum & enamel care -cetylpyridinium chloride,1
Other,oral intervention with cetylpyridinium chloride,1
Other,oral and nasal spray by distilled water to control group,1
Other,optional questionnaire completion,1
Other,optional blood completion,1
Other,optimized management of covid-19 positive kidney transplant recipients: single center experience from the middle east,1
Other,online survey questionnaire,1
Other,online survey about dietary and lifestyle habits,1
Other,online questionnaire and interviews,1
Other,pacebo: calcium citrate,1
Other,pandemic period,1
Other,personal freedom message,1
Other,paraclinical examination,1
Other,peroxyl,1
Other,peripheral blood,1
Other,perceived stress scale,1
Other,peep trial,1
Other,patients with hemopathy,1
Other,patients recovering from covid19 receive usual care by allied health professionals,1
Other,patients received standard of care treatment during hospitalization,1
Other,patients covid 19,1
Other,patients admitted to intensive care unit with sars-cov2,1
Other,patients admitted in intensive care units,1
Other,patient with sar-cov-2 infection,1
Other,patient sampling,1
Other,patient quality of life assessment,1
Other,patient management suffering of coronavirus infection,1
Other,patient characteristics,1
Other,passed infection of sars-cov-2,1
Other,particle measurement,1
Other,placebo saline,1
Other,placebo tablet,1
Other,placebo therapy,1
Other,public space exposure,1
Other,pt-x and imt,1
Other,pt pal,1
Other,psychometric scale administration,1
Other,psychological support,1
Other,psychological and sociological interviews,1
Other,psychoeducational intervention,1
Other,psychoeducation,1
Other,psycho-social questionnaire,1
Other,psycho-education video,1
Other,pss (perceived stress scale),1
Other,psqi,1
Other,psg,1
Other,protocolised mechanical ventilation strategy,1
Other,protective ventilation,1
Other,prospective study with two measurement points investigating the impact of viral mitigation protocols on parental burnout,1
Other,prospective study across two time-points examining the impact of viral mitigation protocols on mental health,1
Other,prospective observation,1
Other,ptsd check list (pcl) scale,1
Other,pulmonary and motor rehabilitation,1
Other,prospective cohort in high body mass index patient with covid 19,1
Other,pulmonary physiotherapy techniques,1
Other,questionnaire and optional interview,1
Other,questionnaire and interview,1
Other,"questionnaire administration,blood sampling and genetic analyses.",1
Other,questionnair about emerging legal and ehical disputes over patient confidentiality,1
Other,questionaire,1
Other,quesionnair,1
Other,querying the insee database,1
Other,quantitative analysis for professionals,1
Other,quantitative analysis for patients,1
Other,quality of live assessment,1
Other,quality of life questionnaires,1
Other,quality of life promotion,1
Other,quality of life assessment,1
Other,qualitative interviews (in 40 patients : 20 with covid-19 and 20 without covid-19),1
Other,qualitative analysis for professionals,1
Other,pulmonary telerehabilitation,1
Other,pulmonary tele-rehabilitation,1
Other,prospective oberservational registry,1
Other,prospective chart review,1
Other,placebo vaccine,1
Other,predictors of health care provide,1
Other,predictive factors for clinical response in patients with covid-19.,1
Other,prediction market,1
Other,"predict admission of covid-19 patients to icu and death with routine and quickly avalaible clinical, biological and radiological variables?",1
Other,pre-operative screening,1
Other,prayer,1
Other,postural positioning,1
Other,postpartum women under investigation for coronavirus or diagnosed with covid-19,1
Other,"post traumatic, anxiety and depression evaluation",1
Other,post covid-19 functional satus scale,1
Other,poct,1
Other,plethysmography & dlco,1
Other,plasma therapy using convalescent plasma with antibody against sars-cov-2,1
Other,plasma sampling,1
Other,plasma hyperimmune,1
Other,plasma expansion with ringer's acetate,1
Other,plasma donation,1
Other,plasebo acupressure,1
Other,predictors adverse evolution,1
Other,pregnant women under investigation for coronavirus or diagnosed with covid-19,1
Other,proprietary extract of nerium oleander,1
Other,prevalence of covid-19,1
Other,prophylaxis,1
Other,prone lying position,1
Other,prone decubitus,1
Other,prone,1
Other,prolonged proned positioning,1
Other,prolectin-m; a (1-6)-alpha-d-mannopyranose class,1
Other,project echo,1
Other,progressive muscle relaxation training,1
Other,progressive cycling exercise test to exhaustion,1
Other,produce prescription program,1
Other,probiotics,1
Other,probiorinse,1
Other,pro-sero-cov,1
Other,"pro bnp , vitamin d",1
Other,primary exposure is hypoxia (no intervention),1
Other,"primary care professionals reports of potential patient safety incidents, non-covid-19 related",1
Other,primary care,1
Other,stool analysis,1
Other,stp + covid-19 convalescent plasma (cp),1
Other,adipose tissue,1
Procedure,cuff application with inflation,1
Procedure,elective cancer surgery,1
Procedure,ecmo implantation,1
Procedure,ecg,1
Procedure,early definitive treatment,1
Procedure,double gloves,1
Procedure,direct laryngoscopy,1
Procedure,data collection: clinical care assessments,1
Procedure,curently used therapy for covid-19 non-critical patients,1
Procedure,ct-scan with minimal invasive autopsy,1
Procedure,invasive ventilation strategy,1
Procedure,cpap,1
Procedure,covid icu containment measures,1
Procedure,conventional oxygen therapy,1
Procedure,conventional oxygen,1
Procedure,convalescent plasma,1
Procedure,control,1
Procedure,continuous renal replacement therapy,1
Procedure,combined use of a respiratory broad panel multiplex pcr and procalcitonin,1
Procedure,emergency laparotomy,1
Procedure,emergency surgery,1
Procedure,emergency surgical procedures,1
Procedure,endoscopic intervention,1
Procedure,human biological samples,1
Procedure,hip arthropalsty,1
Procedure,high flow nasal cannula,1
Procedure,hfno,1
Procedure,hemodialysis by protein-leaking dialyzer for covid19 maintenance hemodialysis patients,1
Procedure,gastrointestinal endoscopy,1
Procedure,gastric cancer surgery,1
Procedure,follow-up at 14 days,1
Procedure,filiform needles,1
Procedure,fiberoptic bronchoscopy (fob),1
Procedure,facial fractures reduction or osteosynthesis,1
Procedure,extracorporeal left hemicolectomy anastomosis,1
Procedure,extended sampling and procedures,1
Procedure,expanded hemodialysis for covid19 maintenance hemodialysis patients,1
Procedure,evaluation of changes in the diagnostic-therapeutic pathway for patients affected by pancreatic cancer,1
Procedure,endotracheal intubation,1
Procedure,endoscopic procedure,1
Procedure,colorectal resections,1
Procedure,collection of tears and saliva.,1
Procedure,collection of mucosal lining fluid,1
Procedure,awake proning,1
Procedure,autopsy,1
Procedure,auricular neuromodulation,1
Procedure,auditory evoked potentials (aep),1
Procedure,appendicectomy,1
Procedure,appendectomy,1
Procedure,anesthesia management,1
Procedure,an69-standard,1
Procedure,an69-oxiris,1
Procedure,alveolar recruitment,1
Procedure,airway management during sedation or general anesthesia,1
Procedure,abdominal ultrasound,1
Procedure,a survey form was applied to individuals included in the study face-to-face.,1
Procedure,"""sham""-block with placebo (isotone nacl)",1
Other,"ıt will be compared pain, sleep, fatigue, physical activity level and quality of life and questioning exercise habits before and after the covid-19 outbreak in patients with behçet and fmf.",1
Other,zaritt burden interview,1
Other,work requirement exemption months,1
Other,wofb,1
Procedure,awake prone position,1
Procedure,bariatric procedures,1
Procedure,collection of biological samples,1
Procedure,biological sample collection,1
Procedure,clinical examination,1
Procedure,chest physiotherapy using a non-invasive oscillating device,1
Procedure,carotid artery ultrasound measure,1
Procedure,cardiac surgery,1
Procedure,bronchoalveolar lavage (bal),1
Procedure,bronchoalveolar lavage,1
Procedure,bone marrow harvest,1
Procedure,blood test,1
Procedure,blood sample for seroepidemiological investigation,1
Procedure,blood for research purposes,1
Procedure,blood for pharmacokinetic samples,1
Procedure,blood for anti-drug antibody (ada),1
Procedure,blood collection via fingerprick,1
Procedure,"blood collection at day 8, day 16, day 24, month 6 and month 12 after first symptoms from sars-cov-2 infection",1
Procedure,blink and masseter inhibitory reflex,1
Procedure,biopsies of subcutaneous adipose tissue,1
Procedure,biological samples specific to research,1
Procedure,intracorporeal left hemicolectomy anastomosis,1
Procedure,iv deployment of csvf in sterile normal saline iv solution,1
Other,stp + standard plasma (sp),1
Procedure,standard procedure,1
Procedure,surgical procedure for cancer,1
Procedure,surgery,1
Procedure,study arm,1
Procedure,steam inhalations,1
Procedure,standard therapy recommended by the ministry of health of the russian federation.,1
Procedure,standard therapy recommended by the ministry of health of the russian federation and dalargin intramuscular injection combined with dalargin inhalation,1
Procedure,standard therapy recommended by the ministry of health of the russian federation and dalargin intramuscular injection,1
Procedure,standard therapy recommended by the ministry of health of the russian federation and dalargin inhalation,1
Procedure,standard oxygen therapy,1
Procedure,laparoscopic appendectomy,1
Procedure,standard of care.,1
Procedure,standard of care,1
Procedure,standard care,1
Procedure,sphenopalatine ganglion block with placebo (isotone nacl),1
Procedure,sphenopalatine ganglion block with local anesthetic,1
Procedure,sham treatment,1
Procedure,scheduled surgery,1
Procedure,sars cov-2 swabs,1
Procedure,surgical procedures performed under general anesthesia,1
Procedure,surgical repair,1
Procedure,symptom and exposure surveys,1
Procedure,systematic offer of nurse-driven sars-cov-2 screening combined with usual practice,1
Radiation,angiography scanner,1
Radiation,99mtc-pertechnetate aerosol,1
Radiation,99mtc-pertechnetate,1
Procedure,yoga,1
Procedure,vital signs,1
Procedure,vie scope laryngoscopy,1
Procedure,venepuncture,1
Procedure,vascular surgery,1
Procedure,tracheotomy,1
Procedure,tracheostomy with aerosol box in covid-19 positive patients,1
Procedure,tracheostomy,1
Procedure,tracheal intubation and cardiopulmonary resuscitation,1
Procedure,thyroidectomy,1
Procedure,throat swab,1
Procedure,therapeutic plasma exchange (tpe),1
Procedure,"the study evaluates all surgical patients operated, both elective scheduled and emergent cases",1
Procedure,telephone follow-up,1
Procedure,robot assisted percutaneous cardiovascular intervention,1
Procedure,questionnaire,1
Procedure,pulmonary rehabilitation,1
Procedure,neonatal resuscitation without ppe for the prevention of sars-cov-2 infection,1
Procedure,"nasopharyngeal, oropharyngeal, or saliva swab",1
Procedure,nasopharyngeal and throat swab,1
Procedure,muscle biopsy,1
Procedure,mri scans,1
Procedure,modified cariescare international management,1
Procedure,mitral valve surgery,1
Procedure,microcannula harvest adipose derived tissue stromal vascular fraction (tsvf),1
Procedure,mesenchymal stem cells,1
Procedure,meditation therapy,1
Procedure,medical ozone procedure,1
Procedure,mechanical ventilation,1
Procedure,manual acupuncture,1
Procedure,lung ultrasound (lus),1
Procedure,lung ultrasound,1
Procedure,"liver, lung, heart and kidney biopsy",1
Procedure,lateral position (left and right lateral decubitus),1
Procedure,laparoscopic or open appendicectomy,1
Procedure,neonatal resuscitation with ppe for the prevention of sars-cov-2 infection,1
Procedure,non-cardiac surgery,1
Procedure,prone position ventilation,1
Procedure,non-invasive ventilation strategies,1
Procedure,prone position group,1
Procedure,prone position (pp),1
Procedure,press needles,1
Procedure,plasma exchange and convalescent plasma,1
Procedure,placenta-derived mmscs; cryopreserved placenta-derived multipotent mesenchymal stromal cells,1
Procedure,physical therapy,1
Procedure,physical examination,1
Procedure,photobiomodulation and photodynamic therapy,1
Procedure,percutaneous treatment,1
Procedure,orthopaedic surgical procedures,1
Procedure,oral fluid swab,1
Procedure,oral care with/without aerosolization,1
Procedure,operative management,1
Procedure,olfactory rehab,1
Procedure,obstetric anesthesia and analgesia,1
Procedure,observation for study group,1
Procedure,non-operative management,1
Other,woebot substance use disorder,1
Other,without masks,1
Other,wingate exercise test and on-ice testing while wearing a sham face mask,1
Other,teleconsultation either by phone or by computer consultation. quantitative and qualitative approaches to analysis,1
Other,telephone consult,1
Other,telemonitoring and teleorientation,1
Other,telemedicine to remote outpatient visit in bariatric patient,1
Other,telemedicine consultation,1
Other,telehealth monitoring,1
Other,telehealth applications,1
Other,telehealth,1
Other,telegeriatric intervention,1
Other,teleconsultation either by phone or by computer consultation,1
Other,wingate exercise test and on-ice testing while wearing a face mask,1
Other,teleconsultation,1
Other,telecare group,1
Other,tele-rheumatology,1
Other,tele-pulmonary rehabilitation,1
Other,tele-physiotherapy group,1
Other,tele-medicine platform,1
Other,tele-exergaming tablet,1
Other,taste and olfactory function evaluation,1
Other,telephone interview,1
Other,telephone survey,1
Other,"telerehabilitation i̇ntervention, motor learning",1
Other,telerehabilitation-based relaxation exercise group (eg),1
Other,there is no intervention in this study,1
Other,there is no intervention,1
Other,therapy group,1
Other,therapeutic plasma exchange : 3 sessions in 3 consecutive days (day 1 to day 3),1
Other,therapeutic plasma exchange,1
Other,therapeutic exercise and education,1
Other,therapeutic exercise,1
Other,the study does not required,1
Other,the standard protocol only,1
Other,the effects of covid 19 pandemic on the cardiovascular heath of children with autism spectrum disorder,1
Other,"the drugs used before and during the pandemic, the patient's job status, physical activity conditions, pain status",1
Other,"the covid-19 vaccines bnt162b2, mrna-1273 and chadox1",1
Other,the control group will not receive hydroxychloroquine,1
Other,testis pathology samples,1
Other,tested for sars-cov-2 (regardless of the result),1
Other,temporarily holding the raas inhibitor [intervention],1
Other,telestroke,1
Other,tap water,1
Other,taking biological samples,1
Other,t-detect™ sars-cov-2 assay,1
Other,"surgical face mask (vheal med co., ltd., istanbul, turkey)",1
Other,surge index,1
Other,surge capacity,1
Other,supportive tratment,1
Other,supportive services,1
Other,support as usual,1
Other,supine positioning,1
Other,supine position,1
Other,supervised stretching and strengthening exercise,1
Other,supervised exercise training protocol,1
Other,sudarshan kriya yoga (sky),1
Other,study of the synthesis of antibodies directed against sars,1
Other,study group,1
Other,study d,1
Other,study c,1
Other,study b,1
Other,study a,1
Other,stress and anxiety questionnaire,1
Other,"surgery: dynamic hip screw, hemiarthroplasty, hip replacement, intramedullary nail",1
Other,surgical face mask use only,1
Other,systemic indirect endovenous ozone therapy,1
Other,surgical facial mask,1
Other,symptoms questionnare,1
Other,symptoms entered into the covidx application,1
Other,"symptomatology, treatment. daily activities and anxiety for cardiovascular patients survey (strata)",1
Other,symptom survey,1
Other,symprove (probiotic),1
Other,sweat samples (covidog ancillary study),1
Other,swab,1
Other,suspension or maintenance of angiotensin receptor blockers and angiotensin-converting enzyme inhibitors,1
Other,surveys and questionnaires,1
Other,survey work,1
Other,survey to assess post traumatic stress and anxiety at inclusion and 6 months later,1
Other,survey research,1
Other,survey of sars-cov-19 knowledge,1
Other,survey of acceptability of the different self-samples.,1
Other,survey group,1
Other,survey and questionnaire,1
Radiation,high dose radiation 100 cgy,1
Other,this study is non- interventional,1
Other,this study is not an intervention study,1
Other,thoracic lung ultrasound,1
Other,vitaltalk communication skills training,1
Other,virtual individual cognitive simulation therapy,1
Other,virtual care at home,1
Other,virtual care and remote automated monitoring,1
Other,"virtual assistant first, then human coach",1
Other,viral sequence,1
Other,video-based intervention,1
Other,video-based,1
Other,video dance classes,1
Other,video call,1
Other,video based aerobic exercise,1
Other,venipuncture in peripheral vein,1
Other,vehicle + heparin along with best supportive care,1
Other,vcpm,1
Other,vas scale,1
Other,validation of the poct antigen and antibody tests,1
Other,validation of the ngs method,1
Other,validation of the lamp assays,1
Other,virtual village,1
Other,vitamin c,1
Other,vaccine,1
Other,vitamin d,1
Other,whoqol-bref survey,1
Other,whoqol-bref,1
Other,wfi 5% glucose,1
Other,weight counseling,1
Other,weekly assessment,1
Other,webex physical activity program,1
Other,web-based survey,1
Other,web-based redcap survey,1
Other,wearing surgical face mask sprayed with hypertonic saline,1
Other,"wearable devices, saliva samples, survey measures",1
Other,water (e) mouth rinse with the solution provided,1
Other,water,1
Other,washed microbiota transplantation,1
Other,walk test,1
Other,vv-ecmo,1
Other,volunteer of tip-oa program,1
Other,voice symptom scale (voiss),1
Other,vaccine coverage assessment,1
Other,vacciantion status in health care workers,1
Other,thrombin generation test assay,1
Other,treatment group,1
Other,treated with hyperimmune plasma,1
Other,treadmill exercise,1
Other,travelan otc,1
Other,transthoracic echocardiogram (tte),1
Other,transplant patient,1
Other,"training of youth, community health assistants and community health workers.",1
Other,training load,1
Other,training clinicians in basic critical care and the management of severe covid-19 cases,1
Other,traditional proning arm,1
Other,traditional communication tools,1
Other,tr,1
Other,toothpaste with tin fluoride,1
Other,toothpaste with sodium monofluorophosphate,1
Other,toothpaste with sodium fluoride and zinc,1
Other,tools development,1
Other,to determine the prevalence of renal dysfunction in hospitalized children with covid19 in qatar.,1
Other,thromboprofylaxis protocol,1
Other,treatment for covid-19,1
Other,trust in science message,1
Other,v/q spect-ct,1
Other,tsu,1
Other,usual treatments in intensive care unit according to the current state of knowledge,1
Other,usual orientations,1
Other,usual emergency department practice with physician-directed diagnostic testing,1
Other,usual care only,1
Other,usual care control,1
Other,usual antibiotic treatment,1
Other,users,1
Other,use of virus (covid-19) genome sequence report to inform infection prevention control procedures,1
Other,use of non-invasive ventilation,1
Other,use of high flow nasal cannula alone,1
Other,use of facetime with child and parents during induction,1
Other,use of continuous positive airway pressure,1
Other,urine samples,1
Other,urine collection,1
Other,unsupervised physical activities,1
Other,ultrasonography,1
Other,ultraprotective ventilation,1
Other,online cognitive stimulation therapy,1
Other,on-line survey,1
Other,olfactory retraining,1
Other,covid-19 vaccine,1
Other,cries 13 questionnaire,1
Other,cpc+zn,1
Other,cpc,1
Other,covid19,1
Other,covid-19-impact on quality of life questionnaire,1
Other,covid-19 vaccine hesitancy scale in rheumatic diseases,1
Other,covid-19 vaccine hesitancy associated factors,1
Other,covid-19 vaccine education campaign,1
Other,covid-19 treatments,1
Other,"data research, database analysis",1
Other,covid-19 survey,1
Other,covid-19 standard of care,1
Other,covid-19 serology,1
Other,covid-19 positive via testing,1
Other,covid-19 pneumonia,1
Other,covid-19 pcr and serology testing,1
Other,covid-19 monitoring using wearable sensors and smartphone technology,1
Other,covid-19 infection status,1
Other,cross sectional e-survey on surgeons exposed to any educational intervention,1
Other,cross sectional study using scientifically validated psychometric scales,1
Other,cross-sectional observational study,1
Other,cross-sectional study investigating the association of npis with mental health,1
Other,data collection up to 1 year,1
Other,data collection from medical files,1
Other,data collection from lumbar puncture,1
Other,data collection from blood draw,1
Other,data collection (,1
Other,data collecting,1
Other,dass-21 instrument (depression and anxiety),1
Other,dass questionnaire,1
Other,daily syndromic surveillance,1
Other,daily room disinfection,1
Other,customized questionnaire,1
Other,custom vr,1
Other,current care per ucla treating physicians,1
Other,ct-scan,1
Other,ct score,1
Other,cryo lung biopsies,1
Other,cross-sectional survey,1
Other,covid-19 facility,1
Other,covid-19 exposure,1
Other,covid-19 experience surveys,1
Other,convalescent sars covid-19 plasma,1
Other,convalescent plasma from recovered covid 19 donor,1
Other,convalescent plasma application to sars-cov-2 infected patients,1
Other,convalescent plasma,1
Other,convalescent immune plasma,1
Other,control patients,1
Other,control message,1
Other,control intervention,1
Other,control group quality of life assessment,1
Other,control group - waiting list,1
Other,"control group (pharmacotherapy and/or psychotherapy, n=10)",1
Other,control blend,1
Other,contrast-enhanced mri,1
Other,continuous exercise training,1
Other,continuation of arb/acei,1
Other,continuation of acei/arb,1
Other,consultation,1
Other,connor-davidson resilience scale 10 items (cd-risc 10),1
Other,convalescent plasma with antibody against sars-cov-2.,1
Other,conventional management of patients,1
Other,covid-19 e-package: psychological wellbeing for healthcare workers,1
Other,conventional physical therapy,1
Other,covid-19 antibody test,1
Other,covid-19 and intensive care,1
Other,covid-19 + patients,1
Other,covid wheld,1
Other,covid watch,1
Other,covid visitation restrictions,1
Other,covid rehabilitation program for the elderly (core),1
Other,covid positive via testing,1
Other,covid 19 self-questionnaire,1
Other,covid 19 impact,1
Other,covicu,1
Other,coverall personal protective equipment (ppe-c) suit,1
Other,cost,1
Other,coronavirus disease 2019,1
Other,"coronavirus anxiety scale , covid-19 phobia scale",1
Other,conventional vaccine,1
Other,conventional treatment,1
Other,data monitoring for 48h within the first 24 hours of admission for covid-19,1
Other,decision science-based design,1
Other,olfactory and gustatory tests,1
Other,encephalography measurement,1
Other,epidemiological and demographic characteristics,1
Other,epic risk score display,1
Other,epi-net intervention,1
Other,epds (edinburgh postnatal depression scale),1
Other,eno breathe group,1
Other,enduring happiness and continued self-enhancement (enhance) for covid-19,1
Other,endotracheal intubation,1
Other,endoscopic management according to standard of care,1
Other,emergency general surgical admissions,1
Other,decision tool for clinicians,1
Other,embarrassment message,1
Other,elmo project at covid-19: study in humans,1
Other,electronic survey questionnaire,1
Other,electronic survey,1
Other,electrolytes,1
Other,eit-group,1
Other,eeg based protocol for deep sedation,1
Other,"educational, culturally appropriate covid-19 messages",1
Other,epidemiology of admissions,1
Other,eproms assessment,1
Other,equipment with smartwatch throughout hospital stay on the general ward,1
Other,escola john talabot,1
Other,experts consensus,1
Other,experimental: questionnaire without precaution information,1
Other,experimental: active care group,1
Other,experience of pandemic,1
Other,exercise training group,1
Other,exercise program,1
Other,exercise manual,1
Other,exercise group,1
Other,exercise capacity,1
Other,exercise booklet,1
Other,evaluation of the epidemiological characteristics of coronavirus infection (sars-cov-2),1
Other,evaluation of skin microvascular flow and reactivity,1
Other,evaluate hacor score effectivity in this patients,1
Other,essential oil blend,1
Other,essence oils,1
Other,esoger,1
Other,escola l'horitzó,1
Other,educational video,1
Other,educational program (cartoon),1
Other,edinburgh postnatal depression scale (edps),1
Other,dig axial,1
Other,differences in triage,1
Other,dietary supplement,1
Other,dietary intervention,1
Other,"dietary counselling on food groups according to iyc feeding practices, who",1
Other,diet tracking and survey,1
Other,dialysis,1
Other,diagnostic test,1
Other,diabetes type 2,1
Other,"determination of physical activity, quality of life, stress levels of isolated people at home with the danger of coronavirus.",1
Other,detection of oral lesions,1
Other,description of groups caracteristics,1
Other,"depression, anxiety and stress scale",1
Other,depression,1
Other,demographic and clinical data obtained from hospital's electronic medical record.,1
Other,deep venous disease diagnostic,1
Other,deep breathing training,1
Other,dect,1
Other,difficulties lived by disabled children's parents in the period of covid-19 pandemic,1
Other,dig tilted,1
Other,economic freedom message,1
Other,digital cardiac counseling,1
Other,economic benefit message,1
Other,echocardiography,1
Other,ecg-holter,1
Other,eat-26 questionnaire,1
Other,dysphagia handicap index (dhi),1
Other,dysautonomia,1
Other,during covid-19 pandemic,1
Other,"duration of hospitalization, mortality rate",1
Other,drugs and supportive care,1
Other,draw blood,1
Other,double-trunk mask,1
Other,doppler echo,1
Other,distilled water with the same colorant as the experimental product,1
Other,dissemination and implementation research,1
Other,discontinuation of arb/acei,1
Other,discontinuation of acei/arb,1
Other,digital storytelling intervention,1
Other,congenital malformation,1
Other,concentrated rehabilitation for patients with persistent symptoms post covid-19,1
Other,concentrated oxygen,1
Other,baseline blood sample,1
Other,best available therapy,1
Other,best available care,1
Other,bereavement virtual support group,1
Other,beck depression inventory (bdi),1
Other,beck depression inventory,1
Other,beck anxiety inventory,1
Other,basic treatment,1
Other,baseline message,1
Other,baseline and during hospitalization blood samples,1
Other,concentrated air,1
Other,balance assessments,1
Other,bacterial species isolated,1
Other,awake proning,1
Other,autopsy,1
Other,autologous stem cell transplantation,1
Other,auto-questionnaires (patients co infected hiv sras-cov-2),1
Other,auricular stimulation,1
Other,attendance by ambulance crew,1
Other,best standard of care,1
Other,betadine (c) mouth rinse with the solution provided,1
Other,big five inventory (bfi) scale,1
Other,biobank,1
Other,blood samples for the study of the humoral response to sars-cov-2 variants and of the cellular response after vaccination against covid-19,1
Other,blood sample and data record,1
Other,blood sample analyses,1
Other,blood donation from convalescent donor,1
Other,blood d-dimer assay,1
Other,blood collection,1
Other,blood and derivatives.,1
Other,biospecimen collection,1
Other,biomedomics covid-19 igm-igg rapid test,1
Other,biomarkers in the long term impact of coronavirus infection in the cardiorrespiratory system,1
Other,"biological samples, questionnaires and interviews",1
Other,biological samples collection,1
Other,biological samples,1
Other,biological sample and clinical data collection,1
Other,biological sample,1
Other,biocollection,1
Other,biochemical analysis,1
Other,asynchronous telerehabilitation programme,1
Other,assisting to the event,1
Other,assessment of the sequelae after hospitalization for sars-cov-2,1
Other,"analysis of cytokine response, innate and adaptive immune response, complement activation, and serum neurofilaments as a marker of neurological damage.",1
Other,analysis of blood samples,1
Other,analog scale,1
Other,an auto-questionnaire comprising three psychometric scales,1
Other,alternate nostril breathing,1
Other,all treatment about covid-2019,1
Other,alcohol-based hand sanitizer,1
Other,alcohol mouthwash (listerine) (d) mouth rinse with the solution provided,1
Other,alcohol based hand sanitizer,1
Other,airway pressure release ventilation,1
Other,airwave oscillometry,1
Other,after-each-case room disinfection,1
Other,after covid-19 pandemic,1
Other,aerobic training,1
Other,aerobic exercises,1
Other,aerobic exercise therapy,1
Other,admission to icu for covid-19,1
Other,adjunctive therapies,1
Other,analysis of cell-mediated and antibody-mediated immunity to sars-cov-2 virus,1
Other,anger message,1
Other,assessment of postnatal depression using the the edinburgh questionnaire between 4 and 6 weeks after delivery,1
Other,anonymous survey,1
Other,assessment of dietary changes in adults in the quarantine,1
Other,"assessment of coagulopathy, platelets activation and platelets-neutrophils interplay",1
Other,assessing the impact of covid-19,1
Other,assembled mask,1
Other,ashmolean website,1
Other,ardsnet,1
Other,ards and covid19 treatments,1
Other,arbs and/or ace inhibitors,1
Other,apps,1
Other,application of cdss to provide nutritional care in breast cancer patients from home,1
Other,appendectomy,1
Other,anxiety and depression assessment,1
Other,anxiety,1
Other,antithrombotic therapy (anticoagulant and/or antiplatelet) before admission for covid19,1
Other,antidiabetic treatment,1
Other,antibody-rich plasma from covid-19 recovered patients,1
Other,anti-sars-cov-2 antibody testing,1
Other,blood sampling (4 per year),1
Other,blood sampling for biobank,1
Other,"blood tests sputum, nasal lavage and brushing",1
Other,colgate total® mouthwash,1
Other,colgate peroxyl® mouthwash,1
Other,colgate periogard® mouthwash,1
Other,cognitive tests,1
Other,cognitive testing,1
Other,cognitive performance test,1
Other,cognitive behavioural group therapy for perinatal anxiety,1
Other,"cognitive behavior therapy (cbt), specifically using the facing your fears (fyf) curriculum",1
Other,coca is an observational study based on retrospective data issued from patient medial file.,1
Other,cns magnetic resonance imaging (mri) imaging,1
Other,closed face shield with surgical face mask use,1
Other,"clinical, laboratory and imaging characteristics of pneumonia",1
Other,"clinical, functional and radiological lung involvement evolution",1
Other,clinical trial matching,1
Other,clinical observation,1
Other,clinical interview,1
Other,clinical diagnosis of covid-19 by a health care professional,1
Other,cig tilted,1
Other,colgate total zero,1
Other,"collection of blood, salivary and nasopharyngeal samples.",1
Other,chx0.12+cpc0.05 oral rinse (perioaidactive control),1
Other,collection of samples,1
Other,comprehensive treatment,1
Other,complication,1
Other,complex diagnostic panel,1
Other,completion of survey after peak of pandemic,1
Other,completion of pre-pandemic survey,1
Other,completion of post telemedicine encounter survey,1
Other,complementary and alternative medicine,1
Other,compassion focused intervention,1
Other,comparator,1
Other,comparative observational cohort study,1
Other,community-driven messages to promote covid-19 testing,1
Other,community popular opinion leader (pol) based intervention,1
Other,community mask,1
Other,community interest message,1
Other,community health worker support,1
Other,communication type,1
Other,colonoscopy,1
Other,cig axial,1
Drug,desidustat,1
Other,body position change,1
Other,care modalities,1
Other,cardiovascular magnetic resonance (cmr) imaging,1
Other,cardiorespiratory exercise,1
Other,cardiopulmonary resuscitation,1
Other,cardiopulmonary exercise test,1
Other,cardiopulmonary exercise (online-based),1
Other,cardiopulmonary exercise (centre-based),1
Other,cardiac surgery,1
Other,cardiac and electrodermal recordings,1
Other,cam-icu 7 score,1
Other,brief psychiatric rating scale,1
Other,brief cope scale,1
Other,bresci̇a-covi̇d respiratory severity scale,1
Other,breathing exercises,1
Other,"breathing exercise, intensive spirometry use, supported cough, progressive mobilisation and ambulation",1
Other,breathing exercise with the phone application,1
Other,brain mri scan,1
Other,brain mri assessment,1
Other,care as usual,1
Other,care modalities. quantitative and qualitative approaches to analysis,1
Other,chlorhexidine gluconate (a) mouth rinse with the solution provided,1
Other,caring contacts,1
Other,chiropractic care (one visit),1
Other,chiropractic care (more than one visit),1
Other,chiropractic care,1
Other,chinese medicine treatment,1
Other,chest physiotherapy post-covid19,1
Other,chest ct scan,1
Radiation,cardiac magnetic resonance,1
Other,check-list including lung ultrasound,1
Other,chart review,1
Other,change in kidney function and proteinuria,1
Other,certified cloth face mask plus preventive information,1
Other,cellular and antibody response to spike antigens of sars-cov-2 in both groups in peripheral blood samples,1
Other,cash transfer,1
Other,case fatality rate,1
Other,"cartography of air contamination, environment contamination and biological fluid by sars-cov2 during visceral surgery in covid19 patients.",1
Other,caring contacts without an introductory phone call (cc),1
Other,caring contacts plus introductory phone call (cc+),1
Other,exposed to the novel coronavirus disease 2019,1
Other,exposure (not intervention) - sars-cov-2 infection,1
Other,exposure to covid19,1
Other,modified rankin score,1
Other,muscle-target oral nutritional supplementation,1
Other,multisystem inflammatory syndrome in children (mis-c),1
Other,mri,1
Other,mr-pro-adm,1
Other,moxibustion plus cupping,1
Other,motivational messages,1
Other,mortality,1
Other,monitoring for aggravation,1
Other,modified bai he gu jin tang,1
Other,low peep - fio2 low,1
Other,modification of the planned therapeutic management,1
Other,moderate intensity aerobic exercises,1
Other,moderate exercise training (age group 3; above 45 years),1
Other,moderate exercise training (age group 2; 31 to 45 years),1
Other,moderate exercise training (age group 1; young adult 17 -30 years),1
Other,model validation,1
Other,model building,1
Other,mobile internet survey on self-test,1
Other,museum virtual guided tours,1
Other,n/a - samples collected along routine care samples only,1
Other,na (no intervention),1
Other,nacl 0.9%,1
Other,neutral writing control,1
Other,neuromuscular electrical stimulation,1
Other,neuro -,1
Other,neuro +,1
Other,negative control,1
Other,nebulized sterile saline,1
Other,"ncapp, a cell phone-based auto-diagnosis system",1
Other,nbi images and/or videos,1
Other,nasopharyngeal swabbing procedure (self swabbing first),1
Other,nasopharyngeal swabbing procedure (conventionnal swabbing first),1
Other,naser al-husban,1
Other,nasal swab,1
Other,nasal spray containing anti-sars-cov-2 antibodies derived from bovine colostrum,1
Other,nasal lavage,1
Other,nasal irrigation,1
Other,nasal brushing,1
Other,nacl solution,1
Other,mmrc (modified medical research council) dyspnea scale,1
Other,mindfulness rounds,1
Other,mindfulness based intervention,1
Other,maternal stress,1
Other,"maternal attachment, edinburgh depression scoring and postpartum anxiety scale scores",1
Other,matched placebo hydroxychloroquine,1
Other,maslach burnout inventory questionnair,1
Other,masked saline placebo,1
Other,management strategy of outpatient with mild to moderate sars-cov-2 pneumonia,1
Other,maintenance or reduction of immunosuppression,1
Other,magnetic resonance spectroscopy (mrs).,1
Other,machine learning/ai algorithm,1
Other,machine learning,1
Other,machine based evaluation,1
Other,lung ultrasound (lus),1
Other,lung ultrasound,1
Other,lung mechanics at different peep,1
Other,lung ct scan analysis in covid-19 patients,1
Other,low-intensity psychosocial interventions through telemental health,1
Other,low-intensity aerobic training,1
Other,low tailored message plus covid-19 vaccine message,1
Other,maternal sars-cov-2 infection,1
Other,maximal effort test,1
Other,microscopy of defined brain regions on autopsy specimens,1
Other,measurement of circulating sflt1 concentration,1
Other,microcrystalline cellulose capsule,1
Other,mhealth assessments,1
Other,methylene-blue photodisinfection,1
Other,mesenchymal stromal cell-based therapy,1
Other,mesenchymal stem cells,1
Other,mental health student,1
Other,medium chain triglyceride oil,1
Other,medical research council (mrc) dyspnea scale,1
Other,medical record review - inpatient treatment,1
Other,medical record review,1
Other,medical follow-up,1
Other,medical consultation,1
Other,media intervention,1
Other,mechanical trombectomy,1
Other,measurement of sublingual microcirculation,1
Other,measurement of respiratory muscle force,1
Other,measurement of oxygen saturation,1
Other,new ppe,1
Other,newborns from covid 19 positive mothers,1
Other,news score,1
Other,nutritional intervention,1
Other,nutrition support,1
Other,nutrition,1
Other,"nursing care to reduce anxiety, fear and loneliness",1
Other,not bravery message,1
Other,"not applicable, this is an observational study",1
Other,not applicable as observational study,1
Other,not applicable (observational study),1
Other,not applicable (na),1
Other,nosocomial infection/hospital acquired infection,1
Other,"normal saline solution (nss), placebo, day 21 - phase 2",1
Other,"normal saline solution (nss), placebo, day 21 - phase 1",1
Other,"normal saline solution (nss), placebo, day 189 - phase 2",1
Other,"normal saline solution (nss), placebo - phase 2",1
Other,"normal saline solution (nss), placebo - phase 1",1
Other,normal saline placebo,1
Other,normal saline 0.9%,1
Other,"none, this study is observational",1
Other,nutritional assessment,1
Other,obesity,1
Other,none - na,1
Other,observation group 1,1
Other,olfaction testing,1
Other,old ppe,1
Other,ointment and dressing for external use,1
Other,off the shelf vr,1
Other,ofatumumab,1
Other,obvio-19 app,1
Other,observational study only,1
Other,observational only,1
Other,observational of different courses of sars-cov-2 infection in different phases (acute vs. post-acute) and settings,1
Other,observational cohort study on the natural history of hospitalized sars-cov-2 patients.,1
Other,observation to monitor patients for these infections,1
Other,observation only,1
Other,"observation of patients with known, suspected, or at risk for covid-19 infection",1
Other,observation of different courses of sars-cov-2 infection in different phases (acute vs. post-acute) and settings,1
Other,observation of covid 19 pneumonia,1
Other,observation of breathing pattern,1
Other,observation no intervention,1
Other,none - observational,1
Other,none - descriptive study,1
Other,nhanes smell and taste tests,1
Other,no intervention-mechanistic study,1
Other,"no intervention, observational",1
Other,"no intervention, observation only",1
Other,"no intervention will be administered, this is a retrospective observational study.",1
Other,no intervention performed,1
Other,no intervention on patients,1
Other,no intervention is planned,1
Other,no intervention as it is an observational study,1
Other,no intervention / evaluation of the ferritin and glycosylated ferritin by standard approved serological tests,1
Other,no intervention / compare the difference in respiratory rate between h0 and h12 of the initiation of morphine between the control and interventional groups,1
Other,no intervention - quality of life measure,1
Other,no intervention - exposure is to covid-19,1
Other,no intervention (survey study for medical doctors).,1
Other,no intervention (only interview),1
Radiation,low dose whole lung radiotherapy for older patients with covid-19 pneumonitis,1
Other,no active intervention (observational only),1
Other,nitazoxanide placebo,1
Other,nil intervention,1
Other,"no intervention, this is an observational study that uses validated questionnaires and qualitative interviews..",1
Other,no intervention. method study. psychometric testing,1
Other,none (observational study),1
Other,no intervention. observational cohort study,1
Other,none (not interventional),1
Other,non-interventional study,1
Other,non-hospitalization procedures,1
Other,non invasive visual acuity testing,1
Other,non intervention,1
Other,non applicable,1
Other,no special intervention,1
Other,no screening testing strategy,1
Other,no rinsing,1
Other,no research related technology based social interactions,1
Other,no message,1
Other,no intervetion will be used,1
Other,no interverntion,1
Other,no interventions planned,1
Other,"no interventions performed. just collecting data, blood samples and post-mortem biopsies.",1
Other,no interventional study,1
Other,no intervention; observational study,1
Other,low tailored message,1
Other,low peep - fio2 high,1
Other,"exposure to telemedicine, after the onset of the pandemic",1
Other,group 1,1
Other,health enhancement program,1
Other,hd-tdcs 4ma,1
Other,hd-tdcs 2ma,1
Other,guilt message,1
Other,guduchi ghanvati,1
Other,group1,1
Other,group b (sample collection),1
Other,group a (sample collection),1
Other,grocery store gift cards,1
Other,lopinavir/ ritonavir placebo,1
Other,"gps reports of potential patient safety incidents, non-covid-19 related",1
Other,gown personal protective equipment (ppe-g) suit,1
Other,gm-csf,1
Other,glycaemic levels,1
Other,glucose control and sensor usage,1
Other,global survey,1
Other,general public cohort,1
Other,general lifestyle advice to breast cancer patients by phone,1
Other,health questionnaire,1
Other,healthcare workers with the coronavac vaccine,1
Other,healthy lifestyle advise,1
Other,hemodynamics changes at different peep,1
Other,hospital treatment of covid disease,1
Other,hospital bedroom booking,1
Other,hospital anxiety and depression scale,1
Other,hospital admission,1
Other,home-use test and follow-up questionnaire,1
Other,home-cov rule implementation,1
Other,home-based stretching and strengthening exercise,1
Other,home-based exercise,1
Other,home sample collection of concerning mole with physician supervision,1
Other,home exercise program,1
Other,home exercise,1
Other,home care monitoring,1
Other,hit-exercise,1
Other,high-intensity aerobic training with high protein diet,1
Other,high peep without end inspiratory pause,1
Other,high peep with end inspiratory pause,1
Other,high intensity interval training,1
Other,gastroscopy in transnasal techique,1
Other,gas exchanges at different peep,1
Other,gad-7 general anxiety disorder scale,1
Other,"ffp2\n95 protective face mask (musk protective technology, gaziantep, turkey)",1
Other,fenofibrate/fenofibric acid,1
Other,feeling good digital app,1
Other,feces samples (covi-biome ancillary study),1
Other,fecal and oral samples,1
Other,favipiravir placebo,1
Other,fatigue severity scale,1
Other,farmalarm,1
Other,face-to-face rehabilitation,1
Other,face-to-face consultation,1
Other,eye movement desensitisation and reprocessing recent traumatic event protocol,1
Other,extra-cvd virtual care,1
Other,extra blood sample,1
Other,exposure: covid-19 infection,1
Other,exposure to the sars-cov-2 and its consequences,1
Other,exposure to the sars-cov-2,1
Other,"exposure to the fics annual meeting (june 9-11 2021, paris congress center)",1
Other,exposure to the dutch measures due to the covid-19 pandemic.,1
Other,ffp2 respirator,1
Other,ffp3 respirator,1
Other,gad-7 (generalized anxiety disorder) scale (post containment),1
Other,fibrin generation markers assays,1
Other,gad-7 (generalized anxiety disorder) scale (during containment),1
Other,gad-7 (general anxiety disorder) scale,1
Other,gad-7 (7-item generalized anxiety disorder),1
Other,further processing of health data,1
Other,fulfilling questionaires,1
Other,frequency,1
Other,food diary,1
Other,follow-up visit,1
Other,follow-up phone call,1
Other,follow-up of patients with covid-19,1
Other,follow-up based,1
Other,follow up calls,1
Other,focus group discussions,1
Other,fluorescein,1
Other,filling in an online survey,1
Other,file inquiry,1
Other,fibromyalgia impact questionnaire,1
Other,hospitalisation for sars-cov2 infection,1
Other,"hospitalisation, necessity of icu, mortality rate, lung involvement",1
Other,hospitalization,1
Other,"ivermectin 5 mg/ml oral solution, dexamethasone 4-mg injection, aspirin 250 mg tablets",1
Other,investigation of the prevalence of test positivity,1
Other,investigation of smell and taste disorders,1
Other,invasive mechanical ventilation,1
Other,intravenous saline injection (placebo),1
Other,intestinal parasite,1
Other,interview by psychologists,1
Other,intervention training:,1
Other,intervention group_rehabilitation program,1
Other,intervention group,1
Other,internet-based intervention,1
Other,intensive care unit admission ratio,1
Other,integrated clinical evaluation,1
Other,inspiratory muscle training placebo group,1
Other,inspiratory muscle training group,1
Other,inspiratory muscle training,1
Other,inspiratory muscle and exercise training,1
Other,inspiratory + expiratory muscle training placebo group,1
Other,it is a survey,1
Other,"ivermectin 5 mg/ml oral solution, dexamethasone 4-mg injection, enoxaparin injection. inpatient treatment with mechanical ventilation in icu.",1
Other,injectable placebo,1
Other,ivermectin impregnated mask,1
Other,longcovidkidsdk,1
Other,longan nasal spray,1
Other,local standard of care,1
Other,liver injury,1
Other,life questionnaires,1
Other,leukapheresis,1
Other,let it out (lio)-c,1
Other,less-frequency hemodialysis,1
Other,learning running subcuticular sutures on the gamified educational network,1
Other,laughter theraphy,1
Other,labs,1
Other,laboratory test positive for sars-cov-2 virus,1
Other,kinesiotherapy protocol,1
Radiation,low-dose radiotherapy,1
Other,ketogenic diet,1
Other,kb109 + self supportive care,1
Other,kaplan meier analysis,1
Other,inspiratory + expiratory muscle training group,1
Other,inhaled supplemental oxygen,1
Other,hospitalization for premature birth,1
Other,"immune response monitoring , blood samples",1
Other,ier-r (posttraumatic stress),1
Other,identification of genetic variants,1
Other,icu recovery + physical therapy,1
Other,ice swimming,1
Other,"hypoxia : 14.3 and 12.7% fio2, hypercapnia 7% co2, inspiratory mechanical constraint",1
Other,hypothermia via cooling machine- arctic sun 5000,1
Other,hypertension,1
Other,hyperbaric oxygen therapy,1
Other,hyper immunoglobulins containing anti-corona vs2 immunoglobulin,1
Other,hydroxychloroquine/chloroquine,1
Other,hydrogen peroxide (b) mouth rinse with the solution provided,1
Other,human milk donors,1
Other,"human coach first, then virtual assistant",1
Other,host immune factors,1
Other,host genotype,1
Other,hospitalized patients for covid-19 infection,1
Other,hospitalized children with covid19,1
Other,ilr implantation,1
Other,impact event score,1
Other,inhalation of n-acetylcysteine,1
Other,impact of event scale-revised,1
Other,"inhalation of 8,4% sodium bicarbonate",1
Other,inhalation of 5% sodium chloride,1
Other,infusion placebo,1
Other,infrared energy and dietary supplement,1
Other,informed consent,1
Other,information on covid-19,1
Other,inflammatory cytokines and chemokines profiles of patients with dexmedetomidine administration,1
Other,infectious disease and cardiology clinical consultations,1
Other,individualized-chinese herbal medicine,1
Other,individualised ayurveda,1
Other,incidence of bleeding complications in ards patients on veno-venous ecmo,1
Other,incentive spirometer/respiratory exerciser,1
Other,in-person monitoring,1
Other,in-hospital mortality rate,1
Other,in vivo brain pet-tspo acquisitions,1
Other,impliminting online distance learning,1
Other,impact of respiratory isolation on quality of life,1
Other,chlorine dioxide,1
Drug,canakinumab 150 mg/ml [ilaris],1
Drug,desferal 500 mg injection,1
Biological,microbiome spray,1
Biological,mrna covid-19 vaccine,1
Biological,mrna covd19 vaccine,1
Biological,monitoring of the immune response,1
Biological,mon002,1
Biological,moderna mrna-1273 vaccine,1
Biological,"moderna covid-19 vaccine, mrna-1273 (100 μg)",1
Biological,moderna,1
Biological,mmr vaccine,1
Biological,mf59 adjuvanted sars-cov-2 sclamp vaccine 5mcg,1
Biological,natural killer cells infusion,1
Biological,mf59 adjuvanted sars-cov-2 sclamp vaccine 45mcg,1
Biological,mf59 adjuvanted sars-cov-2 sclamp vaccine 15mcg,1
Biological,mesencure,1
Biological,mesenchymal stromal cells infusion,1
Biological,mesenchymal stem cells transplantation,1
Biological,mesenchymal stem cells derived from wharton jelly of umbilical cords,1
Biological,mesenchymal stem cell therapy,1
Biological,mesenchymal cells,1
Biological,mrna-1273 sars-cov-2 vaccine,1
Biological,mrna-1273 sars-cov-2 vaccine from moderna,1
Biological,mrna-1273 vaccine,1
Biological,mrna-1273.211,1
Biological,nasopharyngeal swabs,1
Biological,nasopharyngeal swab,1
Biological,n-803,1
Biological,mvc-cov1901(saline),1
Biological,mvc-cov1901(s protein with adjuvant),1
Biological,mvc-cov1901(mid-dose),1
Biological,mvc-cov1901 (high-dose),1
Biological,mvc-cov1901,1
Biological,mva-sars-2-st,1
Biological,mva-sars-2-s vaccinations (days 0 & 28),1
Biological,multistem,1
Biological,multiple doses of anti-sars-cov-2 convalescent plasma,1
Biological,multipeptide cocktail,1
Biological,mscs-derived exosomes,1
Biological,mscs,1
Biological,msc treatment,1
Biological,mrna-1283,1
Biological,menacwy vaccine,1
Biological,menacwy single dose + paracetamol,1
Biological,menacwy prime & saline placebo boost + paracetamol,1
Biological,lilly bamlanivimab,1
Biological,licensed seasonal influenza vaccine,1
Biological,licensed covid-19 vaccine,1
Biological,lanadelumab,1
Biological,koçak-19 inaktif adjuvanlı covid-19 vaccine 6 µg/0.5 ml vaccine,1
Biological,koçak-19 inaktif adjuvanlı covid-19 vaccine 4 µg/0.5 ml vaccine,1
Biological,kds-1000,1
Biological,kamada anti-sars-cov-2,1
Biological,jnj-78436735,1
Biological,ixekizumab,1
Biological,"investigational vaccine against sars-cov-2 [mv-014-212] dosage 3, two doses, intranasal drops",1
Biological,"investigational vaccine against sars-cov-2 [mv-014-212] dosage 3, single dose, intranasal spray",1
Biological,"investigational vaccine against sars-cov-2 [mv-014-212] dosage 3, single dose, intranasal drops",1
Biological,"investigational vaccine against sars-cov-2 [mv-014-212] dosage 2, single dose, intranasal drops",1
Biological,"investigational vaccine against sars-cov-2 [mv-014-212] dosage 1, single dose, intranasal drops",1
Biological,intravenous infusions of stem cells,1
Biological,intravenous immunoglobulin therapy,1
Biological,intravenous immune globulin,1
Biological,ligilactobacillus salivarius mp101,1
Biological,lilly bamlanivimab + etesevimab,1
Biological,menacwy boost,1
Biological,liquid alpha1-proteinase inhibitor (human),1
Biological,menacwy,1
Biological,medium dosage inactivated sars-cov-2 vaccine on a 0- and 14-day schedule,1
Biological,matching placebo,1
Biological,ly3819253,1
Biological,low-dose recombinant sars-cov-2 vaccine (cho cell),1
Biological,low-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years) & two dose regimen,1
Biological,low-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years) & three dose regimen,1
Biological,low-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years) & two dose regimen,1
Biological,low-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years) & three dose regimen,1
Biological,low-dose placebo (60-85 years) & two dose regimen,1
Biological,low-dose placebo (60-85 years) & three dose regimen,1
Biological,low-dose placebo (18-59 years) & two dose regimen,1
Biological,low-dose placebo (18-59 years) & three dose regimen,1
Biological,low or upper respiratory tract sample,1
Biological,low dose of kbp-covid-19,1
Biological,low dosage inactivated sars-cov-2 vaccine on a 0- and 14-day schedule,1
Biological,longeveron mesenchymal stem cells (lmscs),1
Biological,nasovax,1
Biological,nbp2001 adjuvanted with alum (rbd 30μg/dose),1
Biological,respiratory infections,1
Biological,primary exposure status of pfizer-biontech covid-19 vaccine,1
Biological,qazcovid-in®-vaccine against covid-19,1
Biological,qazcovid-in® - covid-19 inactivated vaccine,1
Biological,ptx-covid19-b,1
Biological,psc-04,1
Biological,protrans®,1
Biological,prolastin,1
Biological,primepro™/ primemsk™,1
Biological,primepro,1
Biological,pneumococcal vaccine,1
Biological,nbp2001 adjuvanted with alum (rbd 50μg/dose),1
Biological,plasma from convalescent patients with covid-19,1
Biological,plasma from a volunteer donor,1
Biological,plasma exchange,1
Biological,plasma,1
Biological,placebo; 0.9% saline,1
Biological,placebo/aluminum adjuvant of inactivated sars-cov-2 vaccine,1
Biological,placebo vaccine,1
Biological,placebo spray,1
Biological,quadrivalent influenza vaccine (qiv),1
Biological,randomized booster,1
Biological,rapa-501-allo off-the-shelf therapy of covid-19,1
Biological,ravulizumab,1
Biological,"reporting of anosmia, ageusia and other clinical symptoms",1
Biological,regeneron casirivimab + imdevimab,1
Biological,rectal swab,1
Biological,recovered covid 19 patients plasma,1
Biological,recombinant two-component covid-19 vaccine (cho cell),1
Biological,recombinant sars-cov-2 ad5 vectored vaccine,1
Biological,recombinant novel coronavirus vaccine (adenovirus type 5 vector) for inhalation,1
Biological,recombinant novel coronavirus vaccine (adenovirus type 5 vector) 0.5ml,1
Biological,recombinant novel coronavirus vaccine (adenovirus type 5 vector) 0.3ml,1
Biological,recombinant novel coronavirus vaccine (adenovirus type 5 vector) -placebo,1
Biological,recombinant new coronavirus vaccine (cho cell) group,1
Biological,recombinant ndv vectored vaccine for sars-cov-2,1
Biological,recombinant interferon alfa-2b,1
Biological,recombinant human anti-sars-cov-2 monoclonal antibody(25mg/kg;50mg/kg;100mg/kg),1
Biological,recombinant ad5 vectored covid-19 vaccine,1
Biological,recently vaccination,1
Biological,rbd-based protein subunit vaccine (zf2001) against covid-19,1
Biological,placebo on a 0- and 14-day schedule,1
Biological,placebo for inhalation,1
Biological,placebo booster,1
Biological,oral polio vaccine + information,1
Biological,one covid-19 vaccine candidate (tmv-083) administration - high dose,1
Biological,omalizumab,1
Biological,octagam 10%,1
Biological,observational study: this registry data will provide more specific information about how people with blood cancer respond to covid-19 virus and/or a covid-19 vaccination.,1
Biological,nvx-cov2373,1
Biological,normal saline 0.9%,1
Biological,normal saline,1
Biological,non-convalescent plasma (control plasma),1
Biological,non-convalescent fresh frozen plasma (standard plasma),1
Biological,non applicable,1
Biological,"nk cells,il15-nk cells,nkg2d car-nk cells,ace2 car-nk cells,nkg2d-ace2 car-nk cells",1
Biological,nk cells,1
Biological,nitrate-deplete beetroot juice,1
Biological,ngm621,1
Biological,nestacell®,1
Biological,nebulized platelet lysate,1
Biological,ndv-hxp-s vaccine,1
Biological,one dose of bnt162b2 vaccine,1
Biological,other vaccine against sars-cov-2,1
Biological,placebo 2,1
Biological,otilimab,1
Biological,placebo 1,1
Biological,placebo - phase i,1
Biological,"placebo (two doses), priming",1
Biological,placebo (plasma-lyte 148),1
Biological,phosphate-buffered saline,1
Biological,pfizer-biontech covid-19 vaccine bnt162b2 (30 µg)( comirnaty®),1
Biological,pfizer-biontech covid-19 vaccine,1
Biological,pfizer comirnaty vaccine,1
Biological,pfizer,1
Biological,peripheral blood samples,1
Biological,pembrolizumab (mk-3475),1
Biological,peginterferon beta-1a,1
Biological,pathogen-specific aapc,1
Biological,pathogen reduced sars-cov-2 convalescent plasma,1
Biological,partially hla-matched sars-covsts,1
Biological,ozone auto-hemotherapy,1
Biological,oxford-astrazeneca covid-19 vaccine,1
Biological,intradermal injection of bcg vaccine,1
Biological,ino-4800,1
Biological,injection of secretome-mscs,1
Biological,covid-higiv,1
Biological,covishield,1
Biological,covigenix vax-001 placebo,1
Biological,covigenix vax-001,1
Biological,covigen 4.0 mg im or placebo im,1
Biological,covigen 2.0 mg im or placebo im,1
Biological,covigen 0.8 mg id or placebo id,1
Biological,covid19 vaccine,1
Biological,covid19 convalescent plasma infusion,1
Biological,covid-evax,1
Biological,injection and infusion of lv-smenp-dc vaccine and antigen-specific ctls,1
Biological,covid-19 vaccine moderna dispersion for injection - moderna biotech,1
Biological,covid-19 vaccine astrazeneca suspension for injection,1
Biological,covid-19 vaccination,1
Biological,covid-19 specific t cell derived exosomes (cstc-exo),1
Biological,"covid-19 inactive vaccine, recombinant human adenovirus serotype number 26, mrna vaccine",1
Biological,covid-19 exposure,1
Biological,covid-19 convalescent plasma treatment,1
Biological,covid-19 convalescent plasma (ccp) plus standard of care (soc),1
Biological,coviv only (1st and 2nd dose),1
Biological,coviv+iiv4; coviv+ppv23,1
Biological,covivac,1
Biological,cpg 1018/alum-adjuvanted scb-2019 vaccine,1
Biological,ds-5670a,1
Biological,dose finding phase (mtd),1
Biological,determination of covid-19 vacciantion efficacy,1
Biological,descartes 30,1
Biological,dental pulp mesenchymal stem cells,1
Biological,delns1-ncov-rbd laiv,1
Biological,decidual stromal cells (dsc),1
Biological,db-001,1
Biological,cyp-001,1
Biological,cynk-001,1
Biological,cvncov 6 μg,1
Biological,cvncov 12μg,1
Biological,cvncov 12 μg,1
Biological,ct-p59/placebo,1
Biological,ct-p59,1
Biological,csl760,1
Biological,csl324,1
Biological,covid-19 convalescent plasma (ccp),1
Biological,covid-19 convalescent hyperimmune plasma,1
Biological,covid-19,1
Biological,concentrate beetroot juice,1
Biological,comparable placebo,1
Biological,comirnaty - biontech manufacturing gmbh,1
Biological,"comirnaty (covid-19, mrna vaccine)",1
Biological,comirnaty,1
Biological,collection of blood samples in order to create a biocollection,1
Biological,collection of biological samples,1
Biological,cohort 3 hdt 301 vaccine,1
Biological,cohort 2 hdt 301 vaccine,1
Biological,cohort 1 hdt 301 vaccine,1
Biological,clbs119,1
Biological,ck0802,1
Biological,chulacov19 mrna vaccine,1
Biological,chadv68-s-tce,1
Biological,chadv68-s,1
Biological,chadox1-s [recombinant],1
Biological,chadox1 ncov-19 two dose + paracetamol,1
Biological,chadox1 ncov-19 single dose + paracetamol,1
Biological,completion of covid19 vaccine at least 4 weeks ago,1
Biological,control (albumin 5%),1
Biological,covid vaccines,1
Biological,convalescent anti-sars-cov-2 plasma,1
Biological,covid 19 convalescent plasma,1
Biological,covi-vac,1
Biological,covi-guard,1
Biological,covepit (ose13e),1
Biological,covaxin,1
Biological,covax-19™,1
Biological,covac-2,1
Biological,coronovac,1
Biological,coronavac vaccine,1
Biological,convp,1
Biological,convalescent plasma treatment,1
Biological,convalescent plasma transfusion,1
Biological,convalescent plasma of patients with covid-19,1
Biological,convalescent plasma infusion,1
Biological,convalescent plasma as therapy for covid-19 patients,1
Biological,convalescent plasma 2 units,1
Biological,convalescent plasma 1 unit,1
Biological,dupilumab,1
Biological,dvx201,1
Biological,emapalumab,1
Biological,hyperimmune plasma,1
Biological,human umbilical cord derived cd362 enriched mscs,1
Biological,human normal immunoglobulin (ivig),1
Biological,human cord tissue mesenchymal stromal cells,1
Biological,hmsc,1
Biological,hiv,1
Biological,high-titer covid-19 convalescent plasma (ht-ccp),1
Biological,high-titer convalescent covid-19 plasma (ccp1),1
Biological,high-titer anti-sars-cov-2 plasma,1
Biological,high-dose recombinant sars-cov-2 vaccine (cho cell),1
Biological,high-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years) & two dose regimen,1
Biological,high-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years) & three dose regimen,1
Biological,high-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years) & two dose regimen,1
Biological,high-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years) & three dose regimen,1
Biological,high-dose placebo (60-85 years) & two dose regimen,1
Biological,high-dose placebo (60-85 years) & three dose regimen,1
Biological,high-dose placebo (18-59 years) & two dose regimen,1
Biological,high-dose placebo (18-59 years) & three dose regimen,1
Biological,human umbilical cord mesenchymal stem cells + best supportive care,1
Biological,"ic14, a monoclonal antibody against cd14",1
Biological,high dosage inactivated sars-cov-2 vaccine on a 0- and 14-day schedule,1
Biological,iibr-100 high-dose (prime),1
Biological,infusion iv of mesenchymal stem cells,1
Biological,inactive sars-cov-2 vaccine (vero cell),1
Biological,inactivated sars-cov-2 vaccine (vero cell）,1
Biological,inactivated sars cov 2 vaccine (vero cell) wuhan/beijing/placebo,1
Biological,in01 vaccine,1
Biological,immunoglobulin,1
Biological,immune response characterization,1
Biological,immune plasma,1
Biological,imm-101,1
Biological,imdevimab,1
Biological,iiv4 for the 1st dose and ppv23 for the 2nd dose,1
Biological,"iibr-100, low dose (prime)",1
Biological,iibr-100 top-dose (prime-boost),1
Biological,iibr-100 medium-dose (prime-boost),1
Biological,iibr-100 medium dose (prime),1
Biological,iibr-100 low-dose (prime-boost),1
Biological,iibr-100 high-dose (prime-boost),1
Biological,high dose of kbp-covid-19,1
Biological,hepatitis a vaccine,1
Biological,eq001,1
Biological,gam-covid-vac lyo,1
Biological,fluvirin,1
Biological,flucelvax,1
Biological,flu shot,1
Biological,ffp,1
Biological,f-652,1
Biological,exposure to covid-19,1
Biological,experimental group,1
Biological,exg-5003,1
Biological,exchange blood transfusion from normal donor,1
Biological,ex vivo expanded wharton's jelly mesenchymal stem cells,1
Biological,evaluation of the immunogenicity of the vaccine in haemodialysis patients,1
Biological,eucorvac-19,1
Biological,erucov-vac 6 µg/0.5 ml vaccine,1
Biological,erucov-vac 3 µg/0.5 ml vaccine,1
Biological,erucov-vac,1
Biological,equine covid-19 antiserum,1
Biological,eq001 placebo,1
Biological,fluzone high dose,1
Biological,gamunex-c,1
Biological,had5-s-fusion+n-etsd (suspension for injection),1
Biological,"garadacimab, factor xiia antagonist monoclonal antibody",1
Biological,group b (placebo),1
Biological,group b (ag0302-covid19),1
Biological,group a (placebo),1
Biological,group a (ag0302-covid19),1
Biological,gls-5310,1
Biological,gc5131,1
Biological,gbp510 adjuvanted with as03 (rbd 25μg/dose)- stage 2,1
Biological,gbp510 adjuvanted with as03 (rbd 25μg/dose) - stage 1,1
Biological,gbp510 adjuvanted with as03 (rbd 10μg/dose) - stage 2,1
Biological,gbp510 adjuvanted with as03 (rbd 10μg/dose) - stage 1,1
Biological,gbp510 adjuvanted with alum (rbd 25μg/dose)- stage 2,1
Biological,gbp510 adjuvanted with alum (rbd 25μg/dose) - stage 1,1
Biological,gbp510 adjuvanted with alum (rbd 10μg/dose) - stage 2,1
Biological,gbp510 adjuvanted with alum (rbd 10μg/dose) - stage 1,1
Biological,gbp510 (rbd 25μg/dose)- stage 2,1
Biological,gbp510 (rbd 25μg/dose) - stage 1,1
Biological,gbp510 (rbd 10μg/dose) - stage 1,1
Biological,rescure™,1
Biological,risankizumab,1
Biological,chadox1 ncov-19 full boost,1
Combination Product,stem cell educator-treated mononuclear cells apheresis,1
Device,actigraphy,1
Device,accuchek inform ii platform,1
Device,a 940-nm diode laser,1
Device,2019-ncov igg/igm rapid test cassette,1
Device,18f-fdg pet-ct,1
Combination Product,tomeka®,1
Combination Product,systemic treatment,1
Combination Product,stem cells,1
Combination Product,standard therapy for covid-19 patient,1
Device,bva-100,1
Combination Product,standard therapy,1
Combination Product,standard care,1
Combination Product,smoliv,1
Combination Product,shampoo and saline,1
Combination Product,shampoo and listerine,1
Combination Product,saline and saline,1
Combination Product,saline and listerine,1
Combination Product,respiratory rehabilitation,1
Device,active pbmt/smf,1
Device,adam sensor,1
Device,aerosol box (splashguard),1
Device,aerosol-reducing mask,1
Device,bone conduction headphones,1
Device,biovitals,1
Device,biosensors,1
Device,bidirectional oxygenation mouthpiece,1
Device,bedside lung ultrasound,1
Device,automated oxygen administration - freeo2,1
Device,auscul-x,1
Device,auricular percutaneous neurostimulation,1
Device,audio-visual triage system (avt),1
Device,assist,1
Device,arfc mask,1
Device,apple watch series 5,1
Device,anne one,1
Device,alexa amazon,1
Device,akl-t01,1
Device,airgo respiratory monitor,1
Device,airflo2,1
Combination Product,recombinant bacterial ace2 receptors -like enzyme of b38-cap (rbace2) plus aerosolized 13 cis retinoic acid,1
Combination Product,quinquina-stevia/azythromycin,1
Combination Product,purwet,1
Combination Product,immunofree tablets and reginmune capsule,1
Combination Product,hyperbaric oxygen,1
Combination Product,hydroxycloroquine and azythromycine,1
Combination Product,hydroxychloroquine/azithromycine,1
Combination Product,hydroxychloroquine sulfate + azithromycin,1
Combination Product,hydroxychloroquine plus nitazoxanide,1
Combination Product,hydroxychloroquine and azithromycin,1
Combination Product,hydroxychloroquine + azithromycin + / - tocilizumab,1
Combination Product,glutamine,1
Combination Product,furfat,1
Combination Product,favipiravir and hydroxychloroquine,1
Combination Product,drugs: na-831 (0.20 mg/kg) plus gs-5734 (2.00 mg/kg),1
Combination Product,drugs: na-831 (0.10 mg/kg) plus gs-5734 (1.00 mg/kg),1
Combination Product,cospherunate/phytomedicine/azythromycien,1
Combination Product,cospherunate/azythromycine,1
Combination Product,control group,1
Combination Product,comparable placebo of oral polio vaccine and placebo of drug,1
Combination Product,combination of oral polio vaccine and na-831,1
Combination Product,hyperbaric oxygen treatment (hbot) i.e. inhalation of pressurized oxygen delivered by a hyperbaric chamber (drug/device),1
Combination Product,inopulse,1
Combination Product,purphl,1
Combination Product,insulin film,1
Combination Product,purinf,1
Combination Product,purclo,1
Combination Product,purapo,1
Combination Product,placebo 0.20 mg + 2.00 mg/kg,1
Combination Product,placebo 0.10 mg + 1.00 mg/kg,1
Combination Product,placebo,1
Combination Product,observational (registry),1
Combination Product,nutrition consult and protein supplementation,1
Combination Product,no severe covid-19,1
Combination Product,na-831and dexamethasone,1
Combination Product,na-831 and atazanavir,1
Combination Product,"menthol 0.02%, methyl salicylate 0.05%, n- acetyl cysteine 1.2 gm%, and diclofenac sodium 1gm%",1
Combination Product,mefloquine + azithromycin + / - tocilizumab,1
Combination Product,js016 (anti-sars-cov-2 monoclonal antibody),1
Combination Product,"jinhua qinggan (jhqg) granules, traditional chinese medicine",1
Combination Product,ivermectin plus nitazoxanide,1
Combination Product,iota carrageenan nasal spray and ivermectin oral drops (used as buccal drops),1
Device,butterfly iq,1
Device,c2rx,1
Biological,rph-104 80 mg,1
Device,current ipac-uhn ppe,1
Device,dexcom g6,1
Device,device: physiomer undiluted seawater nasal spray,1
Device,device used to record voice for screening,1
Device,cytosorb-therapy,1
Device,cytosorb 300 ml device,1
Device,cytosorb,1
Device,cytokine hemadsorption,1
Device,cytokine adsorption,1
Device,current health,1
Device,c3+ holter monitor,1
Device,ct-v,1
Device,ct-imaging,1
Device,ct of the chest,1
Device,crp-apheresis,1
Device,cri management,1
Device,cpap treatment,1
Device,covx,1
Device,covvr,1
Device,dianose,1
Device,digital oximeter monitoring,1
Device,digivis visual acuity app,1
Device,direct laryngoscope,1
Device,ensoetm device,1
Device,emergency ventilator splitter,1
Device,ema + automated text message intervention,1
Device,elmo project at covid-19: proof of concept and usability,1
Device,electronic portable aromatic rehabilitation (epar) diffuser,1
Device,electrical stimulation - sham,1
Device,electrical stimulation,1
Device,electrical impedance tomography,1
Device,electric pad for human external pain therapy,1
Device,elecsys semi-quantitative anti-sars-cov-2 antibody test,1
Device,echocardiography,1
Device,ecco2r,1
Device,earsats pulse oximeter probe,1
Device,e-ink screen,1
Device,double-trunk mask,1
Device,doctor spot,1
Device,doctella telehealth monitoring,1
Device,covsurf drug delivery system,1
Device,covidfree@home,1
Device,covid-19 sars-cov igg/igm antibody rapid test,1
Device,connected devices measurements,1
Device,closed-loop control of oxygen supplementation by o2matic,1
Device,cliniporator® and epsgun,1
Device,cliniporator,1
Device,clinical decision support system based on non-invasive multimodal monitoring,1
Device,chatbot on covid-19 vaccine hesitancy,1
Device,cereset research,1
Device,cerebral compliance and hemodynamics monitoring,1
Device,centricyte 1000,1
Device,cbc-diff monocyte volume width distribution,1
Device,carragelose,1
Device,carrageenan nasal and throat spray,1
Device,cardiac and electrodermal recordings,1
Device,caption ai,1
Device,capillary blood glucose testing with masked cgm,1
Device,capillary and salivary sampling,1
Device,canswab,1
Device,calm meditation app,1
Device,cloth face mask,1
Device,continuous blind glucose measurement device (free style pro),1
Device,covid-19 barrier box,1
Device,continuous glucose monitor (cgm),1
Device,covid 19 on pregnancy outcomes,1
Device,cov-scan rapid covid-19 antigen test,1
Device,coronacheck device,1
Device,core warming,1
Device,cordio app,1
Device,conventional therapy first,1
Device,conventional oxygen therapy,1
Device,conventional n95 respirator,1
Device,conventional (low flow) oxygen delivery via nasal cannula,1
Device,control swab,1
Device,control group,1
Device,contrast-enhanced cmr,1
Device,continuous vital sign monitoring - isansys patient status engine,1
Device,continuous positive airway pressure (cpap) treatment,1
Device,continuous positive airway pressure (cpap) therapy using oxyjet,1
Device,continuous positive airway pressure,1
Device,"continuous glucose monitoring (cgm, dexcom g6)",1
Combination Product,co-ultrapealut,1
Combination Product,cardiovascular and respiratory systems monitoring,1
Combination Product,azithromycin with amoxicillin/clavulanate,1
Biological,sbi-101,1
Biological,serological covid-19 vaccine immunogenicity,1
Biological,"selenium, zinc and copper, vitamin a, d, e plasma concentrations during patient hospitalization",1
Biological,scta01 placebo,1
Biological,screening test for covid ( rt pcr and ct chest),1
Biological,scb-2019 with cpg 1018 adjuvant plus alum adjuvant,1
Biological,scb-2019 with as03 adjuvant,1
Biological,scb-2019,1
Biological,sc-ad6-1,1
Biological,sarscov2 convalescent plasma,1
Combination Product,azd7442,1
Biological,sars-cov2-ctls,1
Biological,sars-cov-2 vlp vaccine,1
Biological,sars-cov-2 virus vaccines,1
Biological,"sars-cov-2 vaccine(vero cell), inactivated",1
Biological,sars-cov-2 vaccine formulation 2 without adjuvant,1
Biological,sars-cov-2 vaccine formulation 2 with adjuvant 2,1
Biological,sars-cov-2 vaccine formulation 2 with adjuvant 1,1
Biological,sars-cov-2 vaccine formulation 1 with adjuvant 2,1
Biological,serological surveillance,1
Biological,serological test,1
Biological,serology sars-cov2,1
Biological,serology test,1
Biological,stool collection or fecal swab,1
Biological,standard-titer convalescent covid-19 plasma (ccp2),1
Biological,standard plasma (ffp),1
Biological,standard of care (soc) plus placebo,1
Biological,standard donor plasma,1
Biological,st266,1
Biological,sras-cov-2 vaccination immunological response,1
Biological,sputnik v,1
Biological,specific antibody and cellular immune response after anti-sars-cov-2 vaccine administration,1
Biological,specific anti-sars-cov-2 antibodies,1
Biological,soc plus 15mg/kg eb05 iv,1
Biological,sinopharm vaccine,1
Biological,sinopharm,1
Biological,"shingrix (zoster vaccine recombinant, adjuvanted)",1
Biological,serum tube collection,1
Biological,serum test,1
Biological,serology testing profiles description,1
Biological,sars-cov-2 vaccine formulation 1 with adjuvant 1,1
Biological,"sars-cov-2 vaccine (vero cells), inactivated",1
Biological,"sars-cov-2 vaccine (vero cell), inactivated",1
Biological,sars-cov-2 mrna vaccine formulation 2,1
Biological,sars-cov-2 mrna vaccine (cvncov),1
Biological,sars-cov-2 mrna vaccine,1
Biological,sars-cov-2 convalescent plasma treatment,1
Biological,sars-cov-2 antigen-specific cytotoxic t-lymphocytes,1
Biological,sars-cov-2 antibody based ivig therapy,1
Biological,sars-cov-2 adjuvanted recombinant protein vaccine (monovalent),1
Biological,sars-cov-2 adjuvanted recombinant protein vaccine (bivalent),1
Biological,sarilumab,1
Biological,sample,1
Biological,sam-lnp-s-tce,1
Biological,sam-lnp-s,1
Biological,saliva sample,1
Biological,saline placebo,1
Biological,saline control,1
Biological,saline containing 1% human serum albumin（solution without uc-mscs）,1
Biological,"sab-185 (3,840 units/kg)",1
Biological,"sab-185 (10,240 units/kg)",1
Biological,sars-cov-2 mrna vaccine formulation 1,1
Biological,sars-cov-2 mrna vaccine formulation 3,1
Biological,sars-cov-2 vaccine (inactivated),1
Biological,sars-cov-2 neutralizing antibody titer,1
Biological,sars-cov-2 vaccine,1
Biological,sars-cov-2 vaccination,1
Biological,sars-cov-2 specific t cells,1
Biological,sars-cov-2 rs/matrix-m1 adjuvant (initial vaccination period),1
Biological,sars-cov-2 rs/matrix-m1 adjuvant (crossover vaccination period),1
Biological,sars-cov-2 rs/matrix-m1 adjuvant,1
Biological,"sars-cov-2 rs/matrix-m adjuvant, days 0 and 21 - phase 2",1
Biological,"sars-cov-2 rs/matrix-m adjuvant, day 0 - phase 2",1
Biological,"sars-cov-2 rs/matrix-m adjuvant, day 0 - phase 1",1
Biological,sars-cov-2 rs/matrix-m adjuvant - phase 1,1
Biological,sars-cov-2 rs/matrix-m adjuvant - day 189 - phase 2,1
Biological,sars-cov-2 rs/matrix m1-adjuvant,1
Biological,sars-cov-2 rs - phase 1,1
Biological,sars-cov-2 recombinant protein vaccine formulation 3,1
Biological,sars-cov-2 recombinant protein vaccine formulation 2,1
Biological,sars-cov-2 recombinant protein vaccine formulation 1,1
Biological,sars-cov-2 non-immune plasma,1
Biological,stools,1
Biological,t memory cells and nk cells,1
Biological,t regulatory cells,1
Biological,vaxzevria,1
Biological,vaccine inoculation against sars-cov-2,1
Biological,vaccine bcg,1
Biological,vaccine anti-covid19,1
Biological,vaccination with janssen vaccine followed with pfizer vaccine (heterologous boosting).,1
Biological,vaccination with janssen vaccine followed with moderna vaccine (heterologous boosting).,1
Biological,vaccination with janssen vaccine followed with janssen vaccine (homologous boosting).,1
Biological,vaccination once with janssen vaccine (only priming),1
Biological,vaccinated with polio vaccine (ipv),1
Biological,v591,1
Biological,v590,1
Biological,v-sars,1
Biological,umbilical cord wharton's jelly-derived human,1
Biological,umbilical cord mesenchymal stem cells + heparin along with best supportive care.,1
Biological,umbilical cord mesenchymal stem cells,1
Biological,umbilical cord lining stem cells (ulsc),1
Biological,umbilical cord derived mesenchymal stem cells,1
Biological,ucmscs,1
Biological,vaccine therapy,1
Biological,vbi-2902a,1
Biological,"two doses of placebo at the schedule of day 0, 28（high-dose group）",1
Biological,vir-7831 (gen1),1
Combination Product,autologous activated platelet-rich plasma,1
Combination Product,atazanavir and dexamethasone,1
Combination Product,aerosolized all-trans retinoic acid plus oral tamoxifen,1
Combination Product,aerosolized 13 cis retinoic acid plus inhalation inhaled testosterone,1
Combination Product,aerosolized 13 cis retinoic acid plus inhalation administration by nebulization captopril 25mg,1
Combination Product,aerosolized 13 cis retinoic acid in combination with spike protein based vaccine,1
Combination Product,acupuncture and standard care,1
Combination Product,80 ppm nitric oxide delivered through lungfit delivery system,1
Combination Product,4plants/azythromycin,1
Combination Product,150 ppm nitric oxide delivered through lungfit delivery system,1
Combination Product,13 cis retinoic acid doses orally in combination with spike protein based vaccine,1
Biological,zofin,1
Biological,wj-mscs,1
Biological,vxa-cov2-1,1
Biological,viral vector vaccine,1
Biological,viral specific t-cells (vsts),1
Biological,vir-7831 (gen2),1
Biological,"two doses of placebo at the schedule of day 0, 28（middle-dose group）",1
Biological,"two doses of placebo at the schedule of day 0, 14 #middle-dose group#",1
Biological,tak-019,1
Biological,two dose chadox1 ncov-19/covishield 0.5ml,1
Biological,two covid-19 vaccine candidate (tmv-083) administrations - low dose,1
Biological,two covid-19 vaccine candidate (tmv-083) administrations - high dose,1
Biological,trv027,1
Biological,trivalent split influenza vaccine,1
Biological,tozinameran,1
Biological,to monitor the effectiveness of the single dose ad26.cov2.s covid-19 vaccine,1
Biological,tigerase® and best available care,1
Biological,thymic peptides,1
Biological,"three doses of placebo at the schedule of day 0, 14, 28（high-dose group）",1
Biological,"three doses of placebo at the schedule of day 0, 14, 28 #middle-dose group#",1
Biological,"three doses of placebo at the schedule of day 0, 14, 28 #high-dose group#",1
Biological,"three doses of middle-dose recombinant sars-cov-2 vaccine (cho cell) at the schedule of day 0, 14, 28",1
Biological,"three doses of high-dose recombinant sars-cov-2 vaccine (sf9 cell) at the schedule of day 0, 14, 28",1
Biological,"three doses of high-dose recombinant sars-cov-2 vaccine (cho cell) at the schedule of day 0, 14, 28",1
Biological,therapeutic plasma exchange (tpe),1
Biological,thawed plasma,1
Biological,tak-919,1
Biological,two dose chadox1 ncov-19/covishield 0.25ml & 0.5ml,1
Biological,two dose menacwy vaccine,1
Biological,"two doses of placebo at the schedule of day 0, 14 #high-dose group#",1
Biological,two dose menacwy vaccine min. 4 weeks apart,1
Biological,two doses of placebo at the routine vaccination schedule,1
Biological,two doses of placebo at the emergency vaccination schedule,1
Biological,"two doses of pilot scale inactivated sars-cov-2 vaccine at the schedule of day 0,14 in elderly",1
Biological,"two doses of pilot scale inactivated sars-cov-2 vaccine at the schedule of day 0,14",1
Biological,"two doses of middle-dose recombinant sars-cov-2 vaccine (sf9 cell) at the schedule of day 0, 28",1
Biological,"two doses of middle-dose recombinant sars-cov-2 vaccine (cho cell) at the schedule of day 0, 14",1
Biological,two doses of medium dosage inactivated sars-cov-2 vaccine at the routine vaccination schedule,1
Biological,two doses of medium dosage inactivated sars-cov-2 vaccine at the emergency vaccination schedule,1
Biological,"two doses of inactivated sars-cov-2 vaccine at the schedule of day 0,28 and one dose quadrivalent influenza vaccine on day 14.",1
Biological,"two doses of inactivated sars-cov-2 vaccine at the schedule of day 0,28 and one dose quadrivalent influenza vaccine on day 0 or day 28.",1
Biological,"two doses of high-dose recombinant sars-cov-2 vaccine (sf9 cell) at the schedule of day 0, 28",1
Biological,"two doses of high-dose recombinant sars-cov-2 vaccine (cho cell) at the schedule of day 0, 14",1
Biological,"two doses of high dosage inactivated sars-cov-2 vaccine at the schedule of day 0,28",1
Biological,two doses of high dosage inactivated sars-cov-2 vaccine at the routine vaccination schedule,1
Biological,two doses of high dosage inactivated sars-cov-2 vaccine at the emergency vaccination schedule,1
Biological,"two doses of commercial scale inactivated sars-cov-2 vaccine at the schedule of day 0,14",1
Biological,two doses of bnt162b2 vaccine,1
Biological,chadox1 ncov-19 half boost,1
Biological,chadox1 ncov-19 0.5ml prime plus boost,1
Drug,deltarex-g,1
Behavioral,internet-delivered cognitive behavior therapy (icbt) for dysfunctional worry related to the covid-19 pandemic,1
Behavioral,"intervention, tbn",1
Behavioral,intervention program,1
Behavioral,intervention group coronacope,1
Behavioral,intervention for tecc model,1
Behavioral,intervention for covid-19 preventive protocols,1
Behavioral,intervention app,1
Behavioral,intervention,1
Behavioral,interpersonal psychotherapy,1
Behavioral,internet-based self-help after 3 weeks,1
Behavioral,mencare+/bandebereho fathers'/couples' group education,1
Behavioral,internet-based self-help,1
Behavioral,internet-based guided self-help based on cbt principles,1
Behavioral,internet-based cognitive behavioral therapy,1
Behavioral,internet cognitive behavioral therapy plus chamindwell,1
Behavioral,intermittent prone positioning instructions,1
Behavioral,insurance navigation,1
Behavioral,instrumental activities of daily living shaping,1
Behavioral,informed,1
Behavioral,"knowledge, attitude, practice, awareness, preference",1
Behavioral,kukaa salama: mhealth intervention,1
Behavioral,kundalini yoga and anxiety reduction training,1
Behavioral,lay telephone coaching,1
Behavioral,meditation and anxiety reduction training,1
Behavioral,medication review,1
Behavioral,medical music,1
Behavioral,mechanical ventilator settings and position,1
Behavioral,maslach burnout inventory (mbi),1
Behavioral,low-intensity remote patient monitoring (rpm-low),1
Behavioral,low-concentration essential oil,1
Behavioral,low intensity nudges,1
Behavioral,lottery incentive,1
Behavioral,loss protection,1
Behavioral,lock-down and social distancing,1
Behavioral,lift mindfulness,1
Behavioral,lift,1
Behavioral,lifestyle program,1
Behavioral,lifestyle change promotion program,1
Behavioral,lifestyle (meditation),1
Behavioral,lifestyle (exercise),1
Behavioral,informational videos and social media campaigns encouraging cancer screening.,1
Behavioral,informational sheet,1
Behavioral,information assigned in community,1
Behavioral,heat therapy,1
Behavioral,healthy minds program foundations training,1
Behavioral,healthcare worker focused outreach,1
Behavioral,healthcare providers' communication about the covid-19 vaccine,1
Behavioral,health warning leaflet,1
Behavioral,health care worker survey,1
Behavioral,hbcc project and soap,1
Behavioral,handwashing stations at the public places and no soap,1
Behavioral,hads,1
Behavioral,habit,1
Behavioral,guided online support program,1
Behavioral,growth mindset ssi,1
Behavioral,gratitude,1
Behavioral,gossip intervention,1
Behavioral,geneva emotional competence test (geco),1
Behavioral,generic best practices,1
Behavioral,generalized anxiety disorder-7 (gad-7),1
Behavioral,general recommendation,1
Behavioral,heart rate variability biofeedback,1
Behavioral,high intensity activities,1
Behavioral,independent control,1
Behavioral,high intensity interval training,1
Behavioral,increasing willingness and uptake of covid-19 vaccination,1
Behavioral,increasing willingness and uptake of covid-19 testing and vaccination,1
Behavioral,in-person postoperative visit,1
Behavioral,in-person instruction,1
Behavioral,immediate vs. delayed provision of antibody test results,1
Behavioral,humanistic care,1
Behavioral,hospital: usual care (uc),1
Behavioral,hospital: dd-ca,1
Behavioral,hospital anxiety depression measure,1
Behavioral,hope intervention,1
Behavioral,home-based exercise training,1
Behavioral,home exercise program,1
Behavioral,hiking challenge,1
Behavioral,high-intensity remote patient monitoring (rpm-high),1
Behavioral,high-concentration essential oil,1
Behavioral,high touch multi-pronged behavioral intervention,1
Behavioral,high intensity interval training group,1
Behavioral,meditation app usage,1
Behavioral,mental imagery,1
Behavioral,personal exercise intervention,1
Behavioral,online bibliotherapy programme,1
Behavioral,online psychological intervention for healtchare workers,1
Behavioral,online mindfulness group,1
Behavioral,online lifestyle intervention,1
Behavioral,online kkh sports singapore program with usual care,1
Behavioral,online intervention mental health covid-19,1
Behavioral,online intervention grief covid-19,1
Behavioral,online instruction,1
Behavioral,online cognitive behavioral therapy (cbt),1
Behavioral,occupational health workers,1
Behavioral,message directing subjects to information on covid-19 vaccine safety and efficacy,1
Behavioral,observation of behavior and covid-19 infection will be conducted.,1
Behavioral,observation,1
Behavioral,nurse-community-family partnership intervention,1
Behavioral,nudge,1
Behavioral,non-mindfulness intervention,1
Behavioral,no video,1
Behavioral,no racial inequality highlighting,1
Behavioral,no messaging,1
Behavioral,online social network and collective intelligence intervention,1
Behavioral,online support group,1
Behavioral,online survey,1
Behavioral,onsite point-of-care,1
Behavioral,peer resilience champion,1
Behavioral,peer mentor delivery,1
Behavioral,patient-centred advice on telephone consultation in tb patients:,1
Behavioral,patient mychart scheduling link,1
Behavioral,patient health questionnaire-9 (phq-9),1
Behavioral,patient educational video,1
Behavioral,patient education,1
Behavioral,participate in a massive musical event,1
Behavioral,partial vepmp intervention,1
Behavioral,parentchat for parents of children ages 2-17,1
Behavioral,parent positive,1
Behavioral,overcoming anxiety in pregnancy and postpartum online self-directed program,1
Behavioral,opt-out recruitment email,1
Behavioral,opt-out framing,1
Behavioral,opt-in recruitment email,1
Behavioral,opt-in (in-bound),1
Behavioral,opt-in (call-back),1
Behavioral,no activities of the hbcc project and also no soap (pure control),1
Behavioral,newsfeed function,1
Behavioral,negative covid test result - hypothetical scenario,1
Behavioral,minimal attention control intervention,1
Behavioral,mindfulness-based stress reduction,1
Behavioral,mindfulness-based health promotion,1
Behavioral,mindfulness-based cognitive therapy,1
Behavioral,mindfulness training program,1
Behavioral,mindfulness training (mt) connect,1
Behavioral,mindfulness training,1
Behavioral,mindfulness session(s),1
Behavioral,mindfulness program,1
Behavioral,mindfulness intervention,1
Behavioral,mindfulness based cognitive therapy for resilience during covid-19 plus chamindwell,1
Behavioral,mindfulness alone (mo) intervention,1
Behavioral,mindfulness + compassion intervention (mc),1
Behavioral,mindfullness based cognitive program,1
Behavioral,mind body syndrome therapy for long covid,1
Behavioral,mhealth platform,1
Behavioral,messaging informed by construal level theory,1
Behavioral,messaging,1
Behavioral,mindfulness-sos for refugees,1
Behavioral,minnrap peer support program,1
Behavioral,navigation services,1
Behavioral,mobile mental health app - 1,1
Behavioral,nature+mindfulness,1
Behavioral,nature only,1
Behavioral,narrative writing,1
Behavioral,music therapy,1
Behavioral,muscle relaxation therapy,1
Behavioral,multimodal teleprehabilitation,1
Behavioral,motivational telephone intervention,1
Behavioral,motivational social support from nurse with additional support from significant other,1
Behavioral,motivational social support from nurse,1
Behavioral,motivational interviewing and covid-19 symptom monitoring system,1
Behavioral,motivational interviewing,1
Behavioral,motivation,1
Behavioral,morning yoga-based breathing support,1
Behavioral,mobile phone support,1
Behavioral,mobile mental health app - 4,1
Behavioral,mobile mental health app - 3,1
Behavioral,mobile mental health app - 2,1
Behavioral,general messages,1
Behavioral,general health education,1
Behavioral,general communication message,1
Behavioral,"change in knowledge, motivation, skills, resources",1
Behavioral,clinician endorsement,1
Behavioral,choices and judgements,1
Behavioral,choice of assignment: opt-in,1
Behavioral,choice of assignment: enhanced active choice,1
Behavioral,choice of assignment: active choice,1
Behavioral,chat-based support,1
Behavioral,chat-based instant messaging support,1
Behavioral,change in preference to surgery under covid-19 pandemic.,1
Behavioral,chamindwell,1
Behavioral,gender concordant,1
Behavioral,chair-yoga program,1
Behavioral,chain-referral,1
Behavioral,burnout,1
Behavioral,buddy assigned in community,1
Behavioral,buddy,1
Behavioral,brief skills for safer living,1
Behavioral,brief mindfulness based intervention,1
Behavioral,brief interpersonal telepsychotherapy,1
Behavioral,co-mestring (co-coping),1
Behavioral,"coaching, cleaning, communication, collaboration",1
Behavioral,cognitive and behavioral intervention.,1
Behavioral,cognitive behavioral brief-telepsychotherapy,1
Behavioral,convenient scheduling link,1
Behavioral,controls,1
Behavioral,control period,1
Behavioral,contain covid anxiety ssi,1
Behavioral,connect2test intervention,1
Behavioral,concurrent treatment of ptsd and substance use disorders using prolonged exposure (cope),1
Behavioral,computer task questionnaires,1
Behavioral,compass,1
Behavioral,comparison group,1
Behavioral,comparator,1
Behavioral,"community-based, mobile van testing",1
Behavioral,community organization led outreach,1
Behavioral,communication,1
Behavioral,combination,1
Behavioral,com-covid anonimous survey,1
Behavioral,collection of odour samples,1
Behavioral,cognitive training,1
Behavioral,brief informational infographic,1
Behavioral,brief educational video,1
Behavioral,brief counseling,1
Behavioral,assigned strategies: active choice,1
Behavioral,antimicrobial stewardship prospective audit and feedback,1
Behavioral,ama acknowledgement drug pricing,1
Behavioral,african american sender in informational videos.,1
Behavioral,african american sender acknowledgement,1
Behavioral,advance care planning video and conversation,1
Behavioral,advance care planning video,1
Behavioral,active control:healthy living,1
Behavioral,act,1
Behavioral,"acp educator led, video assisted discussion",1
Behavioral,acknowledgement racial injustice ama,1
Behavioral,acceptance and commitment therapy (act) exercises,1
Behavioral,a survey,1
Behavioral,a $20 survey incentive,1
Behavioral,a $10 survey incentive,1
Behavioral,5-week prevention program,1
Behavioral,4-week intervention,1
Behavioral,2: no instruction regarding positioning,1
Behavioral,anxiety reduction training,1
Behavioral,assigned strategies: enhanced active choice,1
Behavioral,brief cognitive behavioral therapy,1
Behavioral,assigned strategies: opt-in,1
Behavioral,brief behavioral activation with mental imagery,1
Behavioral,breast feeding adherence,1
Behavioral,brac's business-as-usual,1
Behavioral,blended gaming covid-19 training system (bgcts),1
Behavioral,biobehavioral tele-rehabilitation sessions,1
Behavioral,best message alone,1
Behavioral,best message + augmented message or implementation strategy,1
Behavioral,behaviour change technique intervention to improve quality of life,1
Behavioral,behavioral: ocat-sham,1
Behavioral,behavioral: ocat,1
Behavioral,behavioral economics,1
Behavioral,behavioral and cognitive assessment,1
Behavioral,behavioral activation ssi,1
Behavioral,basic body awareness therapy,1
Behavioral,award plus covid-specific advice,1
Behavioral,award advice,1
Behavioral,attention control,1
Behavioral,coping strategies video,1
Behavioral,cosh self-help smoking cessation booklet,1
Behavioral,cost-benefit frame,1
Behavioral,entrée: interpersonal skills,1
Behavioral,entrée: behavioral skills,1
Behavioral,enriched survey feedback,1
Behavioral,enhanced response team,1
Behavioral,enhanced hygiene measures,1
Behavioral,enhanced follow through message,1
Behavioral,emphasis of government involvement,1
Behavioral,emphasis of academic researchers involvement,1
Behavioral,emotional support plan,1
Behavioral,emotional freedom techniques (eft),1
Behavioral,emotional freedom technique,1
Behavioral,emotion regulation training via telehealth,1
Behavioral,emdr,1
Behavioral,ema alone,1
Behavioral,ei open ended pre-survey and semi structured interview,1
Behavioral,ehealth for covid-19 prevention and support,1
Behavioral,ehealth +counselling contacts,1
Behavioral,ehealth,1
Behavioral,entrée: cognitive skills,1
Behavioral,environmental exposure and clinical features,1
Behavioral,educational meetings and visual prompts,1
Behavioral,evaluation,1
Behavioral,gamification,1
Behavioral,full vepmp intervention,1
Behavioral,fsfi survey,1
Behavioral,fresh start,1
Behavioral,focused/targeted message,1
Behavioral,fixed site standard of care testing,1
Behavioral,financial incentives,1
Behavioral,family risk messaging,1
Behavioral,family nurture intervention (fni),1
Behavioral,facebook ads on the importance of staying safe during the thanksgiving / christmas holiday,1
Behavioral,face mask awareness,1
Behavioral,experimental group,1
Behavioral,experimental,1
Behavioral,experience resolution methodology (erm),1
Behavioral,exercise group,1
Behavioral,exercise,1
Behavioral,examine the impact of covid-19 during pregnancy,1
Behavioral,educational vocal health modules,1
Behavioral,education sessions,1
Behavioral,"couple hopes guided, internet-delivered, self-help intervention",1
Behavioral,decisions of limitations and stop processing,1
Behavioral,data collection,1
Behavioral,daily monitoring,1
Behavioral,daily coping toolkit,1
Behavioral,current clinical practices of participating physicians,1
Behavioral,culturally adapted cognitive behavioral intervention (ca-cbi),1
Behavioral,cross-sectional study examining the impact of information sources to obtain information about covid-19 on depression and anxiety symptoms,1
Behavioral,critical dialogue,1
Behavioral,crisis management coaching,1
Behavioral,crisis intervention therapy,1
Behavioral,credible messenger,1
Behavioral,covid19,1
Behavioral,covid-surgres questionaire,1
Behavioral,covid-19 symptom monitoring system,1
Behavioral,covid-19 related health warning leaflet,1
Behavioral,covid-19 positive pregnant women,1
Behavioral,covid-19 breastfeeding support,1
Behavioral,covax facts,1
Behavioral,data registry,1
Behavioral,deep breathing exercise with triflo,1
Behavioral,edinburgh postnatal depression scale,1
Behavioral,delayed vepmp intervention,1
Behavioral,eca-ace vaccination promotion intervention,1
Behavioral,eating habits,1
Behavioral,early rehabilitation,1
Behavioral,early occupational therapy,1
Behavioral,early access,1
Behavioral,e-psychotherapy,1
Behavioral,duty frame,1
Behavioral,doctorgram patient kit,1
Behavioral,distribution of free face masks,1
Behavioral,discussion board for social support+personalized feedback,1
Behavioral,discussion board for social support +basic feedback,1
Behavioral,digital social activity video intervention,1
Behavioral,digital problem solving tool,1
Behavioral,digital health online platform,1
Behavioral,dialectical behavioral therapy (dbt) skills,1
Behavioral,diabetter together,1
Behavioral,desmond,1
Behavioral,personal behaviours,1
Behavioral,personal protective measures,1
Biological,chadox1 ncov-19 0.5ml boost,1
Biological,adimrsc-2f,1
Biological,allogenic pooled olfactory mucosa-derived mesenchymal stem cells,1
Biological,allogeneic wharton's jelly-mscs (wj-msc),1
Biological,allogeneic nk transfer,1
Biological,allogeneic human dental pulp stem cells (bsh btc & utooth btc),1
Biological,aldesleukin,1
Biological,aks-452,1
Biological,adsorbed sars-cov-2 (inactivated) vaccine,1
Biological,administration of equine immunoglobulin anti sars-cov-2,1
Biological,adenovirus type-5 vectored covid-19 vaccine,1
Biological,arct-021 two higher dose priming,1
Biological,adcovid,1
Biological,adcld-cov19,1
Biological,ad5-ncov,1
Biological,act-20-msc,1
Biological,act-20-cm,1
Biological,abncov2 vaccine,1
Biological,abatacept,1
Biological,"a middle-dose recombinant covid-19 vaccine (cho cell) (60-85 years) at the schedule of day 0, 28, 56",1
Biological,anakinra,1
Biological,anti covid 19 intravenous immunoglobulin (c-ivig),1
Biological,anti sars-cov 2 convalescent plasma in critical covid-19 patients,1
Biological,anti sars-cov 2 convalescent plasma in severe covid-19 patients,1
Biological,arct-021 dose regimen 2,1
Biological,arct-021 dose regimen 1,1
Biological,arct-021 dose 4,1
Biological,arct-021 dose 3,1
Biological,arct-021 dose 2,1
Biological,arct-021 dose 1,1
Biological,arct-021,1
Biological,antisars-cov-2 serum,1
Biological,antibody testing,1
Biological,anti-sars-cov-2 immunoglobulin,1
Biological,anti-sars-cov-2 igt seropositivity,1
Biological,anti-covid-19 human immunoglobulin,1
Biological,anti-coronavirus antibodies (immunoglobulins)obtained with dfpp from convalescent patients,1
Biological,anti-coronavirus antibodies (immunoglobulins) obtained with dfpp form convalescent patients,1
Biological,anti-cd14,1
Biological,anti- sars-cov-2 plasma,1
Biological,anti sars-cov-2 equine hyperimmune serum,1
Biological,"a middle-dose recombinant covid-19 vaccine (cho cell) (18-59 years) at the schedule of day 0, 28, 56",1
Biological,"a middle-dose placebo (60-85 years) at the schedule of day 0, 28, 56",1
Biological,"a middle-dose placebo (18-59 years) at the schedule of day 0, 28, 56",1
Behavioral,white sender in informational videos,1
Behavioral,wellness education,1
Behavioral,well-being assessment,1
Behavioral,web-based psychosocial peer-to-peer support,1
Behavioral,web based questionnaire,1
Behavioral,vr for psychoeducation and relaxation,1
Behavioral,virtual-care cognitive behavioural therapy,1
Behavioral,virtual reality exposure therapy,1
Behavioral,virtual peer support platform,1
Behavioral,virtual group intervention,1
Behavioral,virtual group exercise,1
Behavioral,virtual family-based treatment,1
Behavioral,views and experiences of health care professionals working in intensive care units during the covid-19 pandemic,1
Behavioral,video-based psychotherapy,1
Behavioral,video text,1
Behavioral,video chat +personalized feedback,1
Behavioral,video chat + basic feedback,1
Behavioral,video based exercise,1
Behavioral,white sender in acknowledgement,1
Behavioral,who recommendations (waiting condition),1
Biological,"a high-dose recombinant covid-19 vaccine (cho cell) (60-85 years) at the schedule of day 0, 28, 56",1
Behavioral,written information,1
Biological,"a high-dose recombinant covid-19 vaccine (cho cell) (18-59 years) at the schedule of day 0, 28, 56",1
Biological,"a high-dose placebo (60-85 years) at the schedule of day 0, 28, 56",1
Biological,"a high-dose placebo (18-59 years) at the schedule of day 0, 28, 56",1
Biological,50 µg spfn_1b-06-pl + alfq (qs21 adjuvant),1
Biological,30 µg cov2 sam (lnp),1
Biological,"3-doses schedule 3 of covid-19 vaccine (vero cell), inactivated",1
Biological,"3-doses schedule 2 of covid-19 vaccine (vero cell), inactivated",1
Biological,"3-doses schedule 1 of covid-19 vaccine (vero cell), inactivated",1
Biological,3 µg cov2 sam (lnp),1
Biological,25 µg spfn_1b-06-pl + alfq (qs21 adjuvant),1
Biological,2019-ncov pcr,1
Biological,20-valent pneumococcal conjugate vaccine (20vpnc),1
Biological,2 doses of vaccine,1
Biological,10 µg cov2 sam (lnp),1
Biological,1 µg cov2 sam (lnp),1
Behavioral,yoga group,1
Behavioral,written summary of rounds,1
Biological,arct-021 single dose priming,1
Biological,arct-021 two lower dose priming,1
Behavioral,personal risk messaging,1
Biological,bm-allo.msc,1
Biological,bnt162b2sa,1
Biological,bnt162b2.b.1.351,1
Biological,bnt162b2 vaccine,1
Biological,bnt162b2 mrna covid-19 vaccine,1
Biological,bnt162b2 30mcg,1
Biological,bnt162b2 20mcg,1
Biological,bnt162a1,1
Biological,bm-mscs,1
Biological,blood tests,1
Biological,astrazeneca/oxford vaccine,1
Biological,blood samples collection,1
Biological,blood sample collection,1
Biological,blood sample and salivary sample,1
Biological,blood plasma,1
Biological,blood draw,1
Biological,blood collection,1
Biological,biological: spike protein based vaccine such as chadox1 ncov-19 vaccine,1
Biological,biological: oral polio vaccine,1
Biological,bnt162b3,1
Biological,bnt162c2,1
Biological,bone marrow mesenchymal stem cell derived extracellular vesicles infusion treatment,1
Biological,bronchial fibroscopy,1
Biological,chadox1 ncov-19 0.5ml (3.5-6.5x10^10vp) late vaccine two (lvt),1
Biological,chadox1 ncov-19 0.5ml (3.5-6.5x10^10vp) late vaccine (lv),1
Biological,chadox1 ncov-19 (qpcr),1
Biological,chadox1 ncov-19 (abs 260) + 2.2x10^10vp (qpcr) boost,1
Biological,chadox1 ncov-19 (abs 260),1
Biological,cell therapy protocol 2,1
Biological,cell therapy protocol 1,1
Biological,ccp,1
Biological,castem,1
Biological,casirivimab,1
Biological,cap-1002 allogeneic cardiosphere-derived cells,1
Biological,cap-1002,1
Biological,cad3-marburg,1
Biological,cad3-ebo-s,1
Biological,c19-ig 20%,1
Biological,c144-ls and c-135-ls,1
Biological,c135-ls + c144-ls,1
Biological,biological: mrna-1273,1
Biological,biological: covid-19 convalescent plasma,1
Biological,biological/vaccine: recombinant new coronavirus vaccine (cho cells) placebo group,1
Biological,bactrl-spike,1
Biological,bacmune (mv130),1
Biological,bacille calmette-guérin (bcg),1
Biological,azd7442 600 mg im (male),1
Biological,azd7442 300 mg iv (male and female),1
Biological,azd7442 300 mg im(male),1
Biological,azd7442 1000 mg iv (male),1
Biological,azd7442 (iv),1
Biological,azd7442 (im),1
Biological,azd7442,1
Biological,aviptadil,1
Biological,avdoralimab,1
Biological,autologous non-hematopoietic peripheral blood stem cells (nhpbsc),1
Biological,autologous hb-admsc's,1
Biological,autologous adipose-derived stem cells,1
Biological,autologous adipose msc's,1
Biological,at-100,1
Biological,asunercept,1
Biological,bactek-r,1
Biological,bbv152a - phase i,1
Biological,biological/vaccine: recombinant new coronavirus vaccine (cho cells) high-dose group,1
Biological,bbv152a - phase ii,1
Biological,biological/vaccine: recombinant new coronavirus vaccine (cho cell) low-dose group,1
Biological,biological/vaccine: bnt162b2 10mcg,1
Biological,biological/vaccine: angiotensin peptide (1-7) derived plasma,1
Biological,biological test,1
Biological,biological sampling,1
Biological,biological samples,1
Biological,"biological collection with nasopharyngeal samples, saliva, blood, stool and urine",1
Biological,biological collection (patients co infected hiv sras-cov-2),1
Biological,biological assays in particular on the lipid metabolism,1
Biological,biological,1
Biological,bcg vaccine (freeze-dried),1
Biological,bcg group,1
Biological,bcg,1
Biological,bbv154 vaccine,1
Biological,bbv152c - phase i,1
Biological,bbv152b - phase ii,1
Biological,bbv152b - phase i,1
Behavioral,video about safety and effectiveness of adult seasonal flu vaccination,1
Behavioral,"usual care, infection control briefing",1
Behavioral,usual care positioning with no instructions,1
Behavioral,registery data collection,1
Behavioral,"remotely monitored, mhealth (remm) supported high intensity interval training (hiit)",1
Behavioral,remote service delivery model,1
Behavioral,remote pulmonary rehabilitation,1
Behavioral,remote problem management plus,1
Behavioral,remote cognitive behavioral therapy for insomnia,1
Behavioral,remain covid free ssi,1
Behavioral,reinforcement learning message delivery,1
Behavioral,rehabilitation,1
Behavioral,reframing,1
Behavioral,use of social media during covid-19,1
Behavioral,referral card,1
Behavioral,referral and digital brochure,1
Behavioral,recharge,1
Behavioral,reading a book,1
Behavioral,racial/ethnic frame,1
Behavioral,racial inequality highlighted,1
Behavioral,race concordant,1
Behavioral,questionnaire for evaluation of confinement on deviant sexual fantasies,1
Behavioral,resilience program,1
Behavioral,resistance training,1
Behavioral,restore: recovering from extreme stressors through online resources and e-health,1
Behavioral,reward re-training,1
Behavioral,self-help therapy,1
Behavioral,self-help booklet,1
Behavioral,self-guided exercises,1
Behavioral,self-focused acts,1
Behavioral,self-compassion for chronic pain virtual group treatment program,1
Behavioral,"self-collected, home-based testing",1
Behavioral,self-care tools,1
Behavioral,self-benefit,1
Behavioral,self-administered structured questionnaire,1
Behavioral,self-acupressure,1
Behavioral,self study,1
Behavioral,scarcity message,1
Behavioral,scarcity,1
Behavioral,sars-cov-2 vaccine,1
Behavioral,sampler skills,1
Behavioral,saliva-based testing,1
Behavioral,routine psychological support,1
Behavioral,questionnaire completion,1
Behavioral,questionnaire : preparedness for caregiving scale,1
Behavioral,questionaire to husband and wife,1
Behavioral,prayer,1
Behavioral,positive psychotherapy,1
Behavioral,positive psychology (pp) exercises,1
Behavioral,positive feedback,1
Behavioral,positive covid test result - hypothetical scenario,1
Behavioral,placebo videos,1
Behavioral,placebo control (non-behavioral infographic),1
Behavioral,physical therapy that include a standardized cycling training with no additional functional electrical stimulation,1
Behavioral,physical therapy that include a standardized cycling training with functional electrical stimulation,1
Behavioral,physical exercise training,1
Behavioral,physical and cognitive activity,1
Behavioral,physical activity counseling,1
Behavioral,physical activity,1
Behavioral,phone-call screening and management by a medical student/general practitioner tandem,1
Behavioral,phone call,1
Behavioral,phase 3 cardiac rehabilitation,1
Behavioral,personalized health education,1
Behavioral,personalized ambulatory training,1
Behavioral,post-intensive care unit syndrome,1
Behavioral,pre_dinner yoga-based breathing support,1
Behavioral,ptsd,1
Behavioral,pre_lunch yoga-based breathing support,1
Behavioral,pt-pal,1
Behavioral,psychological triaging intervention,1
Behavioral,psychological treatment,1
Behavioral,psychological assessment,1
Behavioral,psychological and physical rehabilitation based humanistic care,1
Behavioral,psychological and behaviour change support,1
Behavioral,psycho-education,1
Behavioral,psychiatric counseling,1
Behavioral,prosocial-benefit,1
Behavioral,prosocial acts,1
Behavioral,promotores de salud,1
Behavioral,prolonged exposure therapy,1
Behavioral,progressive muscle relaxation,1
Behavioral,problem-solving and relationship improvement intervention.,1
Behavioral,problem solving therapy (pst).,1
Behavioral,problem management plus,1
Behavioral,preventive information,1
Behavioral,self-management booklet (switch: stay well during covid-19),1
Behavioral,self-questionnary,1
Behavioral,semi-directive interview,1
Behavioral,transcendental meditation,1
Behavioral,training session adressing information and health literacy,1
Behavioral,"training for awareness, resilience, and action (tara)",1
Behavioral,tobacco use,1
Behavioral,time management & participation & the leisure time activity,1
Behavioral,therapy intervention,1
Behavioral,therapist guided e-therapy,1
Behavioral,theory-based messages,1
Behavioral,the psychosocial effects of covid-19 pandemic on dental professionals,1
Behavioral,the prepare program,1
Behavioral,text messaging only,1
Behavioral,text message content,1
Behavioral,text material for psychoeducation and audio for relaxation techniques,1
Behavioral,telesimulation,1
Behavioral,telepsychoeducation without personalized videos,1
Behavioral,telepsychoeducation with personalized videos,1
Behavioral,telepsychoeducation,1
Behavioral,telephonic medical visit,1
Behavioral,"training video on anxiety, fear and loneliness in the covid-19 environment.",1
Behavioral,transcendental meditation (tm),1
Behavioral,telephone-based coaching,1
Behavioral,transcendental meditation (tm) and experience resolution methodology (erm),1
Behavioral,use of mobile application,1
Behavioral,uniform random message delivery,1
Behavioral,unified protocol for covid-19 parenting stress (up-covid),1
Behavioral,unavailable covid test result - hypothetical scenario,1
Behavioral,ultra brief online mindfulness-based intervention,1
Behavioral,typical surgical covered mask,1
Behavioral,turkish physicians,1
Behavioral,trier social stress test,1
Behavioral,trial-based cognitive therapy,1
Behavioral,treatment as usual (tau),1
Behavioral,treatment as usual,1
Behavioral,trauma-informed yoga video recording,1
Behavioral,trauma informed yoga,1
Behavioral,trauma informed psychotherapy,1
Behavioral,transparent mask,1
Behavioral,transitional online peer support group (n=20),1
Behavioral,transfer package from ci therapy,1
Behavioral,telephonic interview during the italian lockdown.,1
Behavioral,telemedicine visit,1
Behavioral,shared decision making,1
Behavioral,standard charity resources,1
Behavioral,speed of processing training,1
Behavioral,space parenting program,1
Behavioral,software messaging,1
Behavioral,socialization,1
Behavioral,social proof,1
Behavioral,social media & news consumption,1
Behavioral,social distancing advertisements,1
Behavioral,social,1
Behavioral,soap distributed but no activities of the hbcc project,1
Behavioral,sms-based support,1
Behavioral,sms message support,1
Behavioral,smell training,1
Behavioral,sm-ema,1
Behavioral,simulation intervention,1
Behavioral,simple cognitive task,1
Behavioral,simha kriya,1
Behavioral,shg,1
Behavioral,sse educational intervention,1
Behavioral,standard message,1
Behavioral,telehealth phone calls,1
Behavioral,standard response team,1
Behavioral,telehealth coaching sessions,1
Behavioral,tele-interventions related to diabetes management and mental well-being,1
Behavioral,tele-delivered psychological intervention,1
Behavioral,technology based social interactions,1
Behavioral,tailored recommendations,1
Behavioral,tailored best practices,1
Behavioral,surgical mask,1
Behavioral,supportive trauma exposure preparation program,1
Behavioral,supportive therapy ssi,1
Behavioral,supportive therapy,1
Behavioral,subacute rehabilitation,1
Behavioral,student-senior isolation prevention partnership (ssipp),1
Behavioral,structured telephone support (sts),1
Behavioral,striveweekly,1
Behavioral,stress first aid,1
Behavioral,stress and emotion management,1
Behavioral,stigma awareness video intervention,1
Device,esophageal catheter,1
Device,expiratory training device,1
Device,external evacuation device (eed),1
Dietary Supplement,l. reuteri dsm 17938 + vitamin d,1
Dietary Supplement,m capsules 148 mg,1
Dietary Supplement,licorice extract,1
Dietary Supplement,"lactoferrin, green tea extract",1
Dietary Supplement,lactoferrin (apolactoferrin),1
Dietary Supplement,lactoferrin,1
Dietary Supplement,lactobaciltus rhamnosus gg placebo,1
Dietary Supplement,lactobaciltus rhamnosus gg,1
Dietary Supplement,lactobacillus,1
Dietary Supplement,l-citrulline,1
Dietary Supplement,omnibiotic aad,1
Dietary Supplement,ketogenic diet with phytoextracts,1
Dietary Supplement,ketogenic diet,1
Dietary Supplement,investigational product - viracide,1
Dietary Supplement,inflammation (iii),1
Dietary Supplement,inflammation (ii),1
Dietary Supplement,inflammation (i),1
Dietary Supplement,immunoformulation,1
Dietary Supplement,group d:placebo oropharyngeal spray + placebo taken po,1
Dietary Supplement,maf capsules 148 mg,1
Dietary Supplement,manremyc,1
Dietary Supplement,melatonin,1
Dietary Supplement,microbiome immunity formula,1
Dietary Supplement,omega dha / epa,1
Dietary Supplement,"ol-1, standard dose",1
Dietary Supplement,"ol-1, high dose",1
Dietary Supplement,nutritional support system (nss),1
Dietary Supplement,"nusapure standardized olive leaves capsule, 750 mg (50% oleuropein)",1
Dietary Supplement,nricm101,1
Dietary Supplement,nigella sativa oil,1
Dietary Supplement,nicotinamide riboside,1
Dietary Supplement,nicotinamide,1
Dietary Supplement,niagen,1
Dietary Supplement,natural honey,1
Dietary Supplement,nad+,1
Dietary Supplement,n-acetylcysteine,1
Dietary Supplement,n-acetyl glucosamine (nag),1
Dietary Supplement,multivitamin with 11mg of zinc,1
Dietary Supplement,molecular hydrogen,1
Dietary Supplement,"micronized and ultra-micronized palmitoylethanolamide (mpea and umpea, 300mg + 600mg) oral suspension",1
Dietary Supplement,group c:active principle oropharyngeal spray + placebo taken po,1
Dietary Supplement,group b: placebo oropharyngeal spray + active principle immunostimulant,1
Dietary Supplement,group a: oropharygeal spray and immunostimulant,1
Dietary Supplement,best standard of care,1
Dietary Supplement,açaí palm berry extract - natural product,1
Dietary Supplement,azinc,1
Dietary Supplement,ayurvedic kadha,1
Dietary Supplement,ayurveda,1
Dietary Supplement,ascorbic acid and zinc gluconate,1
Dietary Supplement,ascorbic acid,1
Dietary Supplement,asbrip,1
Dietary Supplement,artemesia annua,1
Dietary Supplement,arbox,1
Dietary Supplement,antioxidation therapy,1
Dietary Supplement,anatolian propolis,1
Dietary Supplement,alanine,1
Dietary Supplement,adapt-232 oral solution,1
Dietary Supplement,active placebo,1
Dietary Supplement,acetyl l-carnitine,1
Dietary Supplement,acacia senegal,1
Dietary Supplement,abbc1 immunoessential,1
Dietary Supplement,balanced amino acid,1
Dietary Supplement,best standard of care + cardio,1
Dietary Supplement,glucose tablets,1
Dietary Supplement,bioarginina®,1
Dietary Supplement,full spectrum cbd oil,1
Dietary Supplement,ferinject,1
Dietary Supplement,dietary supplementation in patients with covid disease admitted to hospital,1
Dietary Supplement,diet and sun exposure,1
Dietary Supplement,"ddrops® products, 50,000 iu, oral",1
Dietary Supplement,"d-beta-hydroxybutyrate-(r)-1,3 butanediol monoester",1
Dietary Supplement,cretan iama,1
Dietary Supplement,corn oil (placebo),1
Dietary Supplement,control,1
Dietary Supplement,cod liver oil,1
Dietary Supplement,chinese herbal medicine,1
Dietary Supplement,cellulose-containing placebo capsules,1
Dietary Supplement,cbdra60 supplement,1
Dietary Supplement,cbd isolate,1
Dietary Supplement,bromelain,1
Dietary Supplement,broad-spectrum cbd oil,1
Dietary Supplement,bovine plasma-derived immunoglobulin concentrate,1
Dietary Supplement,omni-biotic pro vi 5,1
Dietary Supplement,oral supplement enriched in antioxidants,1
Drug,20 mg prednisone for 14 days,1
Dietary Supplement,zinc picolinate placebo,1
Drug,0.12% chlorhexidine gluconate mouth rinse,1
Drug,0.12% chlorhexidine gluconate,1
Drug,0.1% sodium hypochlorite,1
Drug,0.075% cetylpyridinium chloride (cpc),1
Drug,0.075% cetylpyridinium chloride,1
Drug,"""vernonia amygdalina""",1
Dietary Supplement,β-hydroxy β-methyl butyrate (hmb) enriched amino acid,1
Dietary Supplement,zinc sulfate 220 mg,1
Dietary Supplement,zinc picolinate,1
Dietary Supplement,ovotransferrin,1
Dietary Supplement,zinc gluconate and ascorbic acid,1
Dietary Supplement,zinc citrate,1
Dietary Supplement,zinc acetate,1
Dietary Supplement,zinc (zinc gluconate) & vitamin d (cholecalciferol),1
Dietary Supplement,zinc (zinc gluconate),1
Dietary Supplement,viusid and asbrip,1
Dietary Supplement,viusid,1
Dietary Supplement,vitamins and minerals,1
Drug,0.12% chlorhexidine oral/nasal rinse,1
Drug,0.5% povidone iodine,1
Drug,0.5% povidone/iodine oral/nasal rinse,1
Drug,0.5% w/v povidone-iodide,1
Drug,1: ilt101,1
Drug,1: discontinuation of ras blocker therapy,1
Drug,18f-αvβ6-bp,1
Drug,10% povidone-iodine nasal decolonization swab plus 0.12% chg oral rinse,1
Drug,1.5% w/v hydrogen peroxide,1
Drug,1.5% hydrogen peroxide (h2o2),1
Drug,1% povidone iodine (pvp-i),1
Drug,1% hydrogen peroxide,1
Drug,0.9%nacl,1
Drug,0.9% sodium-chloride,1
Drug,0.9% sodium chloride (normal saline),1
Drug,0.9% sodium chloride,1
Drug,0.9% normal saline,1
Drug,0.9% (w/v) saline,1
Drug,0.6% pvp-i oral and nasal spray to moderately ill covid-19 positive patient,1
Drug,0.6% pvp-i oral and nasal spray to healthy volunteer,1
Drug,0.6% pvp-i oral and nasal spray to asymptomatic to mild covid-19 patient having multiple comorbidity,1
Dietary Supplement,vitamins,1
Dietary Supplement,vitamine d3 supplementation,1
Dietary Supplement,vitamin k2/d,1
Dietary Supplement,quadramune(tm),1
Dietary Supplement,proper diet,1
Dietary Supplement,probiotics (2 strains 10x10^9 ufc),1
Dietary Supplement,probiotics,1
Dietary Supplement,preservision areds formulation soft gels or tablets,1
Dietary Supplement,plant stanol mini drinks,1
Dietary Supplement,placebo starch,1
Dietary Supplement,placebo oil,1
Dietary Supplement,placebo mini drinks,1
Dietary Supplement,placebo magnesium,1
Dietary Supplement,placebo administration,1
Dietary Supplement,placebo + vitamin d,1
Dietary Supplement,placebo (potato starch and magnesium stearate),1
Dietary Supplement,pectin,1
Dietary Supplement,pealut,1
Dietary Supplement,palmitoylethanolamide,1
Dietary Supplement,ozonized oil (hoo,1
Dietary Supplement,oxaloacetate medical food/dietary supplement,1
Dietary Supplement,propolis,1
Dietary Supplement,quercetin phytosome,1
Dietary Supplement,vitamin k2 in the form of menaquinone-7 (mk-7),1
Dietary Supplement,quercetin phytosome (qp),1
Dietary Supplement,vitamin d3 (cholecalciferol),1
Dietary Supplement,vitamin d supplementation in pregnant women,1
Dietary Supplement,vitamin d supplementation,1
Dietary Supplement,vitamin c/zinc,1
Dietary Supplement,"vitamin c, vitamin b complex and zinc acetate",1
Dietary Supplement,vitamin b12,1
Dietary Supplement,vitamin and trace elements,1
Dietary Supplement,vitamin a supplement,1
Dietary Supplement,taxifolin aqua,1
Dietary Supplement,targeted wellness formula c™ sublingual drops - 1200mg - 30 ml (formula c),1
Dietary Supplement,standard enteral nutrition,1
Dietary Supplement,saisei maf capsules,1
Dietary Supplement,rhea health tone®,1
Dietary Supplement,resveratrol placebo,1
Dietary Supplement,resveratrol,1
Dietary Supplement,quercetin treatment,1
Dietary Supplement,quercetin prophylaxis,1
Dietary Supplement,5-ala-phosphate + sfc (5-ala+sfc),1
Dietary Supplement,5-ala-phosphate + sfc (5-ala + sfc),1
Dietary Supplement,25-oh cholecalciferol,1
Diagnostic Test,sars-cov2 serum antibody testing,1
Diagnostic Test,sequence of testing.,1
Diagnostic Test,senior fitness test,1
Diagnostic Test,semen qualitative analysis,1
Diagnostic Test,semen analysis,1
Diagnostic Test,secret questionnaire,1
Diagnostic Test,schirmer test i,1
Diagnostic Test,scanning chest x-rays and performing ai algorithms on images,1
Diagnostic Test,savicell's immunobiopsy™,1
Diagnostic Test,sars-cov2 serology,1
Diagnostic Test,"xiamen wiz biotech co., ltd. sars-cov-2 antigen rapid test",1
Diagnostic Test,sars-cov2 nasal swab,1
Diagnostic Test,sars-cov2 autoantibody detection,1
Diagnostic Test,sars-cov2 antibody measurement,1
Diagnostic Test,sars-cov-2/influenza/rsv rt-pcr,1
Diagnostic Test,sars-cov-2-test,1
Diagnostic Test,sars-cov-2 testing on the eppendorf thermal cycler pcr system using self-collected saliva as the specimen,1
Diagnostic Test,sars-cov-2 testing,1
Diagnostic Test,sars-cov-2 specific igm and igg detection,1
Diagnostic Test,"serelogy testing, rt pcr",1
Diagnostic Test,serodiagnosis of igg and igm,1
Diagnostic Test,serologic assays for antibodies to sars-cov-2,1
Diagnostic Test,serologic immune response evaluation,1
Diagnostic Test,serology to determine sars-cov-2 infection,1
Diagnostic Test,"serology testing, rt pcr",1
Diagnostic Test,serology test,1
Diagnostic Test,serology for covid-19,1
Diagnostic Test,serological tests will be applied on patients blood sampling,1
Diagnostic Test,serological tests for sars cov-2,1
Diagnostic Test,serological testing for covid-19 infection,1
Diagnostic Test,serological test for the detection of igg anti-sars-cov-2,1
Diagnostic Test,serological test for covid-19.,1
Diagnostic Test,serological test and phone interview,1
Diagnostic Test,serological screening for igg and igm antibodies against covid-19,1
Diagnostic Test,serological screening,1
Diagnostic Test,serological assay or igg for sars-cov-2,1
Diagnostic Test,serological assay for sars-cov-2,1
Diagnostic Test,serologic test,1
Diagnostic Test,serologic sars-cov-2 screening,1
Diagnostic Test,serologic immunoassays to sars-cov-2 antibodies,1
Diagnostic Test,sars-cov-2 serological assessment (igg),1
Diagnostic Test,sars-cov-2 screening by molecular biology,1
Diagnostic Test,sars-cov-2 s1/s2 igg,1
Diagnostic Test,sample collection/performance evaluation (a),1
Diagnostic Test,saliva specimen,1
Diagnostic Test,saliva sampling,1
Diagnostic Test,saliva samples,1
Diagnostic Test,saliva sample combined to an anterior nare self-swabbing (self-samples),1
Diagnostic Test,saliva sample (self-sample),1
Diagnostic Test,saliva and nps test,1
Diagnostic Test,saint george respiratory questionnaire,1
Diagnostic Test,"s-binding igg, rbd-binding igg and n-binding igg immunoassays and sars-cov-2 serum neutralization assay, quantitative serum immunoglobulin tests",1
Diagnostic Test,rt-qpcr test,1
Diagnostic Test,rt-pcr sars-cov2,1
Diagnostic Test,rt-pcr for sars-cov-2,1
Diagnostic Test,rt-pcr covid-19,1
Diagnostic Test,rt-pcr and antibody testing,1
Diagnostic Test,rt pcr sars-cov-2,1
Diagnostic Test,rt pcr,1
Diagnostic Test,roth´s test,1
Diagnostic Test,reviewed clinical records and laboratory results,1
Diagnostic Test,samba ii (diagnostic for the real world),1
Diagnostic Test,sample collection/performance evaluation (b),1
Diagnostic Test,sars-cov-2 rt-pcr assay for detection of covid-19 infection,1
Diagnostic Test,sampling,1
Diagnostic Test,"sars-cov-2 research in nasopharyngeal swab, sperm and serologics",1
Diagnostic Test,"sars-cov-2 rapid diagnostic test (covid-presto® igm/igg, aaz, boulogne-billancourt, france)",1
Diagnostic Test,sars-cov-2 pcr and serology tests,1
Diagnostic Test,sars-cov-2 igg antibody testing kit,1
Diagnostic Test,sars-cov-2 igg,1
Diagnostic Test,sars-cov-2 ig g levels,1
Diagnostic Test,sars-cov-2 antigen rapid test,1
Diagnostic Test,sars-cov-2 antibody testing,1
Diagnostic Test,sars-cov-2 antibody test,1
Diagnostic Test,sars-cov-2 antibody immunoassays,1
Diagnostic Test,sars-cov-2 antibody analysis,1
Diagnostic Test,sars-cov-2 ab,1
Diagnostic Test,sars-cov 2 rna pcr urine,1
Diagnostic Test,sars-cov 2 rna pcr semen,1
Diagnostic Test,sampling salivary,1
Diagnostic Test,sampling of sars-cov-2 rna from nasopharyngeal swab specimen or saliva collected via salivette cortisol,1
Diagnostic Test,"sampling (edta blood, pharyngeal and nose swabs, bronchoalveolar lavage ,urine)",1
Diagnostic Test,"serum collection, adverse events collection",1
Diagnostic Test,serum inflammatory biomarkers,1
Diagnostic Test,serum ngal and cystatin c,1
Diagnostic Test,treadmill test (bruce protocol),1
Diagnostic Test,to assess for development of igg antibodies against sars-cov2,1
Diagnostic Test,tlrs activation measurement,1
Diagnostic Test,titanium blood test,1
Diagnostic Test,thrombomodulin modified thrombin generation assay (tga-tm),1
Diagnostic Test,thrombin generation assay (tga),1
Diagnostic Test,throat swab sample for measuring current infection with sars-cov-2,1
Diagnostic Test,throat swab,1
Diagnostic Test,thoraxic computed tomography,1
Diagnostic Test,thorax ct,1
Diagnostic Test,thoracic ct scan,1
Diagnostic Test,"the demographic, clinical, laboratory, and instrumental data",1
Diagnostic Test,testnpass,1
Diagnostic Test,testing sensitivity for sars-cov-2 virus in symptomatic individuals,1
Diagnostic Test,testing procedure for binding antibodies,1
Diagnostic Test,testing of sars-cov-2 antibodies,1
Diagnostic Test,testing for sars-cov-2 rna,1
Diagnostic Test,testing for sars-cov-2 igm/igg,1
Diagnostic Test,transpulmonary pressure measurements,1
Diagnostic Test,tuberculin test,1
Diagnostic Test,test pcr,1
Diagnostic Test,ultrasound lung imaging as part of fast+ evaluation,1
Diagnostic Test,whole exome sequencing,1
Diagnostic Test,weck-cel swab collection,1
Diagnostic Test,vitros anti-sars-cov-2 igg test,1
Diagnostic Test,vitalconnect vital sign patch,1
Diagnostic Test,visual analogue scale,1
Diagnostic Test,virological and serological tests,1
Diagnostic Test,viral culture,1
Diagnostic Test,videofluoroscopy,1
Diagnostic Test,videofluoroscopic swallowing study (vfss),1
Diagnostic Test,venous draw & testing,1
Diagnostic Test,venous blood was collected for biochemistry testing.,1
Diagnostic Test,venous blood was collected for biochemistry testing,1
Diagnostic Test,venous blood collection,1
Diagnostic Test,vaginal fluid covid-19 pcr test,1
Diagnostic Test,vaccination against covid19,1
Diagnostic Test,urine pregnancy test for women of childbearing potential,1
Diagnostic Test,"urinary ngal, timp-2, igfbp7, il-6, viral load and metabolomic",1
Diagnostic Test,testing for sars-cov-2,1
Diagnostic Test,test for sars-cov-2,1
Diagnostic Test,serum sars cov 2 igg screening in health care workers,1
Diagnostic Test,"standard 12-lead ecg, nt-probnp, echocardiography",1
Diagnostic Test,"spirometry, thoracic ct, cpet, 6 minute walking test, sf-36 questionnaire",1
Diagnostic Test,spike protein (s) or the nucleocapsid (n) of sars-cov-2,1
Diagnostic Test,sperm test,1
Diagnostic Test,specimen collection,1
Diagnostic Test,spartan cube point-of care covid-19 test,1
Diagnostic Test,spartan covid-19 v2 system,1
Diagnostic Test,spartan covid-19 test,1
Diagnostic Test,spartan covid-19 platform,1
Diagnostic Test,soton hyperinflammation score,1
Diagnostic Test,sonoclot,1
Diagnostic Test,sona saliva c-19 rapid test,1
Diagnostic Test,soluble urokinase plasminogen activator receptor,1
Diagnostic Test,six minute walk test (6mwt),1
Diagnostic Test,sit to stand test,1
Diagnostic Test,single passive leg movement,1
Diagnostic Test,simple chest tomography,1
Diagnostic Test,sg diagnostics covid-19 antigen rapid test kit,1
Diagnostic Test,sputum analysis,1
Diagnostic Test,"standard q covid-19 ag - test, produced by sd biosensor inc.",1
Diagnostic Test,"test at home's proprietary ""lollipop"" buccal cavity swab",1
Diagnostic Test,standard screening strategy,1
Diagnostic Test,test,1
Diagnostic Test,tem-tpa,1
Diagnostic Test,tears swab,1
Diagnostic Test,tear collection,1
Diagnostic Test,swallowing evaluation with the eat-10 and the volume-viscosity swallowing test (v-vst),1
Diagnostic Test,swabbing of conjunctiva,1
Diagnostic Test,suspected of covid-19 infection,1
Diagnostic Test,susceptibility to infection,1
Diagnostic Test,surveys,1
Diagnostic Test,surfactant assessment,1
Diagnostic Test,"supar, c-reactive protein, ferritin, d-dimer, procalcitonin, interleukin-6, lactate dehydrogenase",1
Diagnostic Test,study questionnaire,1
Diagnostic Test,study of immune-mediated mechanisms in patients tested positive for sars-cov-2,1
Diagnostic Test,stool collection,1
Diagnostic Test,stimulation test with arginine infusion in order to verify the possible existence of damage to the beta cell function induced by covid-19 infection,1
Diagnostic Test,stc-19 score,1
Diagnostic Test,standardized lung ultrasound (lus) examination,1
Drug,1: naproxen,1
Drug,27% ethanol plus essential oils,1
Device,extracorporeal blood purification using the oxiris® (an69st) hemofilter,1
Drug,canakinumab injection 300mg,1
Drug,cd24fc,1
Drug,cbd,1
Drug,captopril 25mg,1
Drug,canrenoate potassium,1
Drug,"cannabis, medical",1
Drug,"cannabidiol, pharmaceutically produced with < 5 ppm thc",1
Drug,candesartan,1
Drug,canakinumab injection 600mg,1
Behavioral,1: prone positioning,1
Drug,clarithromycin,1
Drug,calcium channel blockers,1
Drug,budesonide nasal,1
Drug,budesonide dry powder inhaler,1
Drug,budesonide,1
Drug,btl-tml-covid,1
Drug,broncho-vaxom®,1
Drug,bromhexine oral tablet and/or hydroxychloroquine tablet,1
Drug,bromhexine hydrochloride tablets,1
Drug,cefditoren pivoxil 400mg,1
Drug,ceftaroline,1
Drug,ceftriaxone,1
Drug,celecoxib famotidine,1
Drug,ckd-314 placebo+soc,1
Drug,cimetra-2,1
Drug,cimetra-1,1
Drug,ciclesonide metered dose inhaler [alvesco],1
Drug,ciclesonide inhalation aerosol,1
Drug,"cholecalciferol 50,000 iu",1
Drug,"cholecalciferol 200,000 iu",1
Drug,chlorpromazine (cpz),1
Drug,chlorpromazine,1
Drug,chloroquine phosphate tablets,1
Drug,chlorine dioxide 3000 ppm,1
Drug,chemotherapy,1
Drug,cetirizine and famotidine,1
Drug,"cerebrospinal fluid sampling, meningeal and brain parenchyma biopsies",1
Drug,cerebrolysin,1
Drug,cerc-002,1
Drug,cenicriviroc (cvc),1
Drug,bromhexine hydrochloride,1
Drug,bromhexine and spironolactone,1
Drug,bromhexine 8 mg,1
Drug,bi 767551 inhaled,1
Drug,bi 764198,1
Drug,bge-175,1
Drug,bgb-dxp593,1
Drug,bgb dxp593,1
Drug,bevacizumab,1
Drug,beva+soc,1
Drug,betadine© bucal 100 mg/ml,1
Drug,best supportive care (bsc),1
Drug,best supportive care,1
Drug,berberine,1
Drug,bempegaldesleukin,1
Drug,bemiparin sodium,1
Drug,bemcentinib,1
Drug,bdb-001 injection,1
Drug,bcg-10 vaccine,1
Drug,bat2020,1
Drug,bat + calcifediol,1
Drug,bi 767551 inhalation,1
Drug,bicalutamide 150 mg,1
Drug,brilacidin,1
Drug,bio 300 oral suspension,1
Drug,brii-198,1
Drug,brii-196,1
Drug,bridge therapy,1
Drug,brexanolone,1
Drug,brensocatib,1
Drug,brazilian green propolis extract (epp-af),1
Drug,bovine lipid extract surfactant,1
Drug,bovhyaluronidase azoxymer,1
Drug,botulinum neurotoxin,1
Drug,bolus vitamin d3,1
Drug,bolus placebo,1
Drug,bno 1030,1
Drug,bms-986253,1
Drug,bld-2660,1
Drug,black seed oil cap/tab,1
Drug,bivalirudin injection,1
Drug,bio101,1
Drug,ckd-314+soc,1
Drug,clarithromycin 500mg,1
Drug,2: continuation of ras blocker therapy,1
Drug,cpi-006 1 mg/kg + soc,1
Drug,cyclosporin a,1
Drug,curosurf® (poractant alfa),1
Drug,ct-p59,1
Drug,cst-5: placebo,1
Drug,cst-2: placebo,1
Drug,cst-2: eidd-2801,1
Drug,crest pro-health multi-protection mouthwash,1
Drug,cpi-006 2 mg/kg + soc,1
Drug,cpi-006,1
Drug,clazakizumab 12.5 mg,1
Drug,covid19 vaccine,1
Drug,covid-globulin,1
Drug,covid-19 treatment,1
Drug,covid-19 standard of care,1
Drug,covid-19 standard care,1
Drug,covid-19 group (group i),1
Drug,covid-19 group,1
Drug,covid-19 convalscent plasma,1
Drug,cytotoxic t lymphocytes,1
Drug,daad compound,1
Drug,daclatasvir 60 mg,1
Drug,daily placebo,1
Drug,degarelix,1
Drug,defibrotide injection,1
Drug,defibrotide 25 mg/kg 24 hours continuous infusion for 15 days,1
Drug,decitabine,1
Drug,dasatinib anhydrous,1
Drug,das181 ol,1
Drug,das181 covid-19,1
Drug,darunavir/cobicistat,1
Drug,darunavir and cobicistat,1
Drug,dapsone 100 mg,1
Drug,dapansutrile capsules,1
Drug,dapagliflozin 10 mg,1
Drug,dapagliflozin,1
Drug,danoprevir+ritonavir,1
Drug,dalteparin,1
Drug,dalcetrapib,1
Drug,daily vitamin d3,1
Drug,covid rehab formula granules,1
Drug,covi-msc,1
Drug,covend24,1
Drug,comparator,1
Drug,comirnaty,1
Drug,combined art/hydroxychloroquine,1
Drug,collagen-polyvinylpyrrolidone,1
Drug,colgate total clean mint,1
Drug,colgate peroxyl® -1.5% hydrogen peroxide,1
Drug,colchicine plus symptomatic treatment (paracetamol),1
Drug,colchicine pill,1
Drug,colchicine 1 mg oral tablet,1
Drug,colchicine 0.6 mg,1
Drug,co-trimoxazole,1
Drug,cnm-znag,1
Drug,cm4620-ie (injectable emulsion),1
Drug,closys ultra sensitive rinse mouthwash,1
Drug,clorhexidine dental phb©,1
Drug,clopidogrel 75mg,1
Drug,clofazimine,1
Drug,clazakizumab 25 mg,1
Drug,comparable placebo of drug,1
Drug,conestat alfa,1
Drug,corvax,1
Drug,control arm,1
Drug,corticosteroids and derivatives,1
Drug,corticosteroid with or without colchicine,1
Drug,corticosteroid nasal irrigation,1
Drug,corticosteroid injection,1
Drug,corticosteroid alone,1
Drug,corsodyl® alcohol free -0.2 % chlorhexidine digluconate,1
Drug,coromec registry with ecl-19,1
Drug,cor-101,1
Drug,conventional treatment,1
Drug,"conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation, and lopinavir/ritonavir) and traditional chinese medicines (tcms) granules",1
Drug,"conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation, and lopinavir/ritonavir)",1
Drug,conventional,1
Drug,convalesscent plasma,1
Drug,convalescent serum,1
Drug,control test,1
Drug,control group (standard hospital treatment),1
Drug,control group,1
Drug,bat,1
Drug,basic treatment,1
Drug,baseline disease modifying therapies (dmts),1
Drug,amiodarone,1
Drug,anakinra 149 mg/ml prefilled syringe [kineret],1
Drug,anakinra 100mg/0.67ml inj syringe,1
Drug,anakinra +/- ruxolitinib (stages 2b/3),1
Drug,amy-101,1
Drug,amoxicillin/clavulanate,1
Drug,amoxicillin-clavulanate,1
Drug,amor 18 powder & inhalation,1
Drug,amlodipine,1
Drug,amantadine hydrochloride,1
Drug,base therapy,1
Drug,amantadine,1
Drug,alvelestat,1
Drug,alteplase,1
Drug,alpha1-proteinase inhibitor,1
Drug,"alpha-interferon, abidol, ribavirin, buzhong yiqi plus and minus formula, huhuang detoxicity paste, baimu qingre jiedu paste and high-dose vitamin c treatment",1
Drug,"alpha-interferon, abidol, ribavirin, buzhong yiqi plus and minus formula, huhuang detoxicity paste, baimu qingre jiedu paste and 5% glucose",1
Drug,"alpha-interferon alpha, abidol, ribavirin, buzhong yiqi plus and minus formula, huhuang detoxicity paste, baimu qingre jiedu paste, fumigation/inhalation of vitamin c",1
Drug,alpha one antitrypsin inhalation,1
Drug,anakinra alone (stages 2b/3),1
Drug,anakinra and ruxolitinib (advanced stage 3),1
Drug,anakinra and ruxolitinib (overcome stage 3),1
Drug,anakinra plus osoc,1
Drug,anticoagulation agents (edoxaban and/or high dose lmwh),1
Drug,anticoagulant therapy,1
Drug,antibiotics,1
Drug,antibiotic,1
Drug,anti-sars-cov-2 plasma,1
Drug,anti-sars-cov-2 igy,1
Drug,anti-sars-cov-2 equine immunoglobulin fragments (inosars),1
Drug,anti-sars-cov-2 convalescent plasma,1
Drug,anti-sars-cov-2,1
Drug,anluohuaxian,1
Drug,angiotensin-converting enzyme inhibitors (ace-i) and angiotensin ii receptor blockers (arb),1
Drug,angiotensin receptor blockers,1
Drug,angiotensin receptor blocker,1
Drug,angiotensin ii receptor blockers,1
Drug,angiotensin ii,1
Drug,"analogs, prostaglandin e1",1
Drug,anakinra prefilled syringe,1
Drug,almitrine,1
Drug,allostim,1
Drug,allogeneic mesenchymal stem cell,1
Drug,ace inhibitors and calcium channel blockers,1
Drug,acalabrutinib treatment d,1
Drug,acalabrutinib treatment c,1
Drug,acalabrutinib treatment b,1
Drug,acalabrutinib treatment a,1
Drug,abx464,1
Drug,abivertinib,1
Drug,abidol hydrochloride combined with interferon atomization,1
Drug,abbv-47d11,1
Drug,abbv-2b04,1
Drug,aat( alpha 1 antitrypsin),1
Drug,[18f]fp-r01-mg-f2,1
Drug,[18f]f-arag (2'-deoxy-2'-fluoro-9-β-d-arabinofuranosylguanine),1
Drug,99mtc-pertechnetate aerosol,1
Drug,3-dayivm 200 mcg/kg/day/14-day 75mgasa/day + standard of care (intervention 1),1
Drug,2: usual practice + symbicort rapihaler,1
Drug,2: standard of care,1
Drug,2: placebo comparator,1
Drug,"ace inhibitor, angiotensin receptor blocker",1
Drug,acei,1
Drug,allogeneic and expanded adipose tissue-derived mesenchymal stromal cells,1
Drug,acei/arb,1
Drug,allogeneic and expanded adipose tissue-derived mesenchymal stem cells,1
Drug,alisporivir,1
Drug,albuterol sulfate (nebulizer),1
Drug,albuterol sulfate (mdi),1
Drug,ak119,1
Drug,agent-797,1
Drug,aerosolized isotretinoin plus tamoxifen,1
Drug,aerosolized dnase,1
Drug,aerosolized all trans retinoic acid,1
Drug,aerolized hydroxychloroquine sulfate,1
Drug,adx-629,1
Drug,adm03820,1
Drug,adjuvanted sars-cov-2 subunit vaccine (acov2),1
Drug,adenosine,1
Drug,adalimumab,1
Drug,active comparator,1
Drug,aceis,1
Drug,antihypertensive agents,1
Drug,antithrombin + best available treatment,1
Drug,antiviral agents,1
Drug,azithromycin (azithro),1
Drug,azd1222,1
Drug,avm0703,1
Drug,aviptadil placebo,1
Drug,aviptadil by intravenous infusion + standard of care,1
Drug,aviptadil 67μg,1
Drug,avigan 200 mg ft,1
Drug,avicod 200 mg film tablet,1
Drug,avdoralimab,1
Drug,av-001,1
Drug,auxora,1
Drug,autophagy inhibitor (gns651),1
Drug,atyr1923 3 mg/kg,1
Drug,atyr1923 1 mg/kg,1
Drug,atr-002,1
Drug,atovaquone/azithromycin,1
Drug,atorvastatin-ezetimibe,1
Drug,atorvastatin 80mg,1
Drug,azd1656,1
Drug,azithromycin / ivermectin / ribaroxaban / paracetamol,1
Drug,atorvastatin 20mg,1
Drug,azithromycin / ribaroxaban / paracetamol,1
Drug,baricitinib oral tablet [olumiant],1
Drug,baricitinib or anakinra,1
Drug,baricitinib 4 mg oral tablet,1
Drug,baricitinib + dexamethasone,1
Drug,baricitinib (janus kinase inhibitor),1
Drug,bardoxolone methyl,1
Drug,baf312,1
Drug,bacille calmette-guérin (bcg),1
Drug,azvudine placebo,1
Drug,azvudine,1
Drug,azoximer bromide,1
Drug,azithromycin capsule,1
Drug,azithromycin and hydroxychloroquine,1
Drug,azithromycin 500mg oral tablet,1
Drug,azithromycin 500 milligram (mg) oral tablet,1
Drug,azithromycin 250 mg oral capsule,1
Drug,azithromycin 250 mg,1
Drug,atorvastatin 40mg,1
Drug,atorvastatin 20 mg oral tablet,1
Drug,antroquinonol,1
Drug,artemisia annua leaf,1
Drug,artemether-lumefantrine (al),1
Drug,artecom® (pyronaridine-artesunate),1
Drug,art therapy,1
Drug,art,1
Drug,argatroban,1
Drug,arbidol hydrochloride granules,1
Drug,arbidol 100 mg kapsul,1
Drug,apx-115,1
Drug,aprotinin,1
Drug,aprepitant injectable emulsion,1
Drug,apremilast placebo,1
Drug,apo-hydroxychloroquine,1
Drug,apl-9,1
Drug,apixaban 5mg,1
Drug,apilimod dimesylate capsule,1
Drug,apabetalone,1
Drug,any drug used to treat covid-19,1
Drug,artemic,1
Drug,artemisinin,1
Drug,atorvastatin + l-arginine + folic acid + nicorandil + nebivolol,1
Drug,artemisinin / artesunate,1
Drug,ati-450,1
Drug,atazanavir,1
Drug,atafenovir 200 mg kapsul,1
Drug,at-001,1
Drug,asunercept 400mg,1
Drug,asunercept 25mg,1
Drug,asunercept 100mg,1
Drug,astrostem-v,1
Drug,association of diltiazem and niclosamide,1
Drug,aspirin 81 mg,1
Drug,aspirin 75mg,1
Drug,aspirin 100mg,1
Drug,asp,1
Drug,asc09f+oseltamivir,1
Drug,asc09/ritonavir group,1
Drug,artesunate-amodiaquine,1
Drug,artesunate,1
Diagnostic Test,reverse-transcription polymerase chain reaction (rt-pcr),1
Diagnostic Test,reverse transcription polymerase chain reaction,1
Diagnostic Test,resting 12 lead ecg,1
Device,ventilatory support with oxygen therapy,1
Device,volatile organic compounds analysis (e-noses),1
Device,vivadiag™ covid-19 lgm/igg rapid test,1
Device,viruxal oral and nasal spray,1
Device,virtual reality therapy first,1
Device,virtual reality,1
Device,vielight rx plus,1
Device,vibrolung,1
Device,vesta respirator,1
Device,vascular occlusion test,1
Diagnostic Test,abpm,1
Device,vaccin box,1
Device,v/q system,1
Device,uvc irradiation,1
Device,uv light treatment,1
Device,usual monitoring,1
Device,"use of the pinpointiq solution (physiq, inc.)",1
Device,ultrasound using the telerobotic melody system,1
Device,ultrasound of the lower limbs,1
Device,volatile organic compounds analysis (mass spectrometry),1
Device,volatile organic compounds analysis in sweat (mass spectrometry),1
Device,vv-ecmo,1
Device,vçac,1
Diagnostic Test,a specifically designed self-administered questionnaire,1
Diagnostic Test,a questionnaire or scales,1
Diagnostic Test,[89zr]df-iab22m2c pet/ct scan,1
Diagnostic Test,[68ga]ga-dota-(rgd)2 pet/ct,1
Diagnostic Test,6 minute walk test,1
Diagnostic Test,4c mortality score,1
Diagnostic Test,40-steps-test,1
Diagnostic Test,25 post icu-patients,1
Diagnostic Test,24 hour holter ecg,1
Device,оxygen therapy,1
Device,withings scanwatch,1
Device,web-application,1
Device,web embolization,1
Device,web application users,1
Device,wearable medical device (empatica e4),1
Device,water without an elevated level of kelea,1
Device,ward css,1
Device,ultrasound,1
Device,uexplorer/mct,1
Device,tympanic temperature,1
Device,tape face mask,1
Device,standard of care (intravenous access),1
Device,standard of care,1
Device,standard mask,1
Device,spartan covid-19 system,1
Device,soterix tavns model 0125-lte stimulator - sham-active group,1
Device,soterix tavns model 0125-lte stimulator - active-active group,1
Device,"sonclot coagulation and platelet function analyzer scp1, sienco, usa",1
Device,sledd with a l-mod,1
Device,sham transcranial direct-current stimulation,1
Device,sham device treatment,1
Device,sham,1
Device,seraph®-100 microbind® affinity blood filter,1
Device,sentinox--group b,1
Device,sentinox--group a,1
Device,senti v1.0 device,1
Device,sensiumvitals wearable sensor,1
Device,sensbiosys,1
Device,t-detect covid t-cell blood test,1
Device,tape-software,1
Device,transpulmonary thermodilution,1
Device,tavr or savr,1
Device,transparent sheet,1
Device,transcutaneous auricular vagus nerve stimulation,1
Device,toraymyxin pmx-20r (pmx cartridge),1
Device,tof protocol,1
Device,threshold imt device,1
Device,thermography,1
Device,therapeutic plasmaexchnage,1
Device,therapeutic plasma exchange,1
Device,theram covid-19 rapid antigen test,1
Device,the vie scope laryngoscope,1
Device,the use of the mentalplus® digital game for assessment and rehabilitation of cognitive function after remission of the symptoms of covid-19,1
Device,the standard macintosh laryngoscope,1
Device,the icp monitoring will be performed in a non-invasive method developed by brain4care,1
Device,test group: experimental - uvc therapy applied,1
Device,tensile strength,1
Device,telerehabilitation,1
Device,tcc-covid mhealth solution,1
Diagnostic Test,aaz covid-19 rapid test,1
Diagnostic Test,accuracy of cad4tb and afinion crp assay for pulmonary tb,1
Diagnostic Test,"respiratory symptoms, symptoms of anxiety and depression, and post-traumatic stress screening",1
Diagnostic Test,breath biopsy analysis,1
Diagnostic Test,cag length <22,1
Diagnostic Test,cad4covid+wbc and covid-19 rdt for sars-cov-2 infection,1
Diagnostic Test,c-reactive protein,1
Diagnostic Test,butterfly,1
Diagnostic Test,bronchoalveolar lavage,1
Diagnostic Test,breath test & cheek swab,1
Diagnostic Test,breath sample,1
Diagnostic Test,breath biopsy sampling using the reciva breath sampler,1
Diagnostic Test,breath biopsy,1
Diagnostic Test,additional ct acquisition,1
Diagnostic Test,brainstem responses assessment sedation score (brass),1
Diagnostic Test,brain mri,1
Diagnostic Test,bloodwork,1
Diagnostic Test,blood- and saliva tests,1
Diagnostic Test,blood test for sars-cov2 serology,1
Diagnostic Test,blood test for inflammatory markers,1
Diagnostic Test,blood test for igg antibodies against sars-cov-2,1
Diagnostic Test,blood sampling (venesection),1
Diagnostic Test,cag length >=22,1
Diagnostic Test,cambridge validated viral detection method,1
Diagnostic Test,capillary collection & testing,1
Diagnostic Test,capnography,1
Diagnostic Test,chest cta,1
Diagnostic Test,chest ct scan + baseline spirometry,1
Diagnostic Test,chest ct,1
Diagnostic Test,chest computed tomography (ct),1
Diagnostic Test,chest computed tomography,1
Diagnostic Test,cellular response,1
Diagnostic Test,carotid-femoral pulse-wave velocity,1
Diagnostic Test,carotid artery reactivity testing,1
Diagnostic Test,cardiovascular magnetic resonance imaging,1
Diagnostic Test,cardiopulmonary stress test (cpet),1
Diagnostic Test,cardiopulmonary fitness level,1
Diagnostic Test,cardiopulmonary exercise test,1
Diagnostic Test,cardiac mri,1
Diagnostic Test,cardiac magnetic resonance imaging (cmr),1
Diagnostic Test,cardiac magnetic resonance imaging,1
Diagnostic Test,cardiac magnetic resonance,1
Diagnostic Test,cardiac ct,1
Diagnostic Test,blood samples (collection of 5 ml of blood in a dry tube),1
Diagnostic Test,blood samples,1
Diagnostic Test,blood sample for serology to measure past infection with sars-cov-2,1
Diagnostic Test,assessment of proinflammatory cytokine production and immunophenotypic analysis after stimulation with overlapping s-peptides in peripheral blood mononuclear cells (pbmc),1
Diagnostic Test,assessment of cardiovascular diseases and cardiovascular risk factors,1
Diagnostic Test,"assessing antibody responses, neutralizing capacity and memory b-cell function",1
Diagnostic Test,arterial blood gas test (abg),1
Diagnostic Test,arterial blood gas (abg),1
Diagnostic Test,arterial blood gas,1
Diagnostic Test,ap-23,1
Diagnostic Test,antigen detection test,1
Diagnostic Test,antibody titration,1
Diagnostic Test,antibody testing for sars-cov-2 igg,1
Diagnostic Test,antibody test (sars-cov2),1
Diagnostic Test,antibodies testing,1
Diagnostic Test,anti-spike sars-cov-2 igg,1
Diagnostic Test,anti-sars-cov2 serological controls and serum neutralization,1
Diagnostic Test,anti-covid test,1
Diagnostic Test,anti covid19 igg antibodies,1
Diagnostic Test,amh sampling,1
Diagnostic Test,ai model,1
Diagnostic Test,assessment of lung mechanics and heart-lung interactions,1
Diagnostic Test,assessment of ventilator-associated pneumonia criteria,1
Diagnostic Test,blood sample for serological test,1
Diagnostic Test,asynchronies detection,1
Diagnostic Test,blood group determination,1
Diagnostic Test,blood draw,1
Diagnostic Test,blood count,1
Diagnostic Test,blood collection,1
Diagnostic Test,blood analysis,1
Diagnostic Test,biozek covid-19 antigen rapid test (saliva),1
Diagnostic Test,biozek covid-19 antigen rapid test,1
Diagnostic Test,biomarkers of inflammation,1
Diagnostic Test,biomarkers expression,1
Diagnostic Test,"biomarker (tropt, myoglobin, ck, ck-mb, ldh, d-dimer, crp, pct)",1
Diagnostic Test,biological samples day of delivery,1
Diagnostic Test,biochemistry blood test,1
Diagnostic Test,biochemical analyses,1
Diagnostic Test,bd veritor plus system for rapid detection of sars cov-2,1
Diagnostic Test,background questionnaire,1
Diagnostic Test,axillary sweat sample,1
Diagnostic Test,audio-vestibular evaluation,1
Device,sd biosensor,1
Device,scd,1
Device,sample of blood and saliva,1
Device,intravenous access,1
Device,lifesignals biosensor 1ax*,1
Device,lifelight® data collect oxygen saturation group,1
Device,lifelight® data collect blood pressure group,1
Device,life2000® ventilator,1
Device,kelea excellerated water,1
Device,izephyr hood,1
Device,invasive mechanical ventilation using the unisabana-herons ventilator during 24 hours,1
Device,intubation box,1
Device,intraosseous access,1
Device,saliva test kit,1
Device,intellivent asv,1
Device,inspiratory training device,1
Device,inspiratory muscle trainer,1
Device,inspiratory muscle traiing,1
Device,innova lateral flow device,1
Device,impulse™ una e-stethoscope,1
Device,"ilr, pmk, icd",1
Device,icu cockpit software testing,1
Device,limbix spark,1
Device,low flow ecmo driving by cvvh machine,1
Device,low-field thoracic magnetic stimulation (lf-thms),1
Device,lung ultrasonography,1
Device,mindrhythm harmony,1
Device,mfs,1
Device,metaneb® system,1
Device,mejoracare,1
Device,medical mask,1
Device,mechanical ventilation with the automated bvm compressor,1
Device,mcgrath videolaryngoscope,1
Device,mask without mask adhesive / arm 2,1
Device,mask with mask adhesive/arm 1,1
Device,mask,1
Device,"masimo, lidco",1
Device,marker therapeutics d2000 cartridge (d2000) for use with the spectra optia® apheresis system (optia spd protocol),1
Device,makair,1
Device,magec spine rod,1
Device,lus twelve area,1
Device,lus fourteen area,1
Device,lungfit™,1
Device,"ib10 sphingotest® bio-adm® apparatus (sphingotec gmbh, hennigsdorf, germany)",1
Device,hypothermia,1
Device,hyperbaric oxygen,1
Device,hcfwo,1
Device,geko t3,1
Device,gammacore® sapphire (non-invasive vagus nerve stimulator),1
Device,gammacore® (vagus nerve stimulation),1
Device,freestyle libre 14 day cgm system,1
Device,flow controlled ventilation (evone-ventilator),1
Device,filtration test,1
Device,ffp2,1
Device,fast dissolving film,1
Device,familychildcare (provisional name of app),1
Device,faecal sample collector,1
Device,facial mask,1
Device,face-mask niv,1
Device,face mask + soap,1
Device,face mask,1
Device,extravascular lung water index,1
Device,extraoral vacuum aspirator (eva),1
Device,extracorporeal membrane oxygenation,1
Device,go2 peep mouthpiece,1
Device,heart patch seeded with autologous cardiomyocytes and amnion epithelial stem cells,1
Device,hyperbaric chamber,1
Device,helmet continuous positive airway pressure (cpap),1
Device,hyfe cough tracker,1
Device,"hydrogen-oxygen generator with nebulizer, ams-h-03",1
Device,hydrogen peroxide,1
Device,hydrogen oxygen generator with nebulizer,1
Device,hospital telemedicine management system,1
Device,home pulse oximetry monitoring,1
Device,high-flow nasal cannula treatment,1
Device,high volume evacuation (hve),1
Device,high flow nasal therapy,1
Device,high flow nasal oxygen (hfno) treatment,1
Device,high flow nasal oxygen (hfno),1
Device,high flow nasal cannula hfnc,1
Device,high flow nasal cannula device,1
Device,hemopurifier,1
Device,helmet non-invasive ventilation,1
Device,helmet niv,1
Device,helmet cpap,1
Device,miniprobe alveoflex,1
Device,mls laser,1
Device,modified ipac-uhn ppe,1
Device,prototype swab,1
Device,power breathe,1
Device,point of care testing device for c-reactive protein,1
Device,poc covidx™ rapid antigen test,1
Device,pneumoniacheck,1
Device,placebo-simulation of transcranial direct current stimulation,1
Device,placebo without radiofrequency.,1
Device,placebo pbmt/smf,1
Device,placebo,1
Device,philips lumify ultrasound system,1
Device,personal protective equipment (ppe),1
Device,personal protective equipment,1
Device,performing of lung ultrasound,1
Device,performance evaluation study of realdetect rt-pcr kit for covid-19 detection,1
Device,percutaneous coronary revascularization for stemi,1
Device,pep flute,1
Device,patients receiving nasal high flow,1
Device,patient status engine,1
Device,premier biotech covid-19 igg/igm rapid test cassette,1
Device,pulmonary vascular permeability index,1
Device,oxygen supply,1
Device,pulse oximeter,1
Device,saliva assay,1
Device,saline nasal and throat spray,1
Device,robotic therapy,1
Device,robotic assisted intervention,1
Device,robotic assisted early mobilization,1
Device,ria-device (remote investigation and assessment),1
Device,revoxa oxygen rebrearther,1
Device,resp,1
Device,remote ischemic conditioning,1
Device,real-time cgm,1
Device,rd-x19,1
Device,rapid onsite covid-19 detection,1
Device,rapid antigen testing and onsite pcr testing,1
Device,rapid antigen testing and offsite pcr testing,1
Device,radius ppg tetherless pulse oximetry (masimo),1
Device,radiofrequency therapy,1
Device,q-nrg metobolic cart device,1
Device,oxyhydrogen,1
Device,oxygen hood,1
Device,monitoring physiological data with the hexoskin smart shirt,1
Device,nio® (intraosseous access),1
Device,neuromuscular electrical stimulation,1
Device,nebulized administration of zyesami™ or placebo,1
Device,nasal spray,1
Device,narrow band ultraviolet b-band light,1
Device,nacl,1
Device,n95 respirator,1
Device,n95 mask,1
Device,n-95 respirator,1
Device,musclesound ultrasound,1
Device,multifrequency bioimpedance spectroscopy,1
Device,multiecco2r blood-gas exchanger,1
Device,msct,1
Device,mouthwashes and nose rinse in a conventional way,1
Device,mouthwash and nose rinse with the agnps solution,1
Device,mouthrinse without bêta-cyclodextrin and citrox,1
Device,mouthrinse with bêta-cyclodextrin and citrox,1
Device,"mouthpiece b1(mouthpiece mpc-st gmdn:62534 generic name: endoscopic bite block, basic, reusable",1
Device,neuromuscular evaluation,1
Device,nitric oxide delivered via lungfit™ system,1
Device,oxygen,1
Device,ni̇cas,1
Device,online self-help intervention,1
Device,olo-1 medical molecular sieve oxygen generator,1
Device,olfactory device,1
Device,observational study - no intervention,1
Device,observational measurement of biometric data. no change to health care provided.,1
Device,nordell single e-100 layer mask,1
Device,nordell double e-100 layer mask,1
Device,noninvasive ventilation treatment,1
Device,noninvasive ventilation,1
Device,non-invasive ventilatory support,1
Device,non-invasive red lllt treatment to chest of patient.,1
Device,non-contact mce system,1
Device,non-contact magnetically-controlled capsule endoscopy,1
Device,non-contact ecg,1
Device,non narrow band ultraviolet b-band light,1
Device,noa-001,1
Device,no personal protective equipment (ppe),1
Diagnostic Test,chest mri,1
Diagnostic Test,chest x-ray,1
Diagnostic Test,chitotriosidase activity,1
Diagnostic Test,nasopharyngeal sampling,1
Diagnostic Test,neuropsychological assessment,1
Diagnostic Test,neurology test,1
Diagnostic Test,neuroimaging findings in patients with covid-19,1
Diagnostic Test,neural network diagnosis algorithm,1
Diagnostic Test,netosis markers,1
Diagnostic Test,nasopharyngeal swabs,1
Diagnostic Test,nasopharyngeal swab for covid-19 testing,1
Diagnostic Test,nasopharyngeal swab and main laboratory,1
Diagnostic Test,nasopharyngeal samples,1
Diagnostic Test,inflammatory markers sampling,1
Diagnostic Test,nasopharyngeal covid 19 rt-pcr,1
Diagnostic Test,nasopharyngeal and throat/oropharyngeal swabs analyses by rt-pcr and ddpcr,1
Diagnostic Test,nasopharyngeal (np) swab,1
Diagnostic Test,nasal pharyngeal (np) swab samples,1
Diagnostic Test,nanomix elab® covid-19 rapid antigen panel (non-interventional),1
Diagnostic Test,"n terminal pro b type natriuretic peptide (ntprobnp), d-dimer, and serum tropinin - i",1
Diagnostic Test,multitest 6 color tbnk and bd lyotubes,1
Diagnostic Test,multicapillary column coupled ion mobility spectrometry,1
Diagnostic Test,neutralization assay,1
Diagnostic Test,neutralizing antibodies,1
Diagnostic Test,new qiastat-dx fully automatic multiple pcr detection platform,1
Diagnostic Test,new screening strategy,1
Diagnostic Test,oropharyngeal swab,1
Diagnostic Test,optical coherence tomography angiography,1
Diagnostic Test,optical coherence tomography (oct),1
Diagnostic Test,online survey,1
Diagnostic Test,online questionnaire,1
Diagnostic Test,on-site testing (lumiradx),1
Diagnostic Test,olfactory test,1
Diagnostic Test,olfactometry,1
Diagnostic Test,odd/even birth year intervention groups,1
Diagnostic Test,"obtainment of nasopharyngeal, oropharyngeal, buccal, nasal and saliva samples",1
Diagnostic Test,novel laser inferometry test for corona virus,1
Diagnostic Test,novel coronavirus infection,1
Diagnostic Test,not required,1
Diagnostic Test,non-invasive cardiac imaging,1
Diagnostic Test,no intervention planned due to the observational study design only a diagnostic testing,1
Diagnostic Test,no intervention planned due to the observational study design - only a diagnostic testing,1
Diagnostic Test,ng test,1
Diagnostic Test,mrna in urine test,1
Diagnostic Test,"mri (heart, brain, lungs, liver)",1
Diagnostic Test,monthly serologic igm/g test,1
Diagnostic Test,lung ct,1
Diagnostic Test,low-dose chest ct,1
Diagnostic Test,"liver function tests ,serum ferritin and pcr for covid-19 .",1
Diagnostic Test,liver function tests,1
Diagnostic Test,lamp,1
Diagnostic Test,laboratory tests,1
Diagnostic Test,laboratory samples,1
Diagnostic Test,laboratory blood tests,1
Diagnostic Test,laboratory biomarkers,1
Diagnostic Test,laboratory and instrumental examination,1
Diagnostic Test,laboratory analyses,1
Diagnostic Test,lab workup (on admission and regularly during follow up).,1
Diagnostic Test,knownow sars-cov-2 rapid antigen test,1
Diagnostic Test,kir phenotype evaluation,1
Diagnostic Test,ipss questionnaire,1
Diagnostic Test,ip-10 in cds protocol,1
Diagnostic Test,interleukin-6 gene-174c detection,1
Diagnostic Test,interleukin assessment in semen,1
Diagnostic Test,lung biopsy,1
Diagnostic Test,lung function test,1
Diagnostic Test,monitoring visit - week 8,1
Diagnostic Test,lung function tests,1
Diagnostic Test,monitoring visit - week 4,1
Diagnostic Test,monitoring visit - baseline,1
Diagnostic Test,molecular testing for virus rna using rt-pcr,1
Diagnostic Test,molecular assessment of saliva,1
Diagnostic Test,microcirculation recording,1
Diagnostic Test,mental health questionnaire,1
Diagnostic Test,membrane-based immunoassay kit,1
Diagnostic Test,mcc ims,1
Diagnostic Test,male sexual health questionnaire (mshq),1
Diagnostic Test,mailer-based finger-prick,1
Diagnostic Test,magnetic resonance imaging,1
Diagnostic Test,machine learning model,1
Diagnostic Test,machine learning classification of recurrence and non-recurrence,1
Diagnostic Test,machine learning classification of parenchymal lung change cause,1
Diagnostic Test,lymphocyte monocyte ratio,1
Diagnostic Test,lung ultrasound use in patients hospitalized with covid,1
Diagnostic Test,lung impedance technique,1
Diagnostic Test,oropharyngeal swabs,1
Diagnostic Test,outpatient mri,1
Diagnostic Test,oxidative stress elisa kit,1
Diagnostic Test,radiological detection,1
Diagnostic Test,questionnaires patient,1
Diagnostic Test,questionnaires family,1
Diagnostic Test,questionnaires and neuropsychological assessment,1
Diagnostic Test,questionnaires,1
Diagnostic Test,questionnaire forms,1
Diagnostic Test,questionnaire,1
Diagnostic Test,quasistatic pressure-volume curve,1
Diagnostic Test,quantra system,1
Diagnostic Test,quantitative antibody tests,1
Diagnostic Test,quantitative and qualitative assessments of mental health,1
Diagnostic Test,quantitative analysis of sars-cov-2 antibodies,1
Diagnostic Test,quantitative analysis of anti-sars-cov-2-antibodies,1
Diagnostic Test,quantiferon,1
Diagnostic Test,qualitative and quantitative virus pcr of respiratory secretions in patients with high aerosol concentrations,1
Diagnostic Test,qrt-pcr and serology,1
Diagnostic Test,q16 testing,1
Diagnostic Test,pwv,1
Diagnostic Test,quidel sofia sars antigen fia,1
Diagnostic Test,rapid antigen test,1
Diagnostic Test,pulse oximeter,1
Diagnostic Test,rapid antigen test (panbio ag test),1
Diagnostic Test,respiratory swabs,1
Diagnostic Test,respiratory muscles ultrasound,1
Diagnostic Test,respiratory monitoring,1
Diagnostic Test,respiratory mechanics measurement,1
Diagnostic Test,resp-aer-meter,1
Diagnostic Test,repeat sars-cov-2 igg antibodies at 45-65 days,1
Diagnostic Test,recordings of cough sounds from adults,1
Diagnostic Test,recombinase aided amplification (raa) assay,1
Diagnostic Test,realtime pcr,1
Diagnostic Test,rba-2,1
Diagnostic Test,rarefaction,1
Diagnostic Test,rapid salivary test,1
Diagnostic Test,rapid pathogen detection,1
Diagnostic Test,rapid nasopharyngeal antigen test for sars-cov-2,1
Diagnostic Test,rapid detection test,1
Diagnostic Test,rapid antigen testing versus rt-pcr,1
Diagnostic Test,rapid antigen test for sars cov2,1
Diagnostic Test,pulse oximetry,1
Diagnostic Test,pulmonary function tests (pft),1
Diagnostic Test,passive microwave radiometry,1
Diagnostic Test,plasma igg levels,1
Diagnostic Test,pilot a rapid sars-cov-2 testing strategy,1
Diagnostic Test,physiological testing,1
Diagnostic Test,physical examination,1
Diagnostic Test,phlebotomy,1
Diagnostic Test,pet-ct of 18f-fdg,1
Diagnostic Test,peripheral venous ultrasound,1
Diagnostic Test,peripheral lymphocytes subsets,1
Diagnostic Test,peripheral blood sampling,1
Diagnostic Test,peripheral blood draw,1
Diagnostic Test,performing routine care (clinical and paraclinical tests),1
Diagnostic Test,performance of the test antigenic and test rt-pcr,1
Diagnostic Test,performance evaluation (sensitivity and specificity) for covid-19 diagnosis of the vocus ptr-tof process,1
Diagnostic Test,"pcr, lung ultrasound",1
Diagnostic Test,pcr value,1
Diagnostic Test,pcr for covid-19,1
Diagnostic Test,pcl cov05 - covid 19 ag rapid fia test (rapid antigen test),1
Diagnostic Test,patient health questionnaire (phq-9),1
Diagnostic Test,pk test,1
Diagnostic Test,"platelet count, platelet, mean platelet volume and platelet distribution width in covid-19",1
Diagnostic Test,pulmonary function testing,1
Diagnostic Test,pleth variability index,1
Diagnostic Test,pulmonary anomalies 4 months after documented covid-19 pneumonia,1
Diagnostic Test,public health england gold standard,1
Diagnostic Test,pt-pcr test for sars-cov-2,1
Diagnostic Test,psychological stress and adaptation at work score (psas),1
Diagnostic Test,prognostic score,1
Diagnostic Test,procedure : multimodal microvascular assessment at study inclusion,1
Diagnostic Test,presence of specific anti-sars-cov-2 antibodies,1
Diagnostic Test,post traumatic stress disorder questionnaire (ptsd-8),1
Diagnostic Test,positive for sars-cov-2 infection,1
Diagnostic Test,pool rt-pcr,1
Diagnostic Test,pool lamp,1
Diagnostic Test,polymerase chain reaction (pcr) test,1
Diagnostic Test,point-of-care ultrasonography (pocus),1
Diagnostic Test,point-of-care test for sars-cov-2,1
Diagnostic Test,point-of-care rapid anti-sars-cov-2 antibody test (orient gene biotech) and dry blood spot collection (euroimmun),1
Diagnostic Test,"point of care ultrasound including echocardiography, lung ultrasound, vascular ultrasound",1
Diagnostic Test,poc sars-cov-2 igg antibody test,1
Diagnostic Test,interleuken 6 level measurment,1
Diagnostic Test,indirect calorimetry,1
Diagnostic Test,clia of igg and igm against sars-cov-2,1
Diagnostic Test,ctus examination,1
Diagnostic Test,data collection and rhinopharyngeal swab,1
Diagnostic Test,"d-dimer,cbc.esr,crp,",1
Diagnostic Test,d-dimer test,1
Diagnostic Test,cytokines measurement,1
Diagnostic Test,cytokines dosage,1
Diagnostic Test,cytokine measurements,1
Diagnostic Test,cyp phenotyping,1
Diagnostic Test,cycle threshold,1
Diagnostic Test,covidseq test,1
Diagnostic Test,incremental shuttle walk test,1
Diagnostic Test,covid19 rt-pcr,1
Diagnostic Test,covid19 immunization testing,1
Diagnostic Test,covid-viro® test,1
Diagnostic Test,covid-antibody test,1
Diagnostic Test,covid-19 testing,1
Diagnostic Test,"covid-19 test, polymerase chain reaction for sars-cov-2",1
Diagnostic Test,covid-19 swap test pcr,1
Diagnostic Test,covid-19 swab pcr test,1
Diagnostic Test,detection of anti-covid-19 antibody level,1
Diagnostic Test,determination of sars-cov2 presence in cns,1
Diagnostic Test,"diagnosis of sars-cov2 by rt-pcr and : igg, ig m serologies in the amniotoc fluid, the blood cord and the placenta",1
Diagnostic Test,diagnostic,1
Diagnostic Test,easycov poc,1
Diagnostic Test,duplex ultrasound and computed tomography angiography,1
Diagnostic Test,duplex sonography,1
Diagnostic Test,dräger antigen test sars-cov-2,1
Diagnostic Test,dried blood spot and venous blood collection,1
Diagnostic Test,direct antigen tests for covid-19,1
Diagnostic Test,diffusing capacity of carbon monoxide,1
Diagnostic Test,differential leucocyte count (cldc) device and algorithm,1
Diagnostic Test,diagnostic tests for covid-19 infection,1
Diagnostic Test,diagnostic tests,1
Diagnostic Test,diagnostic test:blood test,1
Diagnostic Test,diagnostic test: serology test for covid-19,1
Diagnostic Test,diagnostic test for sars-cov2 for patients and health staff,1
Diagnostic Test,diagnostic test for detection of sars-cov-2,1
Diagnostic Test,diagnostic test covid-19,1
Diagnostic Test,diagnostic test,1
Diagnostic Test,diagnostic examination for venous thromboembolism,1
Diagnostic Test,covid-19 swab,1
Diagnostic Test,covid-19 survey,1
Diagnostic Test,covid-19 serology igg,1
Diagnostic Test,covid 19 diagnostic test by pcr,1
Diagnostic Test,coronacidetm covid-19 igm/igg rapid test and premier biotech covid-19 igm/igg rapid test,1
Diagnostic Test,copan swabbing and blood sample collection,1
Diagnostic Test,conjunctival swab and nasopharyngeal swab,1
Diagnostic Test,conjunctival rt pcr,1
Diagnostic Test,confirm sars-cov-2 infection,1
Diagnostic Test,confinement and communication during the covid-19 pandemic,1
Diagnostic Test,computed tomography (ct),1
Diagnostic Test,comprehensive assessment of respiratory muscle function.,1
Diagnostic Test,"complete blood picture, bone marrow aspiration cytology",1
Diagnostic Test,complement dosage,1
Diagnostic Test,comparison of sample collection methods,1
Diagnostic Test,comparison of antigen tests with rt-pcr as reference method,1
Diagnostic Test,comet assay,1
Diagnostic Test,collection of swabs,1
Diagnostic Test,collection of breath sample,1
Diagnostic Test,clungene rapid test cassette,1
Diagnostic Test,clinical features and laboratory values,1
Diagnostic Test,covid 19 diagnostic test,1
Diagnostic Test,covid 19 serology,1
Diagnostic Test,covid-19 rt-pcr test,1
Diagnostic Test,covid detect,1
Diagnostic Test,covid-19 presto test,1
Diagnostic Test,covid-19 positive,1
Diagnostic Test,covid-19 pcr swab,1
Diagnostic Test,covid-19 pcr and serology,1
Diagnostic Test,"covid-19 pcr , igm",1
Diagnostic Test,covid-19 pcr,1
Diagnostic Test,covid-19 nasal/pharyngeal swab,1
Diagnostic Test,"covid-19 igg/igm rapid test cassette test (healgen scientific, houston, texas, usa)",1
Diagnostic Test,"covid-19 igg / igm rapid test (whole blood, serum, plasma)",1
Diagnostic Test,covid-19 diagnostic test,1
Diagnostic Test,covid-19 diagnostic pcr,1
Diagnostic Test,"covid-19 antigen/antibody rapid testing, mobile device image capture and telemedicine support",1
Diagnostic Test,"covid-19 antigen and antibody tests, and influenza rapid test",1
Diagnostic Test,covid-19 antibody testing (igg and igm),1
Diagnostic Test,covid-19 antibody testing,1
Diagnostic Test,covid-19 antibody point of care test kit,1
Diagnostic Test,covid-19 antibodies testing,1
Diagnostic Test,ecg from handheld device,1
Diagnostic Test,echo-doppler,1
Diagnostic Test,echocardiogram 2d,1
Diagnostic Test,igg,1
Diagnostic Test,identification by pcr of the sars-cov-2 virus in samples taken from the fetus,1
Diagnostic Test,id now™ covid-19 screening test,1
Diagnostic Test,id now vs. accula,1
Diagnostic Test,iamp test,1
Diagnostic Test,hyperpolarized xenon-129 mri of the lungs,1
Diagnostic Test,humoral and cellular immunity,1
Diagnostic Test,hscore,1
Diagnostic Test,hospital anxiety depression scale,1
Diagnostic Test,"hormone levels (testosterone, fsh, lh, prolactin)",1
Diagnostic Test,home-based sars-cov-2 test kit,1
Diagnostic Test,home spirometry,1
Diagnostic Test,home sleep apnea testing or in-hospital polysomnography,1
Diagnostic Test,heterologous stimuli,1
Diagnostic Test,hematology blood test,1
Diagnostic Test,health-related quality of life,1
Diagnostic Test,hads questionnaire,1
Diagnostic Test,gustatory and olfactory function test,1
Diagnostic Test,identify sars-cov-2 infection by serology,1
Diagnostic Test,igg antibodies immunoassay,1
Diagnostic Test,glycomic analysis,1
Diagnostic Test,igg neutralising antibody titers to s1 and s2 proteins of sars-cov-2 virus,1
Diagnostic Test,impact of covid-19 questionnaire,1
Diagnostic Test,immunoseq,1
Diagnostic Test,immunoglobulin g detection,1
Diagnostic Test,immunogenicity after first and second dose,1
Diagnostic Test,immunfluorescence,1
Diagnostic Test,immune response study,1
Diagnostic Test,"imaging, blood tests",1
Diagnostic Test,imaging of the lungs,1
Diagnostic Test,imaging by thoracic scanner,1
Diagnostic Test,imaging,1
Diagnostic Test,ili and covid-19 detection,1
Diagnostic Test,iief-5 questionnaire,1
Diagnostic Test,igm and igg diagnostic kits to sars-cov-2,1
Diagnostic Test,igm and igg antibodies assay,1
Diagnostic Test,igg test,1
Diagnostic Test,igg sars cov2,1
Diagnostic Test,igg sars cov 2 antibodies,1
Diagnostic Test,graded exercise test,1
Diagnostic Test,global longitudinal strain,1
Diagnostic Test,eeg,1
Diagnostic Test,examinations for the research:,1
Diagnostic Test,euroimmun assay,1
Diagnostic Test,ep,1
Diagnostic Test,ent exam,1
Diagnostic Test,endothelial damage and angiogenic biomarkers,1
Diagnostic Test,elispot: detection of the t cells specific to different sars-cov-2 proteins,1
Diagnostic Test,elisa-test for igm and igg to sars-cov-2,1
Diagnostic Test,elisa and rapid test to detect antibodies against covid-19,1
Diagnostic Test,electronic stethoscope,1
Diagnostic Test,electroencephalogram with ekg lead,1
Diagnostic Test,"electrocardiography ,tomographic imaging",1
Diagnostic Test,"electrocardiogram, transthoracic echocardiography and clinico-biological parameters in routine care",1
Diagnostic Test,"electrocardiogram, telemetry, echocardiogram, laboratory values",1
Diagnostic Test,electrocardiogram (ecg),1
Diagnostic Test,electro impedance tomography,1
Diagnostic Test,electrical impedance tomography (eit),1
Diagnostic Test,"elecsys anti-sars-cov-2 s (roche diagnostics gmbh, mannheim, germany), 2) access sars-cov-2 igg ii (beckman coulter, inc. usa)",1
Diagnostic Test,ejaculated semen sample,1
Diagnostic Test,"evaluation of clinical, instrumental and laboratory diagnostics tests",1
Diagnostic Test,exercise physiology,1
Diagnostic Test,generalized anxiety disorder-7 (gad 7),1
Diagnostic Test,exercise test ecg,1
Diagnostic Test,gas exchange measurement,1
Diagnostic Test,fungal rhinosinusitis,1
Diagnostic Test,functional mri,1
Diagnostic Test,fmd,1
Diagnostic Test,flow cytometry: detection of the sars-cov-2 specific t-helpers and cytotoxic t lymphocytes,1
Diagnostic Test,flow cytometry,1
Diagnostic Test,flavor test,1
Diagnostic Test,fingertip tests for poc assays,1
Diagnostic Test,fingerstick,1
Diagnostic Test,filmarray pneumonia,1
Diagnostic Test,filmarray pcr on respiratory samples,1
Diagnostic Test,fibreoptic endoscopic evaluation of swallowing (fees),1
Diagnostic Test,faeces samples,1
Diagnostic Test,face mask sampling,1
Diagnostic Test,exposure: positive covid-19 infection,1
Diagnostic Test,exposure: negative covid-19 infection,1
Diagnostic Test,experiences in close relationship scale questionnaire (ecr-s),1
Radiation,ultra-low-dose radiotherapy,1
